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The thesis is structured as a PhD by publication; however, some of the chapters form an 
individual manuscript that has been submitted for publication. Chapters 2 to 7 have been 
accepted as publications and are displayed as copies. Because it was crucial to discuss the 
literature and brief the rationale for the research in each manuscript (both published and 
unpublished), there may be some common ideas in the introductory and methodology sections 
among the chapters when reading consecutively.  
In relation to this thesis, we employed both the terms ‘pharmacist-led’ and ‘pharmacy-led’ 
equally, but when we intended to refer other supportive staffs such as pharmacy technicians as 
well, we adhered to the latter terminology. In chapters 9 and 10, the term ‘hospital pharmacist’ 
is predominantly utilized to suit the local situation, and to make a distinction between 
pharmacists involved in clinical services and those engaged in dispensing roles.  
All of the empirical research included in this thesis has been approved by both The University 
of Sydney Human Research Ethics Committee (approval No: 2015/818), and the Institutional 
Review Board of the University of Gondar, Ethiopia (O/V/P/RCS/05/624/2016). Ethics 
approvals and associated documentations are supplied as appendices.  
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Abstract 
Medication errors and their adverse outcomes are the most common cause of patient injuries 
in hospitals globally and have important clinical, economic and humanistic consequences. A 
number of medication safety strategies are available for preventing medication misadventures. 
Medication reconciliation is the safety strategy usually called for, to prevent medication errors 
that occur at care transitions. This strategy has been adopted as a standard practice in many 
developed countries. However, in Ethiopia, there were no published studies on medication 
reconciliation, nor evidence-based interventions aimed to tackle the burden of medication 
errors and subsequent patient harm. This thesis explores the journey to medication 
reconciliation service implementation as a medication safety strategy in Ethiopian public 
hospitals. Before the journey, however, given the lack of consistent reports regarding the 
impact of this strategy overall, we synthesized the evidence supporting the effectiveness of this 
intervention as a medication safety strategy.  
Pharmacists play a role in providing medication reconciliation. Therefore, the overarching aim 
of this thesis was to evaluate the impact of pharmacist-led medication reconciliation 
intervention and to determine whether this strategy is feasible in resource-limited settings or 
not. Implementation of medication reconciliation is not an ultimate end but sustainability is an 
issue, and this should be corroborated by corresponding changes in attitudes, teamwork, 
communication, culture, and leadership. For this purpose, this thesis was informed by a 
sequence of four separate but inter-related studies. It uses methods from both safety and 
implementation sciences for successful implementation of the medication reconciliation 
program. System approaches to patient safety, such as patient safety culture has been explored, 
and patients’ experiences of medication-related adverse events have been discussed followed 
by an implementation of a theory informed medication reconciliation intervention at hospital 
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admission. This thesis thus, utilized a multi-method exploration of patient safety issues to 
develop, implement and evaluate a medication safety program designed to reduce the burden 
of unintentional medication discrepancies at care transitions.  
Chapter 1 Provides the technical background and the rationale from which the present body 
of work is built up on. A brief explanation of the various medication safety strategies and the 
current evidence for the effectiveness of medication reconciliation interventions have been 
presented. This chapter also elaborates the rationale for conducting this research and a 
description of the overall structure of the thesis.  
Chapter 2 reports the results of a systematic review and meta-analysis that investigated the 
effectiveness of pharmacist-led medication reconciliation interventions on some of the clinical 
outcomes studied, including all-cause mortality, hospital readmissions, emergency department 
hospital visits and composite outcomes, and adverse drug event-related hospital visits. This 
study has demonstrated a significant impact from involving pharmacists in the medication 
reconciliation, and most importantly, it helps to cut adverse drug event-related hospital revisits 
(RR 0.33; 95% CI: 0.20–0.53), subsequent emergency department hospital visits (RR 0.72; 
95% CI: 0.57–0.92) and hospital readmissions (RR 0.81; 95% CI: 0.70–0.95). However, this 
review reveals no evidence that such interventions have an impact on mortality and composite 
all-cause readmission and/or ED visits.    
Chapter 3 presents a systematic review and meta-analysis of the impact of pharmacy-led 
medication reconciliation programs on the burden of unintentional medication discrepancies at 
hospital transitions. Medication reconciliation is a resource-intensive process and it was also 
important to identify areas which suited the best for pharmacists. Of the 1,832 articles screened 
for title and abstract, nineteen studies which involved a total of 15,525 adult patients were 
included. Pharmacy-led medication reconciliation intervention usually revealed a trend 
towards reduction in medication discrepancies, compared with usual care. Compared with 
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usual care, single medication reconciliation interventions at transitions in care (either 
admission or discharge) showed a significant reduction of 66% in patients with medication 
discrepancies (RR 0.34; 95% CI: 0.23–0.50) in favour of the intervention. But, there was no 
difference between groups for interventions targeting multiple transitions (RR 0.88; 95% CI: 
0.77–1.02). Subgroup analyses showed that there were no differences for the target of transition 
(admission vs. discharge), type of intervention (multi-faceted intervention vs. medication 
reconciliation), and setting (single center vs. multicenter), nor pharmacists versus pharmacy 
technicians. Importantly, more clinically relevant and discrepancies of higher impact were 
easily identified through pharmacy-led medication reconciliation programs.  
Chapter 4 is also a systematic review and meta-analysis and addresses the impact of an 
electronic tool on the occurrence of medication discrepancies identified through the medication 
reconciliation process. Medication reconciliation process aided with an electronic tool was able 
to minimize the incidence of medications with an unintended discrepancy, mainly drug 
omissions. However, there was no significant reduction in either the proportion of patients with 
medication discrepancies or the mean number of discrepancies per patient. The clinical impact 
of electronic interventions is also less clear. There was a lack of rigorous designs that ascertain 
these findings, however. Effective medication reconciliation likely requires a multi-faceted 
approach involving people, process, technology and that technology intervention alone may 
not consistently reduce errors. 
Chapter 5 presents a systematic review, and it was a broad exploration of the African 
medication safety literature to have an understanding of the burden of medication errors (MEs) 
and adverse drug events (ADEs) in the African hospital setting. Of the 1,316 articles extracted 
from the various databases searched using a systematic search strategy, fifty-one studies met 
the inclusion criteria; of these, 33 focused on MEs, 15 on ADEs and three studies on MEs and 
ADEs. These studies were conducted in nine (of the 54) African countries. The median (IQR) 
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percentage of patients reported to have experienced ADE-related hospital admissions was 2.8% 
(0.7–6.4 %) in the general population, ranging to as high as 5.5% (1.8–8.0%) in the adult 
population. In these studies, it was reported that many ADEs were deemed preventable. The 
most commonly reported types of MEs were prescribing errors. No studies specifically 
assessing medication history or documentation errors in African hospitals were retrieved. 
Major contributing factors for MEs reported in these studies were individual practitioner 
factors (e.g. fatigue and inadequate knowledge/training), and environmental factors, such as 
workplace distraction and high workload.    
Chapter 6 discusses the study protocol for an Ethiopian study, which aimed to implement a 
new pharmacy service (i.e. medication reconciliation) in public hospitals in one of the regions, 
and describes the methodological approach employed to achieve our primary objectives. The 
project was divided into three phases. The first was a mixed-methods study which was 
undertaken to investigate health care professionals’ perspectives of patient safety and patients’ 
experiences of medication-related adverse events. A cross sectional study, utilizing the 
‘Hospital Survey on Patient Safety Culture’ (Chapter 7) questionnaire was conducted among 
health care professionals working in ten Ethiopian public hospitals. This was complemented 
by semi-structured interviews—along with the qualitative findings from the patient’s 
interview, it is presented in Chapter 8. The second phase was a focus group study, designed 
according to the twelve domains from the Theoretical Domains Framework (TDF), to explore 
the barriers and facilitators to medication safety activities delivered by hospital pharmacists 
(Chapter 9). Lastly, a single center, before and after study to evaluate the impact of pharmacist-
conducted admission medication reconciliation in an emergency ward had been conducted 
(Chapter 10).   
Chapter 7 describes the results of the hospital survey. Of the 480 questionnaires, a total of 410 
were returned (response rate, 85.4%). Patient safety culture in the studied hospitals has been 
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found lower than the benchmark studies. Importantly, understaffing followed by problems 
during handoffs and care transitions and punitive response to error were identified as major 
safety problems. Particularly, handoffs and care transitions were largely affected by the lack of 
teamwork across units, punitive response to error reporting and managerial inaction for 
promoting patient safety.    
In addition to system factors presumed to affect patient safety (also presented in Chapter 7), 
the findings in Chapter 8 identified other factors such as individual HCPs, patient and task 
factors that have been identified as challenges to achieve an optimal patient safety in Ethiopian 
public hospitals. Resource limitations (e.g. material deficiencies, poor infrastructure) have been 
indicated as the greatest barriers for patient safety, and these have been scarcely or not reported 
at all in other similar studies elsewhere. Patients expressed a range of perceived experiences 
related to their medication, and a number of strategies required to improve patient safety 
practices have been suggested. Changes in practice, processes, structure, and systems were 
believed to help improve patient safety in the Ethiopian health care system. For example, 
engaging pharmacists in the multidisciplinary team have been one of the suggestions to 
improve medication safety.  
Chapter 9 presents a range of factors that may influence the uptake of medication safety 
interventions delivered by hospital pharmacists. The results of this study demonstrated that 
hospital pharmacists were very much enthusiastic for medication safety activities and were 
positive towards the future of the profession; however, there were many factors that likely 
influenced their behaviour in the clinical practice. For example, dispensing was thought to be 
a core business by the majority of health managers, and thus, hospital pharmacists were 
reinforced for other competing priorities. There was no remuneration schemes or incentives 
arranged for these clinical services delivered by hospital pharmacists, and because of this, most 
pharmacists preferred dispensing to clinical services, which at the time of this study, entitled 
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for duty payment. Theory-based identification of behavioural determinants affecting hospital 
pharmacists’ engagement in medication safety activities were predominantly related to 
‘Knowledge’, ‘Skills’, ‘Environmental constraints’, ‘Motivation and goals’, ‘Social influences’ 
and ‘Social/professional role’.  
Chapter 10 presents a single center investigation of the impact of pharmacist-led medication 
reconciliation intervention on the incidence of unintentional medication discrepancies before 
and after the implementation of this service. While unintentional medication discrepancies 
were highly prevalent at the time of hospital admission, this study also found that pharmacist-
led medication reconciliation intervention was able to minimize the occurrence of 
discrepancies significantly. Thus, implementation of medication reconciliation as a medication 
safety strategy is feasible, and pharmacists may be regarded as key resource personnel for the 
safe use of medications at the time of hospital admission.  
Chapter 11 contextualizes the main findings from the preceding chapters and proposes future 
research directions. Overall, our intervention has an important clinical implication in the 
Ethiopian health care system where medication history taking are purely assigned to physicians 
or physician interns. Notably, pharmacists may be important resource personnel aiding busy 
physicians in availing complete medication histories important for therapeutic decision at the 
time of hospital admission. However, the sustainability of this service utilization is highly 
dependent on other behavioural determinants, such as knowledge and skill, competing 
priorities, role recognition and reimbursement for clinical services. 
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1.1 Overview 
“To err is human, to cover up is unforgivable, and to fail to learn is inexcusable”. 
                          – Sir Liam Donaldson, WHO Envoy for Patient Safety 
 
Unsafe medication practices and errors are the leading cause of injury and avoidable harm in 
both developed and developing countries [1]. By coincidence, in March 2017, the World Health 
Organization (WHO) launched a global initiative to minimize the incidence of preventable 
medication-related adverse events in all countries by 50% over the next 5 years. This is the 
third global patient safety challenge endorsed by the WHO, following the Clean Care is Safe 
Care challenge in 2005 and the Safe Surgery Saves Lives challenge in 2008. The aim is to 
address the weaknesses in health systems that lead to medication errors and their resulting 
harm. It is believed that most medication harms arise from system failures, mainly in the way 
that care is organized and coordinated, especially when patients going through transitions of 
care. Many of these events occur as a result of poor communication and documentation when 
care is transferred [1].    
Medication reconciliation is recognized as an important approach to the Quality Use of 
Medicines. Quality Use of Medicines generally refers to the judicious selection and appropriate 
choice of medicines, as well as the safe and effective use of medicines that are appropriately 
indicated [2]. Medication reconciliation is a process of effectively communicating changes to 
medication regimens during the transitions in care, and is one of the guiding principles to 
achieve continuity in medication management for the Australian hospitals [2]. Since the last 
decade, this strategy is also being effectively implemented across care transitions in many other 
developed countries and endorsed among various patient safety organizations [3-5]. However, 
implementation approaches varied from place to place, and there were no consistent protocols 
urging service utilization. It has been 10 years since the WHO and collaborators have 
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prioritized medication reconciliation as one of the top patient safety strategies, and it is only 
recently that the medication reconciliation standard operating procedure (SOP) was released to 
the public after it has been tested for its success [4]. Although the WHO encourages member 
countries to adopt medication reconciliation SOP, the impact on patient safety in a resource-
limited setting is not yet explored. Notwithstanding, it is also important to take cognizance of 
the fact that, evidence for effectiveness might not be enough for sustainable patient safety, but 
also highly depends on creating a positive culture for patient safety [4, 6]. Successful 
medication reconciliation implementation requires a culture change within the health care 
organization and works best when patients are actively involved in the process [4, 6]. Prior to 
medication reconciliation implementation, however, it is also imperative to understand the 
existing processes that might affect its success.  
Overall, this thesis is a result of a medication safety initiative that has addressed how 
medication reconciliation interventions effectively optimize patient safety at care transitions. 
The journey to this quality improvement approach was based on a single experience from an 
Australian public hospital and was initiated whether this strategy would be feasible in the 
Ethiopian hospital setting. Specifically, this chapter is a brief introduction of the various 
approaches to medication reconciliation practice and highlights a review of medical literature 
regarding the importance of medication reconciliation when patients transfer across hospital 
care transitions. This chapter also elaborates the rationale for conducting this research and a 
description of the overall structure of the thesis.   
1.2 Definitions and Terminologies in Patient Safety 
Patient safety as a discipline has emerged in response to the high burden of avoidable adverse 
events [7]. Patient safety is an overarching umbrella for which a diverse range of safety issues 
resides in the health care, and it has been defined variously. According to the Institute of 
 Part A – Background                                                                                                             5 | P a g e  
 
Medicine (IOM), patient safety is an important aspect of quality of care and is defined as 
“freedom from accidental injury” [8]. The WHO also defined patient safety as “the absence of 
preventable harm to a patient during the process of health care” [9]. Yet, Vincent 2010 [10] 
provides a broadest, but simplest, definition widely used in the international literature.  
 “The avoidance, prevention and amelioration of adverse outcomes or injuries stemming from 
the process of health care” [10]. 
Given the scope of medication use in patient care and the frequency and severity of potential 
harm, medication safety—defined as the freedom from accidental injury due to medical 
care/errors during the medication-use process—is also equally important, and is an essential 
organizational priority [11]. 
The above definitions go some way, but what is most distinct are the variations in which subsets 
of patient safety issues, such as adverse events, medication errors and adverse drug events are 
defined. For example, an adverse event is defined as an unintended injury that is caused by 
medical management (e.g. injuries resulting from improper or delayed diagnosis, or occurring 
during an operation), and that resulted in measurable disability [12]. Medications are the main 
cause of adverse events, and if such injuries arose, they also termed as adverse drug events 
(ADEs) [12, 13]. However, there are yet various terms employed in patient safety related to 
medication [14]; such terms included medication errors, adverse drug reactions, and potential 
and preventable adverse drug events. Although these terms are inconsistently used in the 
literature, some authors have proposed the relationship between these safety issues related to 
medications (Figure 1.1) (adapted from Morimoto et al 2004 [15]). Briefly, medication errors 
(MEs) may or might not cause patient harm. The term ADE included both adverse drug 
reactions (ADRs), in which harm occurs as a result of intrinsic nature of a medication, as well 
as complications from MEs [13, 15]. The WHO definition of ADR is “a response to a drug 
which is noxious and unintended and which occurs at doses normally used in man for the 
 Part A – Background                                                                                                             6 | P a g e  
 
prophylaxis, diagnosis or therapy of disease, or for the modification of physiological functions” 
[16]. An injury that is the result of ME is classified as preventable ADE whereas a non-
preventable ADE is an injury other than an error—for example, the occurrence of anaphylactic 
reactions in a patient with no known previous history of drug allergy. A potential ADE is a 
medication error with the potential to cause an injury but which does not actually cause any 
injury, either because of specific circumstances, chance, or because the error is intercepted and 
corrected [13, 15]. 
  
 
 
 
 Figure 1.1 Relationship between Adverse Drug Events (ADEs), Potential ADEs, and 
Medication Errors (adapted from Morimoto et al 2004 [15]) 
  
Medication errors further encompass other error categories ranging from prescription error to 
monitoring and can occur at any stage of the medication use process [13]. However, there is a 
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lack of consensus regarding the definition of a medication error. For example, a systematic 
literature review found 26 different terminologies employed for a medication error [17]. The 
wide variation in the prevalence of medication errors in the literature is partly a reflection of 
this lack of consensus. For example, Lisby et al [18] applied a more strict definition to error—
using harm or risk of harm as cut-off point—and applying this definition reduced the number 
of medication errors from 34% to 7%.  In its broadest sense, medication error is defined by the 
National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP) 
as “any preventable event that may cause or lead to inappropriate medication use or patient 
harm while the medication is in the control of the health care professional, patient, or consumer. 
Such events may be related to professional practice, health care products, procedures, and 
systems, including prescribing, order communication, product labelling, packaging, and 
nomenclature, compounding, dispensing, distribution, administration, education, monitoring, 
and use”  [19].  
In the literature, there are various approaches to classifying medication errors [20]. One of the 
approaches is to classify based on the types of errors (e.g. wrong medication, dose, frequency, 
route, and patient). Another approach classifies errors according to whether they occur from 
mistakes made during the planning of actions (knowledge-based or rule-based mistakes) or 
errors in carrying out actions (action-based errors, known as “slips”, or memory-based errors, 
known as “lapses”).  Errors may also be classified according to their level of severity. And, 
yet, another most widely used classification consider the stage at which errors are occurred in 
the medication use process, such as prescribing, dispensing, administration and monitoring 
[20]. 
Of particular relevance, another close term employed in association with prescribing errors is 
a medication discrepancy. There is a difference between the two terms, however. The definition 
of prescribing error adopted by Dean et al [21] stated that, “a clinically meaningful prescribing 
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error occurs when, as a result of a prescribing decision or prescription writing process, there is 
an unintentional significant (1) reduction in the probability of treatment being timely and 
effective or (2) increase in the risk of harm when compared with generally accepted practice”. 
One component of this definition encompasses unintentional prescribing changes and 
transcription errors, which might partly define a medication discrepancy. Overall, medication 
discrepancies—also taken as a measure of medication history errors—are defined as a 
discrepancy between medication history obtained by a physician and a comprehensive 
medication history collected by various medication history sources [22]. Nevertheless, apart 
from discrepancies originated from inappropriately taking medication histories by physicians, 
discrepancies can also occur from the patient side—for example, as a result of lack of 
knowledge how to take appropriately prescribed medication [23].  
It is also of interest, to make a distinction between intentional and unintentional medication 
discrepancies. While the latter is certainly categorized as an error, however, some discrepancies 
could also be deliberate actions following changes in patient’s clinical situation (e.g. intentional 
discontinuation of warfarin following bleeding) [23, 24]. Unlike these categories, however, 
there are inconsistencies in the way medication discrepancies are classified, and sometimes 
medication discrepancy is used interchangeably with other medication safety terms, such as 
prescribing errors [24].    
1.3 The Burden of Medication Errors and Adverse Drug Events 
1.3.1 International Context 
Patient safety has received a significant amount of attention, especially in the last two decades. 
The 1999 publication “To Err is Human” by the Institute of Medicine [8], shed light on 
preventable medical errors and on the importance of safe medical care, and since its release, 
patient safety has become the prominent issue for health care. Later in 2004, the WHO and its 
partners launched the World Alliance for Patient Safety in response to patient safety issues, 
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and its goal was to improve patient care worldwide by proposing measures to reduce risks, 
organizing concepts and definitions on patient safety and suggesting that countries pay greater 
attention to the theme [25].   
Varies studies have investigated the extent of medication errors and adverse drug events. Some 
prior works [11, 26] in the 1990’s have shown that 3.7% of hospitalized patients experienced 
an adverse event, of which one out of five events were due to medication errors [11, 26]. A 
systematic review of relatively recent evidence regarding in-hospital adverse events also 
showed that adverse events during hospital admission affect nearly one out of ten patients, and 
15% of the adverse events were medication-related [27]. In either of these findings, ADEs are 
the second most common cause of patient safety incidents next to operation-related adverse 
events [11, 27].   
Medication errors occur frequently in the hospital environment, but only a few tend to actually 
cause ADEs [12]. In one inpatient study in the US [12], the frequency of medication errors was 
5.3 per 100 medication orders, which is much higher than the ADE rate of 0.25 per 100 orders. 
Inversely, it is only one-fifth of the medication errors that result in adverse drug events [12].  
Not only are medication errors and medication-related adverse events frequent but also are 
responsible for considerable patient harm [28–30] and undoubtedly costly [31, 32]—to 
patients, families, and to the society as whole—but, these are often preventable. For example, 
epidemiological studies in high-income and transitional countries estimated an ADE incidence 
of 6.5 to 12 per 100 admissions, and nearly 28–48% of these ADES are deemed preventable 
[28–30, 33]. Again, in 2007, the Institute of Medicine (IOM) estimated that a hospitalized 
patient in the US experience at least one medication error per day [34], and a recent WHO 
report showed that medication errors are the cause of at least one death every day, and injure 
1.3 million people annually in the USA alone [1], and yet, a quarter of medication-related 
injuries can be prevented [34]. In another systematic review of medication safety literature in 
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Australia suggested that at least two medication errors occur for every three patients at the time 
of admission to hospital, and medication-related problems are the cause of 2–3% of hospital 
admissions resulted in nearly 230,000 admissions per year, costing the Australian health care 
system $1.2 billion per annum [35]. Similar rates of adverse drug events have been reported 
from low-and middle-income countries as those of high-income countries; however, the impact 
is about twice as much in terms of the number of years of healthy life lost [36], and the global 
cost associated with medication errors has been estimated at $42 billion USD annually [1].   
Preventable ADEs occurred most often at the stage of prescribing (56%) [28], and prescribing 
errors overall, are the most frequent types of medication errors, occurring in 7% of medication 
orders, 50% of hospital admissions and 2% of inpatients [37]. Over a quarter of hospital 
prescribing errors can be attributed to incomplete medication histories at the time of admission 
[38]. Data have also shown that interfaces of care are particularly high-risk points for 
medication errors as patients transitioning between episodes of care—for example, more than 
half of the medication errors occur at transitions of care [39], and nearly one-fifth of the adverse 
drug events result from errors at interfaces of care [40]. Numerous studies have identified poor 
communication and failure to reconcile medication history at points of patient transfer as a risk 
for medication errors when patients move across transition of care [41–44].  For example, a 
systematic review of 22 studies found that discrepancies between physician-acquired 
prescription medication histories and comprehensive medication histories at the time of 
hospital admission are common, occurring in up to 67% of cases [22].  Care transitions are also 
recognized as vulnerable points for medication-related adverse events because non-intentional 
changes to medications are common and can result in a huge utilization of health care resources 
[45–47]. Medication reconciliation as a strategy to prevent such types of incidents is now 
widely acknowledged and implemented by many hospitals in the developed countries, and to 
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a lesser extent, in the developing nations. This will be explored in detail in Section 1.6 of this 
chapter. 
1.3.2 African Context   
While the issue of patient safety in countries of Africa is not new, there has been a lack of 
relevant policy and regulations that enforce medication safety monitoring [48], partly because 
of lack of good data. In most settings, programs to improve patient safety are not in place 
although the scale of the problem is not different from other reports. Although there is relatively 
little evidence regarding the burden of MEs and ADEs in this continent, few previous studies 
have shown that 4.5–8.4% of all hospital admissions are medication related, of which 1.5–6.3 
% of patients were admitted as a direct result of ADRs [49, 50]. And, it is only recently that 
studies in this regard are emerging in Ethiopia. Yet, the burden of this problem is believed to 
be a public health concern. Two recent ADE studies on the paediatrics have shown an ADE 
incidence of 7.3–9.1% of all paediatric admissions, and notably, nearly one-third to half are 
possibly preventable [51, 52].   
1.4 Conceptual Approaches to Patient Safety  
The 1999 report by the Institute of Medicine (IOM) proposed the application of human factors 
and systems engineering as methods of closing the quality chasm [8]. According to the Human 
Factors and Ergonomics Society [53], ‘‘Human factors (or ergonomics)  is the scientific 
discipline concerned with the understanding of the interactions among humans and other 
elements of a system, and the profession that applies theoretical principles, data and methods 
to design in order to optimize human well-being and overall system performance”.  Carayon et 
al [54] elaborate many reasons to the lack of measurable improvement in patient safety, 
including lack of reliable data on patient safety at the national level and organizational level, 
difficulty in engaging clinicians in patient safety improvement activities and challenges in 
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redesigning and improving complex health care systems and processes. The authors deduce 
part of the problem is due to human factors and systems engineering, and suggest that 
increasing the links between the health sciences and human factors and systems engineering is 
vital to improve patient safety [54].   
The application of human factors engineering in reducing human error and harm to patients is 
well recognized [55]. This needs, however, an understanding of the nature of human errors and 
error management approaches. According to Reason [56], for example, suggests two 
approaches to error management: the person approach and the system approach. Each of these 
approaches has its model of error causation, and therefore, giving rise to different thoughts 
about error management. The person approach of human errors focuses on the unsafe acts—
errors and procedural errors—arising primarily from mental processes such as inattention, 
forgetfulness, carelessness, poor motivation, negligence, and recklessness. The person 
approach focuses on errors of individuals, and this result in practices such as blaming and 
punishment of the person who committed the error, and because of this anticipated actions, 
medication errors are not fully reported. On the other hand, the system approach assumes that 
humans are fallible and are prone to errors, even in the best organizations. Errors are seen as 
consequences rather than causes, existing in the organizations and organizational processes. 
The system approach concentrates on the conditions under which individuals work and tries to 
build defences to avert errors or mitigate their effects.  
Although much of the current emphasis in patient safety is of systems factors, considering the 
personal approach is also important. For example, in a study of prescribing errors using human 
error theory, Dean et al [57] reported that 57% of errors are due to lapses, whereas 39% are 
due to mistakes. This implies that patient safety can only be improved if the factors needed to 
deliver care and those interacting with them should be targeted together.  
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In today’s health care system, patients are experiencing a growing number of transitions of 
care. Care transitions occur when patients are transferred from one care setting to another, from 
one department to another within a care setting, or from one care provider to another [39]. This 
time of transition is considered a high-risk area because of fragment of care or poor 
communication [41–44], and thus, successful care transitions require safe and effective 
interactions of people with their environment [54]. The time when patients are transitioning 
from one setting or provider to another, involves a series of interactions of the patient and the 
health care provider with a task (e.g. information sharing), other people, tools and technologies, 
and a physical, social and organizational context (Figure 1.2) (adapted from Carayon et al 2010 
[54]).   
 
Figure 1.2 Human Factors Model of Interactions (adapted from Carayon et al 2010 [54]) 
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Adherents of the system approach strive for a comprehensive management program aimed at 
targeting the person, the team, the task, the workplace, and the institution as a whole [56]. 
Vincent and colleagues [58] proposed a framework for analyzing risk and safety in clinical 
medicine based on Reason’s model of accident causation [56]. This framework identifies seven 
categories of system factors that can influence clinical practice: institutional context, 
organizational and management factors, work environment, team factors, individual (staff) 
factors, task factors, and patient characteristics. This framework has been used by many authors 
to investigate safety incidents [57, 59, 60].   
The other critical factor, aligned with system approach, important for creating high-reliability 
health care organization is patient safety culture [61]. The Institute of Medicine (IOM) 
suggested that the biggest challenge to moving toward a safer health care system is changing 
the patient safety culture from one in which individuals are blamed for errors to one in which 
errors are treated as opportunities to improve the system and prevent harm [6]. Patient safety 
culture is defined as “a holistic snapshot of enacted norms, policies, and procedures related to 
patient safety that guide the behaviours, attitudes, and cognitions of care providers” [62]. There 
is evidence that links an association between patient safety culture and patient outcomes, 
including reduced adverse events and mortality [62]. Establishing a culture of safety is an 
important pre-requisite for patient safety programs [6], and in many of the health care 
organizations, there is a growing recognition of the importance of establishing a culture of 
patient safety [63–65].    
Patient-centred care has also emerged as a key principle for quality and patient safety [6, 55]. 
The Institute of Medicine (IOM) in its report, suggested that patients and their families should 
be informed about uncertainties, risks, and treatment choices [6]. It also stresses that safety and 
quality should be seen from the perspective of the eyes of patients as well.   
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In general, ADEs in all health care settings may arise from a combination of patient, provider, 
and health care system factors, and is a result of both proximate and latent factors (Figure 1.3). 
While proximate factors  included  those  that  involve  the  patient  and/or  provider, latent key 
determinants that may contribute to ADEs are classified as systemic, organizational,  or  
technical factors (adapted from the US, Department of Health and Human Services [66]). 
 
 
 
  
Figure 1.3 Fishbone Diagram – Selected Determinants of Preventable ADEs (adapted from the 
US, Department of Health and Human Services [66])  
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1.5 Medication Safety Strategies  
While root-cause analysis is an important approach to take preventive measures, it is also vital 
to explore available evidenced tools in the literature that are widely employed to improve 
medication safety by many health care organizations. Various medication safety strategies have 
been recommended for hospital care. For example, prescribing errors may be minimized by the 
introduction of computerized order entry systems [67, 68], by pharmacist participation in ward 
rounds [69], and by introducing standardized medication prescription chart [70]. Besides these, 
another systematic review of strategies employed to mitigate medication errors in an 
emergency department included medication-error reporting, automated dispensing cabinets, 
bar-coding systems, medication reconciliation, standardizing medication use processes, and 
education [71]. Preventing medication errors and ADEs require specific strategies to ensure 
patient safety at each stage of the medication use process [72]. Each of these stages represents 
a possible risk-point, and the following table lists the various strategies to combat the risk of 
medication errors at all steps in the medication use process (Table 1.1) (adapted from the 
Agency for Health care Research and Quality (AHRQ) [72]).  
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Table 1.1 Medication Safety Strategies Employed at Each Stage of the Medication Use Process 
(adapted from the Agency for Health care Research and Quality (AHRQ) [72])  
 Stage          Safety strategy 
Prescribing  Computerized provider order entry, especially when paired with clinical 
decision support systems 
 Medication reconciliation at times of transitions in care 
 Avoid unnecessary medications by adhering to conservative prescribing 
principles 
Transcribing  Computerized provider order entry to eliminate handwriting errors 
Dispensing  Clinical pharmacists to oversee medication dispensing process 
 Use of "tall man" lettering and other strategies to minimize confusion 
between look-alike, sound-alike medications 
Administration  Adherence to the "Five Rights" of medication administration (Right 
Medication, Right Dose, Right Time, Right Route, Right Patient) 
 Barcode medication administration   
 Minimize interruptions to allow nurses to administer medications safely 
 Smart infusion pumps for intravenous infusions 
 Patient education and revised medication labels to improve patient 
comprehension of administration instructions 
 
 
Regardless of the strategies implemented, however, the prevention of medication errors rests 
up on the development of a systems-oriented approach to medication errors, creating a culture 
of safety, and improving medication error identification and reporting [72].  
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1.6 Medication Reconciliation as a Medication Safety Strategy 
Numerous studies have identified the extent and nature of medication discrepancies between 
the medications patients were taking prior to admission and their prescribed medication on 
admission to, and discharge from hospital [22, 41–44]. Medication reconciliation is the safety 
strategy frequently called for, to prevent unintentional medication discrepancies that occur at 
care transitions [3]. In 2006, the WHO Collaborating  Centre for Patient Safety [4] included 
medication reconciliation as one of the five standardized patient safety solutions—also known 
as ‘high 5s’—to achieve measurable, significant, and sustainable reductions in challenging 
patient safety problems. Collaborative countries in the current list are Australia, Canada, 
France, Germany, the Netherlands, Singapore, Trinidad and Tobago, and the USA and UK. 
Recently, the WHO [1] also launched a global medication safety initiative to minimize the 
incidence of preventable medication-related adverse events, and this initiative’s main focus is 
to address the weaknesses in health systems that lead to medication errors and ADEs. It is 
believed that most medication harms arise from system failures, mainly in the way that care is 
organized and coordinated, especially when patients going through transitions of care. The 
majority of these events can be prevented through a formal medication reconciliation process. 
According to the Institute for Health care Improvement [5], medication reconciliation is 
defined as:  
“The process of creating the most accurate list possible of all medications a patient is taking—
including drug name, dosage, frequency, and route—and comparing that list against the 
physician’s admission, transfer, and/or discharge orders, with the goal of providing correct 
medications to the patient at all transition points within the hospital”. 
The WHO High 5s medication reconciliation standard operating procedure (SOP) describes the 
guiding principles for effective implementation of medication reconciliation [4]. The basis for 
effective medication reconciliation is the development, maintenance, and communication of a 
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complete and accurate medication list throughout the continuum of care. Gathering the Best 
Possible Medication History (BPMH) within 24 hours of hospital admission is the first step in 
the process (Figure 1.4) (adapted from WHO [4]), and once this step is completed, identified 
discrepancies should be communicated to the prescriber. Creating the BPMH involves using a 
systematic process for obtaining a medication history, and verifying medication information 
with one or more sources, as appropriate. The BPMH is more comprehensive than a routine 
primary medication history taken without all information available. The sources of medication 
history include: 
1. Patient/family medication interview where possible. 
2. Other sources of information include: 
– Contacting community pharmacists, physicians and/or home care providers 
– Inspection of medication vials/patient medication lists 
– Government medication database 
– Previous patient health records 
 
Figure 1.4 The Four Steps in the Medication Reconciliation Process (adapted from WHO [4]) 
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1.6.1 Approaches to Medication Reconciliation 
Various approaches have been suggested to improve medication reconciliation. Several types 
of information technologies have been in use to support the medication reconciliation process. 
For example, integration of electronic medication reconciliation tools into an internally 
developed computerized order entry system [73, 74] have been found effective, and such tools 
have been reviewed [75]. Shared electronic health records have also been proposed to facilitate 
the medication reconciliation process [76].     
Education of prescribers has been suggested to reduce errors in recording of medications at the 
time of admission to hospital [77], and this approach alongside with other quality improvement 
methods, such as the introduction of medication documentation templates for electronic 
prescribing led to a sustained increase in reconciled medications [78]. There are also other 
studies that used standardized documents, such as the introduction of medication report or 
reconciliation form [79, 80] and developing a limited list of standardized questions [81] that 
seemed promising in reducing the incidence of errors.  
Patient engagement in the medication reconciliation process is one of the best strategies to 
prevent medication discrepancies and is now highly recommended [82]. As patients are the 
primary sources of medication history, patient counselling regarding their medication helps 
identify clinically meaningful discrepancies and improves the quality of medication history 
[83], but if this is hindered by limited health literacy, a significantly higher number of 
medication discrepancies are likely [43]. 
Many studies have evaluated the impact of pharmacists in medication reconciliation [84, 85], 
and the role of collaborative models, such as pharmacist-physician, or pharmacist-nurse 
collaborative medication reconciliation have also been explored as well [45, 46]. The 
medication reconciliation process is a shared responsibility of health care professionals in 
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collaboration with patients and families. It requires a team approach including pharmacists, 
physicians, nurses, pharmacy technicians and other health care providers [4].  
 
1.6.2 Evidence for Effectiveness of Medication Reconciliation    
Many observational studies have confirmed that medication errors at care transitions are 
common, and potentially clinically important. For example, Cornish et al. [42] conducted a 
prospective study of 151 patients admitted to a general ward in a tertiary care teaching hospital, 
using at least 4 regular prescription medications, and has found that 54% of the patients had at 
least one unintended discrepancy between home medications and admission orders. The most 
common discrepancy (46%) was an omission of a regularly used medication, and that 39% of 
discrepancies were judged to have the potential to cause moderate to severe harm. In some 
other selected studies, at least one unintended medication discrepancy has been identified in 
16.8–60% of patients [86–94] (Table 1.2).  
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Table 1.2 Prevalence of Unintentional Medication Discrepancies in Selected Studies  
Abbreviation: ED, emergency department  
  
 
There are a number of hospital-based studies and medication safety initiatives in the USA [73], 
Spain [74], New Zealand [77], Canada [79], Sweden [80], Belgium [81], the Netherlands [83, 
84] and Australia [85] have shown the impact of medication reconciliation in reducing 
medication errors and adverse drug events. For example, a 2012 systematic review [95] of 26 
hospital-based medication reconciliation studies have shown that medication reconciliation 
intervention has resulted in a reduction in medication discrepancies in 17 of 17 studies, 
Author, Year Country, Setting Study design Target of 
intervention 
Medications assessed Patients with at least one 
unintentional discrepancy 
Abu Yassin 2011  
[86] 
Saudi Arabia, 
tertiary referral 
hospital 
Prospective  Admission Prescribed and OTC 
medications, herbal and 
other supplements 
37%    
Allende Bandres 
2013 [87] 
Spain, tertiary 
care hospital 
Retrospective Admission, 
discharge 
Prescription 
medications 
16.8%   
Bahrani 2014 
[88] 
Sweden, internal 
medicine wards   
Prospective  Admission Prescription 
medications 
46%    
Coffey 2009 
[89] 
Canada,  tertiary 
care children’s 
hospital 
Prospective  Admission Prescription and OTC 
medications 
22%      
Gleason 2010 
[90] 
USA, University 
hospital 
Prospective Admission Prescription 
medications 
35.9%    
Grimes 2008 
[91] 
Ireland, academic 
teaching hospital 
Prospective Discharge  Prescription 
medications  
40%    
Manias 2009 
[92] 
Australia, referral 
hospital 
Retrospective   ED Any medications 34.8%    
Vira 2006 
[93] 
Canada, 
community 
hospital 
Prospective Admission 
and 
discharge 
Prescription 
medications 
60%   
Wong 2008 
[94] 
Canada, tertiary 
care teaching 
hospital 
Prospective Discharge Prescription 
medications 
41.3%     
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potential adverse drug events in 5 of 6 studies, and adverse drug events in 2 of 3 studies. 
However, the impact on post-discharge health care utilization was uncertain. In the contrary, a 
2013 systematic review focusing on clinically significant medication discrepancies by Kwan 
et al [96] noted that most medication discrepancies appeared to have no clinical significance, 
and the impact of medication reconciliation on reducing clinically significant discrepancies 
was unclear. On the other hand, both reviews [95, 96] agreed that the actual clinical impact of 
medication discrepancies after discharge appears to be small, and therefore, medication 
reconciliation alone does not seem to reduce emergency department visits or readmissions 
within 30 days. Again, both noted that most successful interventions were those that involve 
pharmacists in the process.  
1.7 Rationale of This Study 
The majority of the works on the scale of MEs and the impact of medication reconciliation on 
the incidence of such errors have been studied in the Western countries. While patient safety 
is a global public health priority which calls for appropriate actions, the burden of MEs and 
ADEs is expected to be higher in developing countries [9, 36], including the Africa region, due 
to resource limitations, such as infrastructure, human resource, and technologies. The African 
Partnerships for Patient Safety and the guideline for developing national patient safety policy 
and strategic plan assist African countries in developing comprehensive actions for patient 
safety, including medication safety, yet, little data are available and research has not been done 
in many resource-poor settings. It has been suggested that studies should be conducted to 
measure the extent of inappropriate use of medications, adverse drug events, and medication 
errors, and each institution should implement national mechanisms to reduce the burden of 
ADEs and MEs [9]. Particularly, there is a lack of medication reconciliation studies in Africa, 
and this thesis explores medication reconciliation as a medication safety strategy in Ethiopia.  
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Although individual medication reconciliation studies conducted elsewhere have been found 
to be effective in reducing the burden of medication errors and discrepancies, it is unclear which 
approaches to medication reconciliation are effective, and who shall be responsible for 
medication reconciliation is still debatable. Previous reviews [95, 96] have shown inconsistent 
findings regarding the impact of medication reconciliation on the incidence of medication 
discrepancies, although both agreed that the impact on post-hospital resource utilization was 
uncertain. Most successful medication reconciliation interventions are due to pharmacist’s 
involvement [95, 96], and yet, the impact on both process and clinical outcomes are largely 
unknown. Given that, at least three disciplines are involved in the medication reconciliation 
process—medicine, pharmacy, and nursing—with little agreement on each profession’s role 
and responsibility for the process [97], and thereby, it is unclear who should take overall 
responsibility for maintaining an accurate medication list. This thesis explores the impact 
pharmacists could bring as a result of their involvement in the medication reconciliation 
process. Alternatively, information technology (IT) provides an opportunity to improve 
medication reconciliation; however, the role of IT and its effectiveness in the reconciliation 
process is not yet clearly determined. Thus, technology solutions to the process have also been 
dealt.  
The initial inception of this project began from anecdotal experiences in the local hospital 
setting; that is, in a tertiary care hospital in Ethiopia. Physician colleagues usually recommend 
pharmacists to take medication history in order to consult patients regarding their medication 
use because physicians noticed that most patients’ understanding of their medication was 
relatively scanty. Since the time when this was communicated, I and my colleagues 
(pharmacists) were new to medication reconciliation practice, and we did not have the know-
how to conduct this, and there existed a lack of understanding of the importance of medication 
reconciliation. However, experiences from Australia showed that the role of medication 
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reconciliation is well acknowledged, and is one of the standards of practice for clinical 
pharmacy services [98]. For example, I and my colleagues in Australia have assessed the extent 
of antibiotic documentation in the transition from intensive care unit (ICU) to wards in one 
metropolitan hospital in Sydney and found that the duration of antibiotics was infrequently 
documented (Appendix 1). This was another lesson I had taken from this study that led to the 
conceptualization of medication reconciliation as a medication safety initiative project for the 
past three years. Besides the antimicrobial stewardship pharmacist, the findings of the 
Australian study were communicated to intensivists and microbiologists with a suggestion to 
include a box on the ICU discharge summary which specifically relates to antibiotics and their 
plan when patients are transferred to wards. In the Australian context, pharmacists are integral 
to the multidisciplinary team and are providing clinical services for years, including medication 
reconciliation. However, pharmacist involvement in patient care is a relatively new concept in 
Ethiopia. Thus, we hypothesized the introduction of medication reconciliation in resource-
limited settings might be beneficial, and this thesis aimed to determine the impact of pharmacist 
conducted medication reconciliation intervention in such settings. 
Introducing medication reconciliation is not a sharp end but it should be supported by 
corresponding changes in attitudes, teamwork, communication, culture, and leadership. 
According to the WHO High 5s medication reconciliation program [4], the culture of the 
organization with respect to interdisciplinary collaboration and teamwork significantly 
influence the effectiveness of the medication reconciliation process, and this has to be explored 
to look at the changes necessary to improve patient safety. This thesis uses methods from both 
safety and implementation sciences for successful implementation of the medication 
reconciliation program. For example, ensuring a culture of safety and organizational support 
for safety processes are key to patient safety improvement, and using a system approach is vital 
to identify factors that influence patient safety, but little is known in Ethiopia. Using a theory 
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to identify the many determinants of the behaviour to be changed (e.g. lack of skill to conduct 
medication reconciliation) before an implementation of a medication safety program, provides 
a robust evidence-base for its success [99], which has been rarely explored in similar studies 
elsewhere.  
Overall, this project is a medication safety initiative focusing on medication reconciliation 
intervention, and the implementation of this initiative is guided by a multi-method approach 
consisting both qualitative and quantitative methods. This overarching aim can be further 
broken down into the following objectives:   
1. To systematically investigate the current evidence to support the effectiveness of 
medication reconciliation interventions 
2. To assess the African medication safety literature on the extent and nature of 
medication errors and adverse drug events 
3. To assess the views and perceptions of health care professionals about patient safety 
and patients’ experiences of medication-related adverse events in Ethiopian public 
hospitals 
4. To identify the barriers and facilitators to hospital pharmacists’ engagement in 
medication safety activities 
5. To investigate the impact of pharmacist-led medication reconciliation interventions on 
the occurrence of unintentional medication discrepancies before and after 
implementation 
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1.8 Thesis Structure  
The aims of this thesis were to explore patient safety culture and patients’ experiences of 
medication-related adverse events and to develop, implement and evaluate a theory-informed 
medication reconciliation intervention, with the aim of minimizing the incidence of 
unintentional medication discrepancies at hospital admission. 
This thesis consists of eleven chapters presented in four parts (Figure 1.5).  
Part A (Chapters 1 to 5) provides the technical background and the rationale from which the 
thesis is built up on, and consecutive literature reviews. Chapters 2 to 4 present systematic 
reviews and meta-analyses of the effectiveness of pharmacist-led and electronic medication 
reconciliation interventions, and the fifth chapter is a systematic literature review of the 
epidemiology of medication errors and adverse drug events in African hospitals.                  
Part B (Chapter 6) describes the study protocol and research methods used in the remaining 
studies which sought to address the aforementioned objectives. This chapter elaborates the 
methodological approaches used in the study, including the behavioural change theory; that is, 
the theoretical domains framework, which had been employed to identify the barriers and 
facilitators to medication safety activities, performed by hospital pharmacists, and was used as 
a foundation for the development of successful medication safety programs, including 
medication reconciliation.           
Part C (Chapters 7 to 10) details the findings of this project. The quantitative results are 
presented in chapters 7 and 10, whereas the qualitative findings are described in chapters 8 and 
9.   
Part D (Chapter 11) briefly summarizes the main findings of this study, provides the main 
conclusions of the research and potential directions for future research.  
Figure 1.5 outlines the overall structure of this thesis.   
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Part A: Background 
Chapter 1: Introduction and thesis structure 
Addresses the impact of medication reconciliation on clinical outcomes and medication errors, particularly through 
pharmacists’ participation and technology support. Also, we explored the extent of medication-related problems 
including errors and adverse drug events in Africa hospital setting  
 
Chapter 2 
Effectiveness of 
pharmacist-led medication 
reconciliation programmes 
on clinical outcomes at 
hospital transitions: a 
systematic review and 
meta-analysis 
Chapter 3 
Pharmacy-led medication 
reconciliation programmes 
at hospital transitions: a 
systematic review and 
meta-analysis 
Chapter 4 
Impact of electronic 
medication reconciliation 
on medication 
discrepancies at hospital 
transitions: a systematic 
review and meta-analysis 
Chapter 5 
Adverse drug events and 
medication errors in 
African hospitals: a 
systematic review 
 
Part B: Study protocol and research methods 
Chapter 6 
Medication reconciliation as a medication safety initiative in Ethiopia: a study protocol 
 
Part C: Research findings 
Chapter 7 
Hospital survey on patient 
safety culture in Ethiopian 
public hospitals: A cross-
sectional study 
Chapter 8 
Health care professionals’ 
perspectives of patient 
safety culture and patients’ 
experiences of medication 
related adverse events  
Chapter 9 
Barriers and facilitators to 
by hospital pharmacists’ 
engagement to medication 
safety activities: A 
qualitative study using the 
TDF approach 
Chapter 10 
Evaluation of the impact of 
pharmacist-led medication 
reconciliation service: A 
single center pre-post study 
 
 
Part D: Discussion and conclusion 
Chapter 11 
Discussion, conclusion and future directions 
Figure 1.5 Thesis Structure 
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8.1 Abstract    
Background:  Patient safety has received international attention over the last two decades; 
however, there are limited reports from Africa. This study aimed to explore health care 
professionals’ perspectives on patient safety and patients’ experiences of medication-related 
adverse events in public hospitals in the Amhara region, in Ethiopia. 
Methods: A Hospital Survey on Patient Safety Culture (HSOPSC) questionnaire was 
administered to the 480 health care professionals (HCPs) working in ten public hospitals in 
Ethiopia. This included free-text comments about patient safety, incident and error reporting 
systems. Semi-structured in-depth interviews with HCPs were conducted. Patients were also 
approached to be interviewed about their experiences of perceived medication-related adverse 
events. Data were analysed using content analysis.   
Results: Of the 410 questionnaires received, 132 health care professionals included free-text 
comments, and a total of 27 semi-structured in-depth interviews were undertaken (including 
19 patients, and eight HCPs). Many HCPs revealed that patient safety incidents were common, 
and most were medication related. HCPs identified 26 factors that influenced patient safety, 
and the data were further merged, resulting in six main themes being identified: ‘work 
environment factors’, ‘organizational and managerial factors’, ‘individual HCPs factors’, ‘task 
factors’, ‘team factors’, and  ‘patient factors’. The greatest barriers to optimal patient safety 
reported were workforce and material deficiencies, physical environment (e.g. poor 
infrastructure) and lack of managerial support for patient safety. Most patients experienced at 
least one perceived medication-related adverse event. Patient’s experiences of medication-
related adverse events did not seem to affect patient’s satisfaction for health services. 
Conclusion: This study showed that patient safety incidents were perceived to be common, 
and many factors were identified as barriers to patient safety. Patients expressed a range of 
experiences related to their medication. 
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8.2 Introduction 
Patient safety is increasingly recognized internationally as a priority for improving the quality 
of patient care [1]. Adverse events in hospitals affect nearly one in ten patients, and some of 
these events are preventable [2]. Medication-related adverse events are the most frequent types 
of adverse events [2] and are associated with prolonged hospital stay, increased economic 
burden and an almost twofold increase in the risk of mortality [3]. Although there is a limited 
data on patient safety literature in the developing countries [4], harm resulting from unsafe 
patient care is thought to be higher in these nations than in developed countries [5].  In Africa, 
this is increasingly viewed as a basic right under the umbrella of universal health care coverage 
and access [6].  
Until recently, most patient safety efforts have been focused on the detection and analysis of 
adverse events. Efforts should also be made to enhance a culture of safety among health care 
professionals to create an approach to prevent adverse events and to create a safe environment, 
where problems can be discussed without fear of retribution [1]. Comprehensive patient safety 
systems, including both a culture of safety and organizational supports for safety processes, are 
key to patient safety improvement. Health care professionals, managers, and patients are 
encouraged to be vigilant in identifying potential or actual errors, taking appropriate measures 
to prevent harm, and disclosing appropriate information on errors that do occur to facilitate 
learning and the redesign of care processes [7]. Patient safety culture is described, according 
to the Agency for Health care Research and Quality (AHRQ) [8], as an understanding of the 
values, beliefs, and norms about what is important in an organization and what attitudes and 
behaviours related to patient safety are supported, rewarded, and expected.  
It has become apparent that health care organizations need to gain a clear understanding of 
patient safety aspects requiring urgent attention and identify the strengths and weaknesses in 
delivering safe patient care [9].  
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Although patient safety and error reduction are the shared responsibility of all health care 
professionals, clinicians rely on patients as a source of evidence for their safety, and patients’ 
engagement in safety initiatives is crucial in achieving higher levels of patient safety [10, 11]. 
Yet, patients may not commonly be involved in reporting adverse events, including 
medication-related events [12]. Examining health care professionals’ perspective of patient 
safety culture and factors influencing patient safety is an initial step, and a shared decision 
between the patient and the health care professional is central to sustainable patient safety 
culture [13]. There is a growing recognition of the importance of establishing a culture of safety 
in health care. Two studies [14, 15] have reported patient safety issues in Ethiopia. While 
research using quantitative methods is necessary to identify and quantitate relevant issues, a 
qualitative methods approach is needed to explore perspectives of health care professionals and 
patients on patient safety and medication-related adverse events.  
8.3 Methods 
8.3.1 Study Setting and Participants 
The study was conducted in the Amhara region of Ethiopia. It is one of the nine regions of 
Ethiopia located in the northern part of the country, with an estimated total population of 
approximately 18 million. This region has 17 public hospitals, 520 health centers, and 2941 
health posts (—also called as satellite health stations) [16]. The Ethiopian health care system 
is challenged by poor health care financing, and it is highly dependent on out-of-pocket health 
expenditure. Out-of-pocket health expenditure (% of private expenditure on health) was 80% 
as of 2011 [17]. Mainly, the population receives health services from public health institutions.  
This study was conducted in 10 conveniently selected public hospitals in the Amhara region 
(four teaching/referral hospitals and six district hospitals). Study participants were recruited 
from these hospitals and included physicians, nurses, pharmacists, other health care 
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professionals (e.g. technicians) and patients. The study was conducted between February and 
August 2016.  
8.3.2 Data Collection 
This qualitative study was performed as part of a larger project, designed to implement patient 
safety programs in a resource limited-setting [18]. The present study [18] aimed at assessing 
health care professionals’ perspectives on patient safety, and patients’ experiences of 
medication-related adverse events through a mixed-methods study comprising a survey and in-
depth interviews. For the survey, we adopted the ‘Hospital Survey on Patient Safety Culture’ 
(HSOPSC) questionnaire developed by the Agency for Health care Research and Quality 
(AHRQ) [19] (Appendix 4.2). This questionnaire consists 42 Likert-scale items that measure 
12 patient safety culture composites, and a section for two outcome variables: overall patient 
safety grade and the number of events reported. This survey includes a collection of socio-
demographic characteristics, and a free-text field for health care professionals to provide 
comments on patient safety, error or incident reporting.   
Purposive and snowball techniques were utilized to identify potential study participants.  
Invitations to participate were sent via letter or email to health care professionals that had 
worked in their hospital for at least 6 months. Patients (aged > 18 years) who were in-hospital 
at the time of data collection and were taking at least two regular medications were also invited 
for interview by a healthcare professional who had been a participant in this study.  A semi-
structured interview guide was used (Appendix 5.6). All interview guides were translated from 
English versions to the local language (Amharic) by two translators who are native speakers 
and working in the health care industry and validated by two of the research team (ABM, DM). 
Informed consent was obtained and we conducted face-to-face interviews at a time and place 
to suit the participants. We encouraged patients to reflect their own experiences of medication-
related adverse events and asked them to describe an example of a known medication-related 
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adverse event they encountered during their hospital visits. We used prompts when necessary 
to encourage further elaboration, and all interviews were conducted by an English/ Amharic 
speaking investigator (ABM). We collected data with each of the two participant groups until 
a point of saturation was reached. The interviews lasted between 20 to 60 minutes for HCPs 
and 15 to 35 minutes for patients. We recorded all interviews using audio-tape with the 
informed consent of participants.   
8.3.3 Data Analysis  
The principal investigator carried out verbatim Amharic transcriptions of all interviews, which 
were then translated into English, and assigned a unique identifier. Texts were analysed using 
a qualitative content analysis as described by Hsieh and Shannon [20]. The current study 
incorporates qualitative data from both text-comments and interview data, and qualitative 
content analysis is best suited for this study as it creates an opportunity for quantification of 
data [21].                                                                      
The first step involved reading of transcripts for overall understanding, and then transcripts 
were coded using conventional content analysis techniques [21]. That is, we highlighted the 
exact words from the text that appeared to capture key words and concepts. We approached the 
text many times, and through the process, labels for codes that reflected the key thought 
emerged. Inter-related or similar codes were then merged into different categories. An 
integrated approach to the coding structure was employed [22], and thus, categories were 
developed inductively and deductively. The categories were also developed taking into 
consideration the main factors affecting patient’s safety proposed by Vincent et al.’s [23] 
multilevel framework (i.e. institutional, organizational and management, work environment, 
task, team, staff, and patient factors). Descriptive statistics were used to summarize the 
demographic data.      
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8.3.4 Ethical Consideration  
The study was approved by The University of Sydney Human Research Ethics Committee 
(HREC) - Project No. 2015/818, and the Institutional Review Board of the University of 
Gondar, Ethiopia (O/V/P/RCS/05/624/2016).   
8.4 Results 
Of the 410 questionnaires received, 132 health care professionals included free-text comments 
related to patient safety, error and incidence reporting. The comments presented here were 
collected from the diverse range of professionals, including nurses, physicians, pharmacists 
and paramedics (e.g. technicians, administrative staffs) across various hospital working units 
(Table 8.1). Additionally, 22 patients and 16 HCPs were invited for an interview; of these, a 
total of 27 semi-structured in-depth interviews were undertaken (19 patients, and 8 HCPs) 
(Figure 8.1). The mean age was 46 (range, 19–79 years) for patients and 30 (range, 26–36 
years) for health care professionals.   
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Table 8.1 Participant Characteristics 
 Characteristics  Number of respondents Percentage of 
respondents (n=132)  
Working unit 
Medical unit 31  24% 
Surgery 13 10% 
Gyn/Obs 14 11% 
Paediatrics 12 9% 
Pharmacy 17 13% 
Laboratory 14 11% 
Others* 29 22% 
Staff position 
Nurses 52 39% 
Physicians 20 15% 
Pharmacists 21 16% 
Technicians 17 13% 
Others** 22 17% 
Years in hospital 
< 1  82 62% 
1 – 5  47 35.5% 
6 – 10  1 1% 
11 – 15  2 1.5% 
16 – 20  0 0% 
≥ 20  0 0% 
Years in current department 
< 1  80 61% 
1 – 5  47 35.5% 
6 – 10  3 2% 
11 – 15  2 1.5% 
16 – 20  0 0% 
≥ 20 0 0% 
Work experience 
< 1  51 38.5% 
1 – 5  65 49% 
6 – 10  12 9% 
11 – 15  1 1% 
16 – 20  2 1.5% 
≥ 20  1 1% 
Working hours per week 
< 20  2 1.5% 
20-39  22 16.5% 
40-59  78 59% 
60-79  16 12% 
80-99  7 5% 
≥ 100  7 5% 
Type of hospital 
District 62 47% 
Teaching or referral 70 53% 
   
 
* Includes departments such as radiology, anaesthesia, orthopaedics, general ward, outpatient 
department, dental clinic, eye clinic; **Includes druggist, anaesthetist, health officer, 
reproductive health specialist, emergency surgeon, dental surgeon, optometrist, anaesthetic 
nurse, clinical ophthalmic assistance 
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 Figure 8.1 Flow Chart of Included Participants 
 
 
 
 
 
 
 
 16 HCPs invited  22 patients invited 
 268 didn’t 
comment 
 No response; 6 
Busy; 2 
3 declined 
 132 HCPS 
provided text-
comments 
 8 HCPs 
interviewed 
 19 patients 
interviewed  
159 People 
included 
 410 HCPs 
returned 
questionnaires 
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Health care professionals’ perspectives on patient safety 
1. Barriers and facilitators to patient safety 
We identified 26 factors that influenced patient safety, and this was further merged, resulting 
in six main themes classified as ‘work environment factors’, ‘organizational and managerial 
factors’, ‘individual HCPs factors’, ‘task factors’, ‘team factors’, and  ‘patient factors’. Seven 
of the 26 factors functioned as both barriers and facilitators, eighteen factors were perceived 
only as barriers, and only one as a facilitator. Table 8.2 presents a summary of the factors 
influencing patient safety, as perceived by the HCPs.  
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Table 8.2 Factors Affecting Patient Safety, as Perceived by Health care Professionals 
 Categories Codes *Number of 
respondents  
Patient safety 
barriers 
Patient safety 
facilitators  
Work environment factors Workforce deficiencies and 
workload 
35 √  
Material deficiencies 34 √  
Physical environment  22  √ √ 
Shift patterns 4 √  
Organizational and 
management factors 
Safety focus 
 
 25  √ √ 
Leadership incapability 9 √  
Political commitment   8 √   
Financial constraints  13 √  
Blame culture 8 √  
Individual HCP factors Lack of adequate knowledge, 
attitude, skills 
19 √  
Staff commitment and 
satisfaction 
14 √ √ 
Professional accountability 5 √ √ 
Task factors  Incident reporting 14  √ √ 
Delay in getting health services 7 √  
Infection prevention 
procedures 
7 √ √ 
Lack of safety protocols 3 √  
Trend prescribing 2 √  
Poor documentation 2 √  
Lack of patient counselling  1 √  
Lack of follow-up 1 √  
Team factors Communication 14 √ √ 
Poor teamwork 13 √  
Lack of supervision 1 √  
Patient factors  Economic constraints 4 √  
Patient involvement   3  √ 
Patient illiteracy 2 √  
* The total number of respondents (from text and interview data) who mentioned the respective 
factors that are perceived to affect patient safety. 
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Work environment 
The majority of HCPs concerned about the lack of enough health care professional, whom able 
to sacrifice himself/herself for patient safety. And, the associated workload, that could also be 
due to the high patient flow, obliged HCPs to engage with routine things, and ended them 
restless. These imply the perceptions of high pressure imposed on them, which could result in 
a lack of time for involving oneself into the patient safety practice, as this is also a time taking 
process. Participants suggested that the health care system should have adequate numbers of 
well-trained health care workers to provide safe quality care. 
“Patient safety is something we have to think about it. With the staffs we have and the spaces 
available for patient admissions greatly impacted the safety of patients. I think this is a general 
comment that should be forwarded to the hospital director or CEO” [Nurse, Gondar university 
hospital]. 
 “It is unthinkable to achieve the best patient safety possible without having enough staffs” 
[Anaesthetist, Debre Markos hospital]. 
In relation to material context, the problem was so vast that the participants expressed 
deficiencies in terms of supplies (e.g. gown, mask, pillow, personal protective materials, and 
mattress), adequate and functional equipment (e.g. CT scan, ultrasound, X-ray), and 
availability of medications, such as antibiotics. Participants also suggested that hospitals should 
have functional equipment and a constant supply of medications in order to enable provision 
of the right treatment at the right time. Also, the unavailability of these services meant that the 
patient should have to look for services out of the hospital, which is usually expensive in the 
studied areas.  
“The other important medication related problem is related to availability. Most of the time 
ceftazidime and antivenom are not available in the hospital pharmacy. So, there is an 
inappropriate excessive cost incurred on the patient as they bought it from community 
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pharmacies. You can imagine a cost for antivenom is 900 birr in the hospital whereas it is 1200 
birr outside. Surprisingly enough, these medications are not available in this hospital” [Nurse, 
Gondar university hospital]. 
Various aspects of the physical environment posed threats to patient safety. There was a strong 
belief among health care professionals that patient safety is about having a safe physical 
environment, including safe infrastructure and cleanliness that create a safe environment for 
patients. A safe environment was characterized as involving well-designed buildings with 
adequate space (e.g. rooms for various services such as patient admissions and waiting area, 
wards, rest rooms, and offices), consistent supply of water and electricity, and furniture (e.g. 
tables, bed). It was also characterized as one which promoted patients’ physical safety by 
maintaining cleanliness. 
“The issue of patient safety is a question for this hospital. Patients are lying on the corridor 
everywhere. I don’t think patients get rid of their disease because of their medication only, it 
also because of other additional psychological treatments” [Nurse, Gondar university 
hospital]. 
Very few people also described as shift changes and schedules were very problematic in 
delivering safe patient care. Unlike the previous two shift system, this was particularly an issue 
after an 8 hour shift endorsed by the Regional Health Bureau; their fear was mostly emanated 
from the provision of incomplete information for the person who going to take over the activity.  
 “…8 hour shift is difficult to hand over the full information from the off going person to the 
ongoing person” [Nurse, Metema hospital]. 
Organizational and managerial factors 
Whereas many HCPs expressed mixed views on the managerial support for patient safety 
initiatives, all described patient safety was something that should be prioritized and involved 
strong leadership. There was, however, a huge gap between what the interviewees agreed and 
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what the administrative staff/leaders were doing. The participants described managers barely 
involved, and there was a lack of commitment to promote patient safety. Their focus was 
mainly on service expansion than working towards improving patient safety, according to 
HCPs. Managers devoted themselves for political acceptance and gave emphasis on unrelated 
matters to patient safety, such as political mobilization of the staffs. And yet, some explained 
their position as a manager was due to their ties with some senior politically affiliated 
individual, and not merit based. 
“Most hospital managers focused whether the customer gets the service or not rather than 
really questioning the customer’s safety is maintained or not, and nobody follows whether the 
patient is getting complete care or not” [Pharmacist, Metema hospital]. 
“Many autocrats are there and are freely paid… no one can freely say about them because 
their relatives may be put on higher/senior management position” [Pharmacist, Debark 
hospital]. 
At the organizational level, financial constraints were mentioned by many HCPs as an 
important factor to the challenge in achieving improved patient safety. The data ascertained 
that these financial problems can extend up to the non-existence of duty programs, and lack of 
incentives and additional benefits for the staffs. They said that these could greatly impact the 
service delivery, and of course, the satisfaction of staffs.  
 “….the hospital partially supports us but we need additional support schemes to strengthen 
our effort. We are doing this service because of our initiative without any additional payment” 
[Pharmacist, Metema hospital]. 
Blame culture was one of the factors influencing patient safety, as perceived by the HCPs. 
There was a strong convergence in views that HCPs were not reporting events due to fear of 
negative repercussions, such as punishment and conflicts at the workplace. Fear of punishment 
was particularly mentioned as a key reason for not reporting patient safety incidents. Openness 
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about incidents, and learned from mistakes were hardly undertaken, and most incidents were 
withheld, with the fear that HCPs who had honestly reported their mistakes were usually 
blamed and/or demoted from their position.   
“It is game to think about patient safety, all personnel does activities by fearing punishment 
from their supervisor, seniors” [Physician, Gondar university hospital]. 
“Most workers do not report errors or events because they fear that they will be responsible 
and questioned” [Pharmacist, Felege Hiowt referral hospital]. 
Individual HCPs factors 
Many HCPs ascertained that there was a severe deficit of knowledge and skills that are 
important for ambitious patient safety initiatives, and few HCPs also believed negative attitude 
towards incident reporting posed a problem on patient’s safety. Yet, there were few HCPs that 
had questioned the quality of professionals, and this was being declined from time to time. And 
thus, training is important to equip the HCPs with the necessary knowledge and skill, and 
sensitization regarding patient safety awareness is part and parcel of the solution. Less 
experienced HCPs, for example, during medication administration might result in 
compromised patient safety and coach them to prevent untoward occurrences were rarely done. 
“I think we need some kind of sensitization to all of the staffs. Besides, whenever there is an 
update on guidelines, it is important to arrange training for the whole staff” [Pharmacist, 
Metema hospital]. 
“For example, if you made the physician to change something he might complain why the nurse 
is doing as such” [Nurse, Gondar university hospital]. 
Participants also noted mixed feelings regarding staffs commitment to quality patient care and 
professional accountability. While most cited that the problems were arose as a result of lack 
of staffs’ interest, various comments were forwarded; to mention a few, running for personal 
benefit, inattentiveness for the patient, and dissatisfaction with the work they were doing. Many 
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added that without the staff being satisfied in the workplace, it was tough to think about quality 
patient care, which in turn, affects the satisfaction of patients. There was also unfairness in 
patients’ treatment, such as taking care of a patient with close social contact but ignoring the 
voiceless. According to participants, there were also very few keen professionals devoted 
themselves for patient safety, even in areas where they are not paid for. 
“The majority runs to have personal benefit and to look like mistake free than for 
questioning/asking/doing for better patient safety directly or indirectly. But few did it” 
[Physician, Gondar university hospital]. 
“Specifically, in the emergency related to triage, emergency is not for an emergency patient 
rather being for those having social contact….Only those having a big family and serious 
people are getting the attention for the service, the calm ones are ignored” [Lab technician, 
Felege Hiwot referral hospital]. 
Task factors 
The majority of the HCPs agreed that patient safety incidents/ errors occurred in their 
workplace, and aware that these were poorly reported. For example, there was no system to 
record and report incidents and there was a view that, because of this, incidents that occurred 
were continually undetected and under-reported. Although there was no robust system for 
incidence reporting including forms and documents, yet, there were few participants expressed 
their view that incidences were rarely occurred, and even when they occurred, they were not 
reported fearing their bad consequences. In the contrary, very few participants pointed out that 
there were staffs engaged in reporting incidents/errors although this was also declining 
recently.  
“We don’t have a culture of reporting when problems occur in a hospital. We are usually 
holding it. As you know the fate of reporting, we don’t have a culture of exposing wrong 
doings” [Nurse, Gondar university hospital]. 
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“No mistakes so far have been reported to me. There is no such type of system. Even if mistakes 
occurred they tend to be held among the health care professionals than being reported” [Nurse, 
Gondar university hospital]. 
Another issue participants rose in relation to task factors were the delay in getting health 
services and procedures related to infection prevention. There were times when patients were 
waiting for a long period of time (more than a week) to get health services, and at times, lab 
results lost, and for services, such as receiving comments for radiology examination, it might 
take up to a day or more. Participants argued that infection prevention was not done 
appropriately, for example, cross contamination was a possibility, and patient transfer of 
specimens without personal protective equipment was a reality. There were fewer participants, 
however, that their hospital had been endorsing proper infection prevention techniques, and the 
incidence of hospital acquired infections was on the verge of declining.  
“There is a delay of lab results because of the shortage of laboratory technicians, 
miscommunications between porters and interns, lab results are repeatedly lost and the patient 
doesn’t get the service timely” [Lab technician, Felege Hiwot referral hospital]. 
Other task-related factors that negatively affect the safety of patients listed were the absence of 
protocols and guidelines for patient safety, trend prescribing, poor documentation, and the lack 
of follow up and patient counselling.   
“Surprisingly enough, the major problems arising are as a result of catching up things as a 
trend and thinking that is appropriate to do that way. But, when we tried to dig out the situation, 
as there was no any scientific evidence for this or there were already changed evidences, rules 
or procedures” [Pharmacist, Metema hospital]. 
Team factors  
Data analysis revealed that communication with colleagues in the workplace could affect 
patient safety, positively or negatively. For example, many believed that patient care is a shared 
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responsibility among the HCPs, and important patient information should thus, be 
communicated. This also paves a way for free discussions regarding patient safety issues, and 
prevents future incidences that might be occurred, and promotes a culture of continuous 
improvement. Participants also believed that HCPs and patients needed to have good 
interpersonal relationships, communication, and cooperation to improve patient safety 
processes and practices. However, many argued that activities were poorly communicated and 
coordinated, teamwork was not prioritized, lack of respect prevailed, and supervision regarding 
patient safety issues was rarely done. 
“There are many obstacles for patient safety, these are: the top managers do not communicate 
well with the health care providers to promote patient safety” [Anaesthetist, Debre Tabor 
hospital]. 
“Most importantly, teamwork is an important thing but usually ignored” [Nurse, Gondar 
university hospital]. 
Patient factors  
The interview data also ascertained patients as factors to the barriers and facilitators to their 
own safety. While financial constraints and illiteracy likely to hinder patient’s safety, patient 
involvement in their care was described as a facilitator to their own safety.  
“What I thought regarding the barriers to medication safety issues is the interaction between 
the pharmacist and the patient. For example, the way you communicate with the patient 
matters. The way they understand might be different from you, and you might think them as 
they understand it. So asking their feedback is very important part of the channel. So receiving 
any feedback from the patient is very important for medication safety” [Pharmacist 2, Debre 
Markos hospital]. 
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2. Common incidents and strategies to improve patient safety  
Beyond the barriers and facilitators to patient safety improvement discussed above, common 
incidents/errors were reported, and suggestions were provided for further enhancing safety. 
Most incidents were medication-related and ranged from minor prescription errors to fatal 
events, such as an overdose of anaesthetics. Apart from medication availability and issues 
related to patient adherence, common incidences as reported by the participants included 
dispensing errors (e.g. atropine was dispensed in place of morphine), wrong diagnosis and 
mismatch between diagnosis and prescribed medication, administering the wrong drugs to the 
wrong patient (e.g. arisen as result of exchange in patient’s name), giving the wrong dose (e.g. 
injecting the wrong dosage and overload of IV fluids), taking a medication for which patients 
are allergic to and/or experiencing serious side effects that need treatment change but were 
actually made to continue, unnecessary and duplication of therapy, the patient is in need of a 
medication but not actually order to take, product defect and drug interactions, and problems 
in writing the prescription including the dose.  
One of the main research questions driving this study was to identify the strategies required to 
enhance patient safety practices, and this was more explored in the in-depth interview. 
Participants identified a range of changes in practices, processes, structures, and systems that 
they believed would help improve patient safety in the Ethiopian health care system. Some of 
the suggestions given were: 
- Involving clinical pharmacists in the multidisciplinary teams 
- Preparing safety protocols, checklists, and guidelines for process evaluation, and 
implementing hospital reform and nursing standards 
- Providing adequate trained human power 
- Improvement of work-place environment (including infrastructure and materials) 
- Instituting leadership for patient safety 
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- Creating positive attitude and awareness of HCPs and hospital managers for patient 
safety 
- Promoting collaboration, teamwork and all stakeholders involvement for patient safety, 
including the patient  
- Allocating a person/team responsible for patient safety evaluation 
- Providing adequate patient education  
Patients’ experiences of medication-related adverse events 
At the time of the interview, patients had been taking medications for their illness for at least 
6 months and for a maximum of 10 years. Most patients’ primary diagnoses were hypertension, 
diabetes mellitus, and heart failure, and the number of medications they had been taking was 2 
to 4. Patients revealed various perceived experiences to their medication; and of these, 14 
patients had encountered at least one medication-related adverse event. These adverse events 
ranged from minor/moderate discomfort, such as heartburn, headache, and dizziness to severe 
events (e.g. unconsciousness). 
“Sometime ago, I was engaged in a heavy duty and unknowingly, I was found unconscious. I 
understood later that it hadn’t been injected in such occasions. I was in the middle of death 
and life! After that, I extremely take caution in the usage of my medications” [Patient 10, Male, 
79]. 
“Even worse I don’t feel good when taking my medicines, it burns my heart” [Patient 11, Male, 
52]. 
“The problem currently is feeling a sense of heart burn, but the medication I was taking before 
didn’t do that” [Patient 6, Female, 35]. 
The majority of patients received medication counselling regarding their adverse impact, and 
had fairly adequate knowledge about their medications and knew why they were taking them. 
However, patients were naive to medication errors or mistakes committed as a result of HCPs 
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during their recent hospital visit. Medication changes were common, and participants believed 
that any changes in their medication brought both negative and positive consequences. For 
example, few participants were very concerned about their medication and questioned whether 
it had added any aggravating effect on their problem. 
“I told my doctors to stop the medication in case I am getting better but they advised me to 
continue it” [Patient 4, Female, 50]. 
“…I was told to drop off all the medications I was taking before…they advised me as the 
medicine I was taking before is not useful for me…they order to take only one medicine…as to 
my thinking this is my problem…if the medicine is not a benefit for me from the beginning, I 
thought it is not good for my health” [Patient 1, Male, 36]. 
Most patients were satisfied with their health services, although those not happy with the 
services were patients perceiving private hospitals were better in maintaining their safety.   
Patient’s experiences of medication-related adverse events did not seem to affect patient’s 
satisfaction for health services, however. Patients had described various perspectives to 
improve their safety, and many of the problems raised were related to high patient flow, 
affordability issues, medication availability, and delay in getting health services. 
8.5 Discussion 
Although unsafe patient care is thought to be higher in the developing nations, less is known 
about patient safety [5]. Investigation of patient safety issues in Ethiopian health care is 
sparsely done and is an area of research that is relatively new. It is only recently that the 
government ratified a five year (2016–2020) strategy for improving quality patient care in the 
nation [24]. The present study provides a wider perspective on patient safety as viewed by both 
HCPs and patients in public hospitals of Amhara region of Ethiopia. 
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As part of the HSOPSC study, we explored HCPs perspectives of patient safety using thematic 
analysis of data that emerged from comments received from the self-administered 
questionnaire, and from an in-depth interview of HCPs. Comments received from HCPs about 
patient safety, including error and incident reporting, and data analysed from an in-depth 
interview of HCPs revealed a significant amount of information about their perceptions of 
patient safety, and the barriers and facilitators that influenced the provision of safe patient care. 
We identified that many HCPs were well aware of patient safety incidents and/or errors but 
rarely reported due to many factors. Six factors that fall at many different levels within the 
health care, ranging from individual health care staffs’ factors and patient involvement to 
organizational context were identified.  
The findings of this study indicated that the greatest barriers for achieving an optimal patient 
safety were workforce and material deficiencies, physical environment (e.g. poor 
infrastructure) and lack of managerial support for patient safety. Most of these factors were 
consistent with the findings reported in previous studies in Ethiopia [14, 15]; however, some 
of the findings such as task factors, and patient factors were scarcely or not reported at all in 
these local studies. Our previous survey showed that, of all the patient safety culture 
composites, staffing received the least score complementing our finding that understaffing is a 
very serious issue that leads to a compromised patient safety. The greatest challenge—lack of 
human resource is not unique to this study, but other similar findings were also observed in 
resource-limited settings, including China [25], Lebanon [26] and Taiwan [27] but received a 
higher rating in the developed nations, such as the USA [28]. There are studies showing that 
heavy nursing workload [29], and lower pharmacy staffing levels [30] adversely affect patient 
safety. Besides nurse staffing levels, Aiken et al [29] also showed that poor nurse work 
environments—a work environment lacking adequate resources, communication, and 
leadership commitment—have a significant effect on patient mortality.    
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Unlike other more developed nations, one of the difficulties and challenges faced by Ethiopian 
health care system is the lack of infrastructure (e.g. rooms for patient admissions), poor 
sanitation, and material deficiencies (e.g. supplies, adequate and functional equipment, and 
medications) for achieving an optimal patient safety outcome. Parts of the problem for all of 
these are interrelated with inadequate government funding and clinical leadership. The 
seriousness of these problems are vast, and in one or the other way, resulting in poor patient 
care, and the problem extends from delaying in getting health services to avoidable patient 
harm. Aveling et al [15] also emphasized in their findings that the scale and impact of material 
deprivation along with the weakness of clinical governance and accountability differentiates 
the findings from high-income countries. Additionally, a lack of management support and 
organizational safety culture were identified by participants in this study as a barrier to patient 
safety in Ethiopian public hospitals. According to the participants, many managers were 
incompetent and not safety conscious, and their primary aim was health service expansion. 
There were yet, managers who devoted their time for the mere purpose of political promotion 
and most appointees were based on political affiliation than clinical leadership. Among the 
participants, there was a strong held belief that without having the appropriate person at the 
right place, it would be tough to achieve what hospitals are striving to do, and it is senseless to 
talk about other problems arisen as result of lack of effective clinical governance. While 
improving patient safety requires adequate resources (e.g. human and material) but these are 
not adequate on their own; also requires managerial support and change in culture and structure 
of governance [31, 32].  
The findings of this study also highlighted individual staff factor considerations, most notably, 
a lack of knowledge, skills, and attitude pertaining to patient safety, otherwise necessary for 
the delivery of safe patient care. The lack of patient safety competencies identified by 
participants encompassed a lack of knowledge and skills pertinent to correctly prescribing 
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medications, administration of injections, and monitoring patients. Although participants noted 
there were few keen staffs committed to sacrifice for patient safety, many did not have interest, 
and usually not happy with what they were doing. Participants, on the other hand, revealed that 
those who adhered to their professional responsibility were the ones who took initiatives for 
improving patient safety. Various task factors were related to patient safety problems, such as 
the absence of incident reporting, not following infection prevention procedures, delay in 
delivering health services, and the lack of safety protocols, patient counselling and follow-up. 
Participants mentioned that poor communication and teamwork, lack of cooperation, respect 
and supervision, together with the lack of an incident reporting system undermine the 
development of a culture of safety in Ethiopian public hospitals. Previous studies [14, 15] also 
showed that inter-professional communication is weak, and this is mostly due to hierarchical 
differences, and patient safety is greatly influenced by the norms and values of professional 
thought and status. These findings also correspond with the findings of studies conducted in 
Sweden [33, 34]. The presence of professional hierarchies reflects that HCPs feel 
uncomfortable, and encounter difficulties to raise their concerns with other colleagues [33].  
An organizational culture that promotes reporting and encourages non-punitive response to 
error and improved communication are reported as important factors to improve patient safety 
culture [34]. However, the participants in our study described that incident reporting was 
infrequently done, when so do, it was usually not documented. 
The HCPs believed that patient involvement in patient’s own safety influenced patient safety 
positively. However, economic constraints and insufficient health literacy negatively impacted 
their safety. These findings were also supported by individual patient interviews. Although 
little is known, there is currently an international move towards patient engagement in their 
care [35]. Yet, this depends on the level of health literacy [36], and findings in our study affirm 
that there were patients who poorly understood their medication and disease, and sometimes 
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they intended to stop their chronic medication. Some patients associated this intention with 
their perceived experiences of medication-related adverse events, and in the contrary, patient’s 
experiences of medication-related adverse events did not seem to affect their satisfaction with 
health services. This might come from the way patients think about their safety; that is, patients 
might associate the medication-related event with the effectiveness of therapy. They might also 
think medication-related adverse events are inevitable occurrences following medication 
taking, and associate their satisfaction with the delivery of other health services (e.g. timeliness, 
affordability, availability). We did not explore the causes of patient’s perceived medication-
related adverse events, but in few patients there seemed a lack of understanding of their 
medication, and at times, medication changes were problematic.   
In the present study, many strategies to promote patient safety have been suggested. The 
multifactorial nature of patient safety barriers and facilitators suggests that patient safety 
solutions are as diverse as their problem [37], and could be directed at various levels, such as 
the health care professional, teams, patients, work environment, and organizations.  Although 
many of the barriers for patient safety in this study were emanated from lack of resources, such 
as human and material, our initiative will not address the broad underlying causes of patient 
safety problems (e.g. inadequate resources), but rather target specific levels, including 
teamwork, communication and process design to prevent medication errors from actually 
reaching the patient [18].           
One of the strengths of this study is, in the previous study (Chapter 7), we depicted that the 
lower scores achieved in the studied areas might not be the direct reflections of the ‘cultural’ 
components but might also be related to resource limitations not addressed in the HSOPSC, 
such as lack of equipment and infrastructure. The HSOPSC as a patient safety measure might 
not exhaustively explore safety issues. However, this study explored patient safety issues from 
the perspectives of both HCPs and patients. Yet, this study has a number of limitations. Text-
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comments were limited in scope as they were collected from a larger hospital-based survey 
(HSOPSC). However, given the anonymous nature of data collected, health care professionals 
were able to provide frank and honest information about patient-safety issues not previously 
discussed, such as political value.  
8.6 Conclusion  
The findings of this study showed that patient safety incidents were common, and many factors 
were identified as challenges to achieve an optimal patient safety in Ethiopian public hospitals. 
Particularly, the greatest barriers to achieve an optimal patient safety were workforce and 
material deficits, the physical environment (e.g. poor infrastructure) and lack of managerial 
support for patient safety. Most patients experienced at least one perceived medication-related 
adverse event. Most patients were satisfied with their health services, although some patients 
perceived private hospitals were better at maintaining their safety.  Patient’s experiences of 
medication-related adverse events did not seem to affect patient’s satisfaction for health 
services. 
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9.1 Abstract 
Background: Hospital pharmacists play a central role in medication safety activities. 
However, in Ethiopia, this role has been launched recently and little is known about the current 
status of this extended services. Using the Theoretical Domains Framework (TDF), we aimed 
to identify the barriers and facilitators to hospital pharmacists’ engagement in medication 
safety activities across various public hospitals in the Amhara region of Ethiopia.   
Methods: Eight focus group discussions, using an interview guide that was drawn upon the 
TDF, were conducted with 44 hospital pharmacists to explore their beliefs regarding their 
involvement in clinical services. Group discussions were audio-recorded, transcribed verbatim, 
and analysed using directed content analysis based on the TDF. Relevant domains were 
identified by applying relevance criteria to each of the domains in the TDF.   
Results: Content analysis revealed six domains that influence hospital pharmacists’ 
engagement in medication safety activities. These domains included ‘Knowledge’, ‘Skills’, 
‘Environmental context and resources’, ‘Motivations and goals’, ‘Social influences’ and 
‘Social/professional role’. Most hospital pharmacists believed knowledge gap was an issue, as 
was the lack of training and supportive skills although some expressed as they were competent 
enough for their skills in identifying medication related problems. Most participants were very 
much enthusiastic for their extended roles, and were positive towards the future of the 
profession; however, competing priorities along with the lack of remuneration and awareness 
(of other health care professionals) regarding the profession’s role were barriers to service 
delivery. There were also a number of resource constraints, such as staffing, infrastructure and 
government funding, and acceptance rate of pharmacist’s recommendation that were likely to 
influence the clinical practice of pharmacists.   
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Conclusion: Using the TDF, this study identified a wide range of barriers and facilitators to 
hospital pharmacists’ engagement in medication safety activities in resource-limited settings.  
There existed considerable interrelationships between domains that were perceived to influence 
hospital pharmacists’ behaviours, and this might assist in designing behaviour change 
interventions that will target common behavioural domains.  
9.2 Introduction  
Medications are the most common health care interventions used to improve the health 
outcome of patients when used safely and appropriately. However, they are also the major 
source of patient safety incidents [1]. The issue of medication safety has received increased 
attention since the publication of To Err is Human: Building a Safer Health System [1] in the 
USA, and is now a concern of many other countries [2–4]. In developing countries such as 
Africa, patient harm from adverse events is thought to be higher than elsewhere the world [5, 
6]. Also, medication errors and adverse drug events in Ethiopia are believed to be significant 
public health problems [7–11], and studies in this regard are increasingly been published.    
Many studies have identified various strategies to improve medication safety in the hospital 
environment, including but not limited to, computerized physician order entry with or without 
clinical decision support [12–14], barcode technology [15], educational sessions [16], and 
pharmacist involvement [17–19]. Specifically, the role of the hospital pharmacist has been 
rapidly evolving beyond the traditional roles of medication dispensing and distribution to 
expanded clinical services [20], and their role in improving medication safety is well 
acknowledged. The hospital pharmacist plays a prominent role in cutting adverse drug events, 
and medication errors [20], and medication safety activities, such as drug use evaluation, 
admission medication histories, adverse drug reaction management, and participation in 
medical rounds are believed to be associated with reduced mortality rates [21]. Also, our 
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previous systematic reviews confirmed the positive impact of pharmacists, particularly when 
pharmacists are engaged in medication reconciliation at care transitions [22, 23]. Unlike the 
developed countries, pharmacists’ involvement in direct patient care is a recent journey in 
Ethiopia [24]. Major changes in the curricula have been made after a 5-year Bachelor of 
Pharmacy (BPharm) with a 1-year clerkship program has been launched in 2009. To date, 
standards and guidelines have been endorsed nationally—for example, the Ethiopian Hospital 
Reform Implementation Guidelines that require pharmacists to deliver direct patient care 
services, and this is taken as a minimum regulatory standard in the health facilities by the 
Ethiopian Standards Authority and the Ethiopian Food, Medicine and Health Care 
Administration and Control Authority (FMHACA) [25]. However, little is known about the 
current status of the implementation of these extended services, as well as the barriers and 
facilitators experienced by hospital pharmacists in delivering patient care services in Ethiopian 
public health facilities. The present study was part of a larger project aimed at implementing 
pharmacist-led medication safety programs (i.e. medication reconciliation) [26], and the 
implementation of this service was guided by a theoretical framework to help identify the 
barriers and facilitators to hospital pharmacists’ engagement in medication safety activities in 
selected public hospitals in the Amhara region, Ethiopia.      
9.3 Method  
9.3.1 Study Setting and Participants  
The study was conducted in eight public hospitals, all located in the Amhara region in the north 
western part of Ethiopia. This region is inhabited by approximately 18 million people and 
comprised of 17 public hospitals, 520 health centers and 2,941 health posts [27]. The Ethiopian 
health care system is challenged by poor health care financing, and close to 80% of the health 
expenditure is dependent on out-of-pocket expense [28], and the population mainly receives 
health services from public health institutions.   
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Pharmacists were recruited from 4 teaching/referral and 4 district hospitals, and there were a 
total of 252 pharmacy staffs (pharmacists, 140; pharmacy technicians, 112) working in the 
studied hospitals at the time of data collection. Of the 140 hospital pharmacists, only 61 were 
involved in direct patient care or clinical pharmacy services and were eligible to be included in 
this study; that is, these pharmacists were either clinical pharmacists or graduate pharmacists 
of the new patient-oriented curriculum or pharmacists with an in-service training on clinical 
pharmacy services. The study was conducted between February and August 2016. 
9.3.2 Study Design 
This is a qualitative study using focus group discussions (FGD). FGDs were employed in this 
study because the interactive nature of focus groups is specifically important when group norms 
and cultural values of particular groups are of interest, and to explore the degree of consensus 
on a given topic [29], including implementation of an intervention to improve medication 
safety. Many factors can affect the adaptability of an evidence based intervention, and the 
success of implementation efforts depends on a careful assessment of barriers to, and 
facilitators of, the behaviour to be changed [30].  A theory based identification of such factors 
provides a theoretically robust evidence base to inform implementation of an intervention [30]. 
The underpinning theoretical model used in this study is the Theoretical Domains Framework 
(TDF). 
Increasing the uptake of evidence into clinical practice and improving patient outcomes needs 
behaviour change. The TDF from health psychology provides the basis for such an approach, 
ensuring that a wide range of possible theoretical explanations for the behaviours can be 
considered. Built from 33 behavioural theories, the TDF was developed to make theories more 
accessible for implementation researchers [31]. According to Michie et al [31], the TDF has 12 
domains to explain behaviour change: (1) ‘Knowledge’, (2) ‘Skills’, (3) ‘Social/ professional 
role and identity’, (4) ‘Beliefs about capabilities’, (5) ‘Beliefs about consequences’, (6) 
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‘Motivation and goals’, (7) ‘Memory, attention and decision processes’, (8) ‘Environmental 
context and resources’, (9) ‘Social influences’, (10) ‘Emotion regulation’, (11) ‘Behavioural 
regulation’ and (12) ‘Nature of the behaviour’. The TDF has been extensively applied across a 
range of clinical behaviours such as prescribing, adverse drug event reporting, and transfusion 
behaviours [32–35].   
  
9.3.3 Data Collection 
In this study, FGDs were guided by questions designed based on the TDF (Appendix 5.6). For 
each of the 12 domains that could act as facilitators or barriers to current medication safety 
practices, the authors developed several interview questions. The number of interview 
questions ranged between 2 and 5 for each of the 12 domains, for a total of 43 questions to 
cover a wide range of beliefs assigned to each domain. The questions were initially drafted by 
one researcher (ABM) and then refined by health service researchers (AJM, JEB) and discussed 
by the research team to check for clinical relevance. Interview guides were translated from 
English versions to the local language (Amharic) by two translators who are native speakers 
and working in the health care industry and validated by two of the research group (ABM, 
DM).  
Initially, pharmacists were selected using a purposive sampling strategy, and this was further 
facilitated with snowball sampling. Selection of participants also considered variations in 
health service structure (teaching/referral and district) to capture a wide range of beliefs in the 
clinical practice of pharmacists. Opportunistically, we also interviewed a mix of hospital 
pharmacists who were attending an in-service training from various public hospitals in the 
region. Participants were recruited by letter invitation, and those willing to participate were 
contacted after a signed consent form had been submitted. The principal investigator (ABM) 
conducted and led the FGDs using the translated version (Amharic) of the topic guide. Prompts 
 Part C – Chapter 9                                                                                                                           181 | P a g e  
were used when necessary and pharmacists were encouraged to talk about their internal beliefs 
and attitudes that may hinder them from providing clinical pharmacy services, including 
medication safety roles. The discussions approximately lasted between 60 to 90 minutes, and 
data were collected until a point of saturation was reached. All discussion sessions were 
audiotaped and recorded.   
9.3.4 Data Analysis    
An Amharic/English speaking investigator (ABM) carried out verbatim Amharic transcriptions 
of all interviews and then translated into English. A coding guide was prepared based on 
previously published definitions [31, 36] and utilized for the purpose of consistent reporting 
(Appendix 8). Using the 12 domains of the TDF as a coding framework, directed content 
analysis of texts into the theoretical domains was performed [37]. Briefly, the analysis involved 
identifying contextualized brief statements related to the barriers and facilitators to medication 
safety activities, categorizing statements into TDF domains and mapping the underlying 
theoretical constructs within domains. The theoretical domains that were judged to be relevant 
were identified by considering the frequencies of the beliefs reported, the presence of 
conflicting beliefs, and evidence of strong beliefs that may influence the behaviour under 
investigation [34]. In establishing domain relevance, all of these factors were considered 
concurrently. Conventional content analysis was also conducted, and both analyses approaches 
were employed so as not to miss any themes [35].     
9.3.5 Ethical Consideration 
The study protocol was approved by the University of Sydney Human Research Ethics 
Committee (project No: 2015/818) and the institutional review board of the University of 
Gondar, Ethiopia (O/V/P/RCS/05/624/2016). All participants gave written informed consent, 
and each group was assigned a unique identifier, and anonymity was maintained at all times 
during the research process.  
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9.4 Results 
Forty-four hospital pharmacists took part in eight focus groups, comprising four to nine 
participants per group (Table 9.1). Participants represented from eight hospitals, the majority 
of whom were males (n= 39). The mean clinical experience and age of the participants were 
2.4 and 25.8 years, respectively (Table 9.1).   
Table 9.1 Number and Characteristics of Participants in Each of the Eight Focus Groups 
 Focus groups Number of 
participants 
Age, mean  Male, n Experience 
(years), mean 
DMH–FG1 5 24.6 5  2 
DMH–FG2 5 24.8 4  1.8 
FHRH–FG1 5 26.8 5 2.8 
FHRH–FG2 5 27.2 4 3 
GUH 6 26.5 5 2.4 
DTH 9 26 7 2.6 
FH 4 25.5 4 2 
Mixed hospitals* 5 24.8 5 2.8 
Total 44 25.8 39 2.4 
*Hospital pharmacists from Metema, Woldiya, Gondar University, and Enat hospitals were involved. 
Abbreviations: DMH, Debre Markos hospital; DTH, Debre Tabor hospital; FHRH, Felege Hiwot 
referral hospital; FH, Finoteselam hospital; FG, focus group; GUH, Gondar university hospital 
 
Barriers and facilitators 
Conventional content analysis across all focus groups did not reveal different themes, and thus, 
we present our findings according to our primary data analysis plan. Using the directed content 
analysis, barriers and facilitators perceived by hospital pharmacists as being more relevant to 
the delivery of medication safety activities were categorized within six of the TDF domains. 
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These domains included ‘Knowledge’, ‘Skills’, ‘Environmental context and resources’, 
‘Motivation and goals’, ‘Social influences’, and ‘Social/professional role’.   
Knowledge and skills  
In most of the discussions, participants did not distinguish between knowledge and skill 
domains—for example, participants mentioned the lack of knowledge and skills altogether as 
barriers to their activities, and thus, in this study, they are presented together. 
Participants expressed mixed views regarding the level of knowledge and skill necessary for 
complete delivery of clinical services and most believed there was a lack of awareness for those 
pharmacists’ extended roles. To the extreme, awareness issues from the pharmacy side were 
severe and its implication in the service delivery process was highly significant. Because these 
were not usually supported with further training, most participants held a strong firm in that 
pharmacists who lacked the know-how about clinical services had greatly impacted the service 
delivery and believed they should be targets for future interventions .  
“…those [pharmacists] who have knowledge about the service, and know what the service is 
about, support the service we are doing. Whereas those who pass most of their time at 
dispensing and not have enough knowledge and awareness about clinical pharmacy are not 
considering as we are working”   [Referral hospital, Focus group#2]. 
Trainings were arranged occasionally; however, most were not suitable to the interest of 
strengthening clinical pharmacy services. ”Even the trainings are more focused on system 
strengthening like APTS [Auditable Pharmaceutical Transactions and Services] and they are 
so much science oriented. They are not clinical based” [Referral hospital, Focus group#3]. 
It was mentioned that, initially, there were some kinds of in-service trainings organized for 
clinical pharmacists to equip them with communication skills and pharmaceutical care. But, 
this had been stopped for a while.    
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“The training that was prepared for the generic pharmacists to equip them clinical knowledge 
was already stopped” [Referral hospital, Focus group#4]. 
Participants also raised issues such as the lack of an evidence and guidelines that showed how 
much their input affects the clinical practice, and this was further supported by the lack of 
consistent service although hospital pharmacists were confident enough in their skills in 
identifying medication-related problems. For instance, medication review was done with a 
limited scope, and there were no organized ways to perform medication reconciliation.  . 
During ward visit, hospital pharmacists took medication history, and used it for   
pharmaceutical care decisions; however, this was done inconsistently and the evidence-base 
was not clear to many.     
“…the history is important for our decision, and we are working on medication reconciliation 
and review although it is not uniform… This is what we are currently doing, but I am not quite 
how strong the evidence for this, probably we will going to evaluate in the process” [Referral 
hospital, Focus group#3]. 
Environmental context and resources   
Initially, this domain was found to be less relevant from the perspective of behavioural change 
theory. But, later we understood that this domain had significant interactions with hospital 
pharmacists’ viewpoints expressed in the other domains considered as relevant in this study, 
such as motivation and goals, social influences and social/professional role. Overall, 
environmental constraints were highly referred by hospital pharmacists as being a major barrier 
to the delivery of medication safety activities. In this part of the domain, there was none who 
mentioned enabling factors regarding resource issues and all shared a common reflection on 
the consequences of environmental constraints on their role. Ranges of resource constraints 
were raised as barriers.   Unlike other clinicians, for example, there had not been any room 
available for practicing pharmacists nearby to the wards they were working.     
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“We are going far from the place where we are, but other HCPs follows patients at their own 
site” [District hospital, Focus group#6]. 
In contrast to dispensing role, hospital pharmacists perceived clinical services add substantial 
time commitments and associated with many hardships.      
“Even we are busy of reading at home, it is not different from an academic life” [Teaching 
hospital, Focus group#5]. 
“Pharmacists don’t want to face hardships” [District hospital, Focus group# 1]. 
The majority of participants also stressed that the lack of human resource was the challenge for   
delivering clinical services. In the studied hospitals, staff attrition was common and most 
participants believed this had been increased recently.   Unlike teaching and referral hospitals, 
district hospitals also faced a severe shortage of other resources, such as reference books, 
guidelines, and computers with internet access. 
Participants reported that ward-based hospital pharmacy services were limited in scope and 
delivered inconsistently. For example, these services were not done over the weakened, and 
duty programs were stopped for a while, and participants believed this had imposed work 
burden when getting back to work on Monday. Participants also felt that, if many of their 
concerns had been solved, they believed this may boost their energy and perceived how much 
the concerned bodies were ready to accept hospital pharmacists’ extended roles. However, 
most pharmacists hesitated whether this had been met, given the lack of government funding 
and support for these services.  Although part of the problem was explained by budget deficits 
nationally, participants cited that at least the government can play a major role in the technical 
support of these extended services. Additionally, clinical services were rarely and irregularly 
documented though there were institutional variations. In most of the studied hospitals, 
pharmacy own documents prepared for the purpose of recording clinical activities were not 
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part of the medical record, or if it had been in place, pharmacist’s documentation was done 
infrequently.    
“…we do believe there is a severe problem of clinical pharmacy documentation. There is no 
body who support us in this regard” [Referral hospital, Focus group#3]. 
Motivation and goals  
A range of conflicting views regarding hospital pharmacists’ motivation and goals were 
collected. For example, most participants believed that what they were doing was a mere 
initiative from their side and not a cascaded role that was approved and endorsed by the 
government. “Now, most of us are doing this work because we are interested in this” [District 
hospital, Focus group#6].  However, creating something out of nothing was challenging, and 
lacked remuneration, and a concern among the majority of hospital pharmacists. Some 
participants stated that patients were highly benefited from the clinical services hospital 
pharmacists were giving although they themselves did not have any extra benefit for these 
additional clinical services.  
“From the perspective of staff, I am feeling like a person giving free service” [Referral 
hospital, Focus group#1]. 
Hospital pharmacists urged concerned bodies in support of these services through a 
remuneration scheme, and they believed this would likely bring major changes in the clinical 
practice of pharmacists.  
“…as you most satisfied with these [staff benefits], you will going to do more interventions, 
and these can bring a good outcome” [Referral hospital, Focus group#4]. 
Although participants strongly believed that there should have been a complete provision of 
clinical services, these were not done because hospital pharmacists would like to prefer a less 
challenging job or else, as a result of human resource shortages, they had been placed for other 
hospital services such as dispensing roles. 
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“As any human, they [hospital pharmacists] might inclined towards a less challenging job” 
Referral hospital, Focus group#4]. 
Participants also believed that, as a result of the cancellation of weakened and duty programs 
which were practiced before, staffs thought that this was the least incentive they were thinking 
of, and this had affected their moral negatively.  
“It is not fair to cancel the Saturday and Sunday services. Before, we did weekend services, 
and even there was duty program and we did CP service and those things at least moralize us” 
[Referral hospital, Focus group#1]. 
Many participants emphasized why hospital pharmacists lacked the inspiration for delivering 
clinical services, whereas they mentioned that the curriculum is very much patient oriented 
unlike the previous courses, yet there were few hospital pharmacists struggled into the duty of 
dispensing with the mere reason of collecting an additional benefit from the extra hours, but 
this was not arranged for clinical services. And because of this, most pharmacists preferred 
dispensing to clinical services.   
“We suffered so much when we studied CP [clinical pharmacy] and the work is challenging, 
but we are treated as previous pharmacists who studied a little bit advanced courses. There 
are many challenges with us. There are many differences in the curriculum, but there are things 
you will lose. For example, the region allows duty only for dispensing, and for this reason, at 
least to collect 500 or 600 birr for the duty program we are doing it rather than the clinical 
service. We don’t dislike the job but it is because of this reasons and not attitude problem that 
most of us prefer dispensing” [Referral hospital, Focus group#2]. 
Surprisingly enough, there were also enthusiastic hospital pharmacists who did not see things 
from resource or financial gains perspective but devoted themselves for the growth of the 
profession. For these groups of participants, human resource was not a challenge if they were 
given the support from health managers, and which in turn, greatly impacted the staff’s 
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motivation and commitment. If given the support from the management, participants 
considered this as their major driving force for their motivation. 
“Nowadays, there is also support from the management and this has been increased from time 
to time, and this is a motivating factor by itself” [Mixed hospitals, Focus group#8]. 
“So, the changes I have seen at the management is like incentives for us” [Mixed hospitals, 
Focus group#8]. 
Social influences 
Although hospital pharmacists were very much enthusiastic for new roles, these were in fact, 
influenced by the lack of acceptance of their role to other members of the health care team and 
lack of managerial support in implementing clinical pharmacy services. From the perspective 
of managerial support, managers overlooked clinical services but more focused on dispensing 
roles, and that was attributed majorly to lack of staff to take over the dispensing role. There 
were also participants expressed their views that managers acknowledged the importance of 
clinical pharmacy services and highly appreciated it but because of the staff shortage matters, 
those pharmacists who were working in the hospital wards were assigned to the dispensing 
rooms. This was more aggravated when more staffs had increasingly left their job whenever 
they got other better opportunities. In addition, controversies over interest also mentioned as a 
reason for not continually deliver this service, particularly between managers from the 
department and the hospital.   
“He [the hospital manager] is ambitious to develop the service more.  However, when you come 
to the department of clinical pharmacy, there is a problem in the way pharmacists are looking 
at the service. Even, you can see that some pharmacists are not attending our morning session” 
[Referral hospital, Focus group#3]. On the other hand, HCPs who were supportive and ready 
to accept pharmacists’ input did have some know-how about clinical pharmacy or had been 
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exposed to some form of sensitization workshops. This was also expressed to some extent in 
pharmacists themselves. 
“Even other health care professionals are accepting our roles except those who don’t have the 
know-how. And even this is because the necessary sensitization was not given to them” 
[Referral hospital, Focus group#3].The level of acceptance was different from institution to 
institution. Various mentions were given for this. First, in institutions where the numbers of 
specialists were fewer, the input from pharmacists was taken as crucial and thus, the rate of 
pharmacist’s acceptance was better. However, in hospitals where there were highly 
experienced seniors, it was a challenge for pharmacists to recommend interventions. And, 
pharmacists recommended interventions were better taken up by those colleagues having the 
same level of seniority. However, there were also pharmacists commenting seniors had the best 
connections with them than others, and their input was better entertained although most seniors 
were not that much aware of cognitive services delivered by hospital pharmacists. In addition, 
those HCPs who believed in team and collaborative works were the most likely candidates for 
promoting clinical pharmacy services.  
 “We know that pharmacists working in Debre Markos and Felege Hiwot are doing better, and 
have better acceptance. Because their level is almost equal” [Teaching hospital, Focus 
group#5]. 
“With seniors, there is no problem to accept your recommendation. Actually, the main 
prescribing authority rests on them. The main problem with other staffs below seniors is they 
need an approval from seniors. As compared to interns, the GPs accept you better” [Referral 
hospital, Focus group#3].Participants mentioned that clinical pharmacy services were included 
as one of the hospital standards and had been  getting the support from government policy side, 
and thus, no health care staff opposed the existences of these services. Notably, government’s 
commitment to enact on behalf of the hospital pharmacist’s impact in the health care system 
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has been found more influential than ever, and the likelihood of accepting pharmacists 
extended roles to other staffs is possibly geared by the government’s pressure.  
“…So, everything rests on the government’s commitment. Our acceptance also depends on the 
government’s work. If the government is committed, for example, to order every health care 
professional to review our recommendation, like nurses, are checking the progress notes of 
physicians, physicians should also review the progress notes of clinical pharmacists, and give 
their decision as accepted or rejected. The biggest responsibility is to the government for other 
staffs to consume pharmacist’s input” [Referral hospital, Focus group#2].    
Social/professional role 
Regarding medication safety activities delivered by hospital pharmacists, it was mentioned that 
professional compatibility was not a concern but what matters was the lack of understanding 
of the profession’s mission in the eye of other health care cadres. There was a considerable 
variation in the clinical practice of pharmacists among institutions—for example, there were 
institutions that praise the role of hospital pharmacists and yet, there were who had seen them 
as fault finders. One pharmacist commented: 
“During identifying DTPs [drug therapy problems] and any other problems related to 
medications, they are considering like we are pointing the one who is responsible for the care 
of the patient” [Mixed hospitals, Focus group#8]. 
Whatever it is, however, the major facilitating factor for this was, role recognition by other 
staff members.  
“Those who understand the health benefit of clinical pharmacy services, for example, some 
physicians are trying to call hospital pharmacists for ward round participation, and give the 
recognition for clinical pharmacists as we are needed during ward round” [Mixed hospitals, 
Focus group#8].  
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 “There are times when the physicians don’t start round unless the clinical pharmacist is 
available” [District hospital, Focus group#6]. 
It was mentioned that the hospital standards currently ratified by the government well 
advocated the integration of pharmacists in care teams. However, few pharmacists believed a 
lack of differentiation between technical and clinical services and role duties for pharmacists 
from the government itself.   
“The government didn’t see the distinction between technicians, pharmacists, and clinical 
pharmacists” [District hospital, Focus group#7]. 
Although there existed some level of recognition from various sides, yet there had been a lack 
of awareness regarding the role of hospital pharmacists in medication safety activities at the 
level of health bureau, regional or federal level.  
“…there are staffs who are not aware of the role of clinical pharmacists. There are staffs who 
ask us what we are doing in the ward, on the other hand, there are who eagerly want us, and 
even among these, there do have various perceptions of the profession” [Referral hospital, 
Focus group#2].  
With regard to social/professional role, there have been numerous unfinished assignments that 
due attention, according to the participants. Awareness campaigns should be devised, and a 
well-designed job description should have been in place. Because of the lack of job description 
best suited for clinical activities, participants felt that there seemed an overlap of activities and 
also, other HCPs perceived as if their role was taken. Few participants commented how other 
staffs, specifically physicians were looking at them; they stressed that their therapy 
recommendation was not usually entertained by the physicians, and the physicians hesitate to 
accept their extended role.  
Regardless of financial gains and acceptance, most hospital pharmacists were positive towards 
the future of the profession. 
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“We are taking the challenges as challenges, and we are thinking the future might be brighter. 
We don’t know what will happen and in that sense, we are trying our best” [District hospital, 
Focus group#6]. 
 “…we are working for the benefit of the profession, not for us, we are paying our life, and we 
are wishing only the best future” [District hospital, Focus group#6]. 
“…we are working expecting the future might be bright” [District hospital, Focus group#6]. 
9.5 Discussion 
To the best of our knowledge, this was the first study to apply the TDF to categorize the barriers 
and facilitators to hospital pharmacists’ engagement in medication safety activities. The present 
study identified a wide range of factors that may influence the uptake of medication safety 
interventions delivered by hospital pharmacists. Overwhelmingly, hospital pharmacists 
identified more barriers than facilitators in delivering clinical services. Derived from the TDF, 
the factors identified in this study were clustered into six domains: ‘Knowledge’, ‘Skills’, 
‘Environmental context and resources’, ‘Motivations and goals’, ‘Social influences’ and 
‘Social/professional role’. In comparison with other studies using the TDF framework, the 
domains ‘Knowledge’, ‘Skills’, ‘Environmental context and resources’, ‘Social influences’ 
were identified as vital areas which could be targeted in the implementation of medication 
safety programs [32, 33, 35], although other issues such as, ‘Motivation and goals’ [32, 33] 
and ‘Social/professional roles’ [32] were also equally important. Outside the TDF, some of our 
findings were consistent with a previous study exploring the factors affecting the 
implementation of clinical pharmacy performance indicators, including medication 
reconciliation [38]. Minard et al [38] reported that the challenges surrounding hospital 
pharmacists’ implementation of these indicators comprised of documentation challenges, work 
burden, environmental constraints and competing priorities. Using a theory-based approach, 
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the present study uncovers additional relevant barriers—for example, the lack of knowledge 
and skills necessary for the execution of clinical services and poor acceptance of pharmacists’ 
recommendation. On the other hand, environmental constraints identified in the current study 
were prominent, and there was none which was mentioned as facilitator in the context of 
resource issues. Most importantly, although all participants frequently and consistently 
reported the ‘Environmental context and resources’ domain without variation in their views, it 
was found that there existed some important interlinks with the domains judged to be relevant. 
For example, as a consequence of human resource deficits, managers reinforced hospital 
pharmacists to take over the dispensing role (‘Motivation and goals’), and because of the 
absence of duty and weekend programs, hospital pharmacists perceived this as a lack of 
government funding and support, which in turn, was a result of the lack of recognition and 
acceptance of these extended roles (‘Social/professional role’). Duncan et al [32] explained the 
interactive nature across the TDF domains and highlighted the importance of considering 
theoretical links between domains as far as interrelationships between domains exist.  
Unlike the environmental constraints, the barriers and facilitators that were reported by hospital 
pharmacists showed inter-institutional and -individual variations in the remainder of domains. 
While the analysis of the interview data indicated major differences in individual thoughts 
related to hospital pharmacists’ knowledge, skills, and social/professional role as well as their 
motivation and goals, inter-institutional variation mainly appeared in the social influence 
domain. Particularly, hospital pharmacists working in district hospitals clearly indicated their 
interventions were better entertained and accepted by other health care members, and there was 
an increasing demand for these services—for example, expressed in the number of telephone 
inquiries and consultations received in these hospitals. Previous studies demonstrating 
pharmacist provided therapy recommendation in care teams have reported positive clinical and 
economic outcomes, and these have been associated with high acceptance rates [39–41]. For 
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instance, when pharmacists participate in ward rounds, they could able to cut two-third of 
preventable ADEs with acceptance rate as high as 99% [40]. Another recent study [42] has also 
shown a high acceptance rate of pharmacist-provided services associated with medication 
reconciliation as compared with other clinical services, such as those related to medication 
indication, efficacy, and therapeutic drug monitoring. Given the positive impact of pharmacist-
led medication reconciliation services [22, 23], and the evidence that these services have shown 
better acceptance [42], it is our opinion that pharmacists’ clinical services in the studied 
hospitals, mainly those above the district level, might be well utilized if they could able to 
implement medication reconciliation services.   
Apart from the challenges encountered with regard to knowledge and skill deficits (e.g. lack of 
supportive skills such as blood pressure measurement, and knowledge about rare 
diseases/diagnosis)—participants associated this with the challenges in the currently designed 
curricula, hospital pharmacist’s roles in medication safety were poorly understood in the 
medical community. Particularly, product-oriented pharmacists’ awareness, and the lack 
thereof, was predominantly affected the extended roles implemented by ward-based 
pharmacists. This finding is consistent with a study that has shown pharmacists’ self-perception 
as barriers to their extended roles [43].  Outside pharmacists, participants highlighted that other 
HCPs recognition of pharmacist’s roles in medication safety activities was limited; however, a 
recent local study reported that a large proportion of HCPs had a positive attitude towards 
clinical pharmacy services but the extent of the available service was below their expectation 
[44]. The present study has also identified that, in the eyes of health managers, dispensing was 
thought to be a core business and thus, hospital pharmacists were reinforced for other 
competing priorities. There were no remuneration schemes or incentives arranged for 
pharmacist’s cognitive services. As a result, many pharmacists preferred dispensing to clinical 
services. A previous national study has also shown that close to two-thirds of pharmacists 
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delivering clinical pharmacy services are dissatisfied with their job, and this is mainly due to 
unattractive incentive packages [25].   
All participants expressed a desire for further trainings and certifications to target their 
knowledge and skills gaps; this was also a motivating factor for delivering these services. To 
target other domains (e.g. ‘Social/professional role’, ‘Social influence’), awareness creation 
campaigns targeting the whole medical community (including the management, other 
pharmacists, and HCPs) may facilitate the uptake of pharmacist’s cognitive services. In 
addition, government recognition and supervision of hospital pharmacists’ clinical services 
have been cited as a main driving factor, and participants perceived these services should not 
have been confined to few settings and national endorsement of these services have been  found 
to be necessary. Bilal et al [45] have also confirmed that Ethiopian graduate pharmacists are 
very much enthusiastic to promote clinical pharmacy service but the challenge is the minimal 
effort made at the level of institutions.     
This study has several strengths and limitations. Applying the TDF approach, we have for the 
first time identified a range of barriers, as well as facilitators in relation to hospital pharmacists’ 
engagement in medication safety activities. As we employed focus group discussions for data 
collection, the data generated was possibly rich [46], and also, the interview guide was 
structured across the TDF domains that could able to elicit as many factors as possible, 
although this renders prioritization  of domains for intervention development difficult [47]. 
However, we adopted the relevance criteria utilized by previous studies for prioritizing relevant 
domains of potential interventional targets [32, 34]. One important challenge in relation to 
coding statements into the theoretical domains was the existence of overlaps between domains. 
In this instance, it might be difficult to determine the origin of barrier and facilitator and 
prioritize interventions [48]. Fortunately, in the current study, the domains that have been found 
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with some interrelationships were included in the priority list of behaviours for possible 
intervention.    
In contrast to other studies which also judged beliefs about capabilities [49], beliefs about 
consequences [33, 49], memory/attention and decision processes [32, 35, 49] as relevant 
domains for a successful medication safety intervention, these domains in our study were 
described infrequently (‘Memory/attention and decision processes’) and varied little (‘Beliefs 
about capabilities’), and participants were confident enough in the positive impact of clinical 
pharmacy services (‘Beliefs about consequences’). Although participants consistently reported 
challenges to the service delivery but in their accounts, we understood that was meant barriers 
encountered in the whole process and not attributed to their incapability in carrying out 
medication review and reconciliation, for example. Additionally, an important point worth 
discussing is regarding the targeted behaviour (i.e. medication safety activities delivered by 
hospital pharmacists) that we would like to intervene have certain unique features as compared 
to other studies. While other studies focused on some specifically targeted behaviours (e.g. 
prescribing behaviour [32, 35], prescribing and dispensing behaviour [35] and ADE reporting 
[33]), our study included a range of bundled interventions, also termed as clinical pharmacy 
services. A core sets of eight clinical pharmacy performance indicators have been established 
[38], including admission and discharge medication reconciliation. However, the issue of 
medication reconciliation was new to the local setting, and we intended to ask our interviewees 
from the broader perspective rather than as an isolated element, and interview questions had 
been designed, accordingly. Hospital pharmacists expressed their beliefs from the broader array 
of these services, and beliefs for each of the afro mentioned domains should have been thus, 
viewed from that angle.     
Another study’s limitation was that it involved a homogeneous group of participants; that is, 
only pharmacists who taught in the newly designed patient-oriented curricula were included. It 
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did not take the thoughts from the perspective of product-oriented pharmacists. However, 
pharmacists were sampled from eight hospitals of varies level (district, general and tertiary), 
and this mix could possibly enhance transferability of findings to other settings.  
9.6 Conclusion 
This is the first study to investigate the potential barriers and facilitators to implementing 
evidence-based medication safety activities delivered by hospital pharmacists using the TDF, 
and is an initial step necessary for informing theory-based interventions to target these barriers. 
The current study sheds light on hospital pharmacists’ perceptions of their clinical services, 
including medication reconciliation, in settings where resources are limited. The majority of 
the participants were very much enthusiastic for their extended roles and were positive towards 
the future of the profession; however, there were a number of factors likely to influence their 
behavior in the clinical practice of pharmacists. The multifaceted behavioural interventions 
surrounding hospital pharmacist’s engagement in medication safety activities were 
predominantly related to six theoretical domains: ‘Knowledge’, ‘Skills’, ‘Environmental 
context and resources’, ‘Motivations and goals’, ‘Social influences’ and ‘Social/professional 
role’. There existed considerable interrelationships between domains that were perceived to 
influence hospital pharmacists’ behaviours, and this might assist in designing behaviour change 
interventions that will target common behavioural domains. 
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10.1 Abstract 
Background: The role of pharmacists in medication reconciliation is highly acknowledged in 
the majority of developed nations. However, the impact of this strategy in resource limited 
countries, such as Ethiopia is not explored. The aim of this study was thus, to investigate the 
impact of pharmacist-led medication reconciliation interventions on the incidence of 
unintentional medication discrepancies before and after the implementation of this service.   
Method: A single center, prospective, pre-post study was conducted in an emergency ward of 
a tertiary care university hospital, and included adult patients (aged over 18 years) that had 
been hospitalized for at least 24 hours and were taking at least 2 home medications on 
admission. The intervention involved the assignment of a pharmacist to the emergency care 
team so as to take the best possible medication history and reconcile this list with the current 
medications in use. The main outcome measures were the incidence and potential clinical 
severity of unintentional medication discrepancies.   
Results: A total of 123 patients were included (pre-intervention, 49; post-intervention, 74). 
The proportion of patients with at least one unintended discrepancy was reduced from 59% to 
10.5% after the intervention (p < 0.0001). The percentage of medications with unintended 
discrepancies was lower in the post-intervention phase than in the pre-intervention phase (3.5% 
vs. 42 %, respectively; p < 0.0001).  The percentage of patients with potentially severe clinical 
impact medication discrepancies reduced significantly after the intervention (p=0.001). Most 
importantly, the likelihood of occurrence of unintentional medication discrepancies was 
approximately 17 times more often in the absence of pharmacist intervention (OR 16.45, 95% 
CI 5.22, 51.85).  
Conclusion: This study has found that pharmacist-led medication reconciliation intervention 
was impactful, and was able to minimize the incidence of unintentional medication 
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discrepancies significantly. Implementation of this strategy is feasible, and pharmacists might 
be key resource personnel for the safe use of medications during care transitions. 
10.2 Introduction 
Medication errors are the leading cause of hospital morbidity, and more than half of the 
medication errors occur at transitions of care, when patients move in and out of a hospital or 
transferred to the care of other health care provider [1]. Numerous studies identified suboptimal 
documentation communication at points of patient transfer as a risk for medication errors, and 
unintentional prescribing changes—also called as medication discrepancies—are common 
during transitions in care [2–7] and are the concerns for patient safety because of their potential 
to cause harm. A systematic review of the incidence of medication history errors revealed that 
19% to 75% of discrepancies between home medications and admission medications were 
errors [8], and up to 39% of the unintentional medication discrepancies could have moderate 
to severe potential for patient harm [9]. Clinically significant medication discrepancies could 
also represent an important contributor to adverse drug events (ADEs) and health care resource 
utilization [7, 9–13]—for example, Coleman et al [13] reported that patients with medication 
discrepancies experienced a significantly higher rate of re-hospitalization at 30 days compared 
with patients without such discrepancies.   
Medication reconciliation is recognized as an important approach to improve the Quality Use 
of Medicines by tackling the burden of medication discrepancies. Medication reconciliation as 
a National Patient Safety Goal (NPSG) was first endorsed in 2005 by The Joint Commission 
[14]. Since the last decade, this strategy is being effectively implemented across care transitions 
in many other settings and endorsed among various patient safety organizations [15–17].  
There is growing evidence that medication reconciliation decreases the frequency of 
unintentional medication discrepancies [18, 19] and adverse drug event-related readmissions 
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[10–12]. Medication reconciliation supported by an electronic tool, as well as pharmacist-led 
approaches have been found effective in reducing unintended discrepancy [20, 21]. Most 
importantly, medication reconciliation programs conducted at single transition (either 
admission or discharge) showed a significant reduction of 66% in patients with medication 
discrepancies in favour of pharmacist-led intervention [21]. This intervention has also shown 
a substantial reduction in the rate of all‐cause readmissions, all‐cause ED visits, and adverse 
drug event‐related hospital revisits although the impact of such programs on mortality and 
composite outcomes was inconclusive [22].  
Medication reconciliation is well acknowledged in many of the developed countries; however, 
the impact of this strategy overall, as well as pharmacist-led medication reconciliation 
initiatives, has not yet been described in sub-Saharan Africa. In the present study, we evaluated 
the impact of pharmacist-led medication reconciliation at the emergency ward of a university 
hospital on the occurrence of unintentional medication discrepancies before and after the 
implementation of this service. We also assessed the potential clinical severity of medication 
discrepancies and compared the differences between pre- and post-intervention groups.   
10.3 Methods  
10.3.1 Study Setting, Design, and Population 
The study was carried out in an emergency ward of Gondar University Hospital (GUH), which 
is a tertiary and public hospital in Gondar town in the Amhara regional state. It is the primer 
hospital in the northwest region of Ethiopia. GUH provides specialized health services through 
its medical and other clinical and diagnostic departments for a catchment population of 
approximately 5 million people.     
This study was part of a larger project aimed at implementing pharmacist-led medication 
reconciliation programs, and the study protocol for the whole project has been published 
elsewhere [23]. The current study was a single center, prospective, pre-post study with no 
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equivalent control group conducted between February and August 2016. Patients in both 
periods were enrolled in the same ward. This study lasted a total of 6 months. .   
Eligible patients were adults (aged over 18 years) taking at least two home/regular medications 
on admission, and patients had to stay for at least 24 hrs to be eligible for inclusion in our study. 
In other words, patients who transferred to other wards or discharged from ED within 24 hrs 
were not included in our study. Patients were provided both verbal and written information, 
and were requested for their willingness to participate in the study, and were included only 
after written informed consent was obtained. Patients were conveniently enrolled on weekdays, 
and recruitment targets were pre-determined using the predefined calculation; that is, the 
sample size was estimated using the prevalence of medication errors in the previous local 
studies, which was identified as 52% to 58% of all prescriptions [24, 25]. Assuming a 45% 
relative reduction in medication errors, 80% power, 5% significance level (two-sided), we 
required a total of 127 patients, 51 for the baseline and 76 for the intervention 
(http://medcal.org). Hospital discharge statistics showed that this sample size would be 
achievable over the study period.   
10.3.2 Data Collection  
For the purpose of this study, medication discrepancies were defined as one or more differences 
in (dosage, frequency, drug, route of administration), as described by the Institute for Health 
care Improvement (IHI) [26], between the current and previous medication (s) a patient was 
taking, whereas medication reconciliation had been adopted as “the process of identifying the 
most accurate list of a patient’s current medicines, including the name, dosage, frequency, and 
route—and comparing them to the current list in use, recognizing and documenting any 
discrepancies, thus resulting in a complete list of medications” [26].   
During the study period, the standard practice in the current ward involved physicians in taking 
patient’s medication history using patient provided information; however, hospital pharmacists 
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did not participate in the medication history taking and prescription review at the emergency 
ward. During the implementation phase, however, hospital pharmacists were assigned and 
involved in taking the best possible medication history (BPMH) [17], which was based on a 
structured interview with the patient about medication use and retrieving other sources of 
medication history, including discharge and referral letters, patient’s own medicines and carrier 
interview. At the time of data collection, five hospital pharmacists, on a weekly rotation basis 
(one per week), were engaged in delivering medication reconciliation service at the emergency 
ward. In this study, a baseline assessment of medication discrepancies had been conducted for 
one month during admission at the emergency ward. It should be noted that before the 
intervention commences, findings from the baseline assessment were communicated to the 
ward team and there were a series of sessions in creating awareness about the impact of 
medication reconciliation overall, as well as the role of pharmacists in the process. A 
pharmacist-led medication reconciliation intervention had been then carried out prospectively 
for two months.  
For the purpose of data collection, one pharmacy staff member who was not involved in the 
intervention had been trained in the techniques of how to get the BPMH by a research 
pharmacist (ABM).  Medication reconciliation was conducted after patients were informed of 
the study and gave written consent. Medication use had been documented through a data 
collection tool prepared for the purpose of this study (Appendix 6.5). Irrespective of the phase, 
a single pharmacist using the same procedure collected medication discrepancies within 24 hrs 
of the patient’s admission; the difference between the two phases of the study lied on the timing 
in taking the BPMH and the assignment of hospital pharmacists to deliver medication 
reconciliation service. During the standard care process, the pharmacist (data collector) 
performed the BPMH after the physician’s admission prescription order whereas, in the 
implementation phase, hospital pharmacists were fully integrated to the admission process and 
 Part C – Chapter 10                                                                                                              211 | P a g e  
conducted medication reconciliation before the physician’s prescription order. In the 
implementation phase of this study, the pharmacist (data collector) compared the BPMH (of 
his own) with the physician’s admission prescription order that had also been considered by 
hospital pharmacists. In both stages of the study, all identified discrepancies had been brought 
to the attention of the physician in charge at admission and verification of these discrepancies 
was made; that is, intentional vs unintentional changes to medications. Intentional medication 
discrepancies were medication changes due to new patient’s clinical status, and were clinically 
justifiable but not documented in the patient’s medical record. Thus, only unintentional 
medication discrepancies (also called as medication errors) had been reported. The main 
outcome measure was the incidence of unintentional medication discrepancies along with their 
potential clinical severity. The potential clinical severity of medication discrepancies was 
judged by a consensus between a clinical pharmacist and a physician using a tool developed 
by Cornish et al [5]. According to this tool, discrepancies were classified as mild—unlikely to 
cause patient discomfort/clinical deterioration, moderate—moderate discomfort/clinical 
deterioration, and severe—severe discomfort/clinical deterioration. 
10.3.3 Data Analysis 
Data were entered into Excel 2013 and analysed using SPSS version 20 (IBM Corp., Armonk, 
NY). Descriptive statistics were used to report patient demographics and clinical 
characteristics. Categorical variables were compared for pre-and post-intervention groups 
using chi-square or Fisher's exact test and continuous variables were compared using Student's 
t test. Univariate and multivariate logistic regression analysis was used to investigate predictors 
of at least 1 medication discrepancy. Statistical significance was set at p < 0.05.  
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10.3.4 Ethical Consideration 
Ethical approval was obtained from the University of Sydney Human Research Ethics 
Committee (HREC)—Project Number: 2015/818, and the Institutional Review Board of the 
University of Gondar, Ethiopia (O/V/P/RCS/05/624/2016).  
10.4 Results 
Patient characteristics 
During the two phases of the study, 123 patients were enrolled in the study, 49 patients were 
included in the pre-intervention study, and 74 patients in the post-intervention. There were no 
significant differences in patient characteristics between the groups, except for a higher mean 
number of current medications in the post-intervention group (4.26 vs 3.55, respectively; P = 
0.04) (Table 10.1). A total of 489 medications were reconciled, 174 drugs in pre-phase and 315 
in the post-intervention, and in both phases of the study, the most prescribed classes of 
medications were anti-infectives (36%), cardiovascular (34%), gastrointestinal (10%), central 
nervous system (6%) and endocrine and metabolic (5%).   
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Table 10.1 Patients’ Demographic and Clinical Characteristics 
 Characteristic Both phases 
(n=123) 
Pre-
intervention 
(n=49) 
Post-
intervention  
(n= 74) 
P-value 
Age, mean (±SD) 45.0 (17.7) 48.6 (18.6) 42.7(16.9) 0.07 
Age >= 65 years, n (%) 24 (19.5) 12 (24.5%) 12 (16.2%) 0.26 
Sex Male (%) 63 (51.2) 23 (46.9) 40 (54.1) 0.44 
Female (%) 60 (48.8) 26 (53.1) 34 (45.9) 
Primary diagnosis, n (%) Infectious diseases 55(44.7) 24 (49) 31 (41.9) 0.189 
Cardiovascular 
system 
30 (24.4) 14 (28.6) 16 (21.6) 
Endocrine and 
metabolic disorders 
11 (8.9) 4 (8.2) 7 (9.5) 
Gastrointestinal 9 (7.3) 1 (2) 8 (10.8) 
Central nervous 
system 
6 (4.9) 2 (4.1) 4 (5.4) 
Respiratory 4 (3.3) 3 (6.1) 1 (1.4) 
Miscellaneous 8 (6.5) 1 (2) 7 (9.5) 
Co-morbidities, mean (±SD) 1.1 (0.8) 1.2 (0.8) 1.1 (0.9) 0.79 
Preadmission medications, mean (±SD) 2.8 (1.2) 3.1 (1.3) 2.7 (1.0) 0.10 
Current medications, mean (±SD) 4.0 (1.8) 3.6 (2.1) 4.3 (1.61) 0.04 
Abbreviation: SD, Standard deviation  
 
Main outcome measures 
In both periods, a total number of 84 unintentional medication discrepancies had been 
identified; 73 discrepancies pre-intervention and 11 unintended discrepancies post-
intervention. The percentage of medications with unintended discrepancies decreased from   
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42% (73/174) to 3.5% (11/315) after the intervention (p < 0.0001). The proportion of patients 
with at least 1 unintended medication discrepancy was 59% (29/49) in the pre-intervention 
phase, compared to 10.5% (8/76) in the post-intervention phase (p < 0.0001) (Table 3). Among 
these 37 patients, 12 patients each had 1 and 2 discrepancies, 9 patients had 3 discrepancies, 2 
patients had 4 discrepancies, and 1 patient each had 6 and 7 discrepancies. The overall 
discrepancy rate was 0.68 per patient (SD 1.28); it was 1.49 (SD 1.66) in the pre-phase and 
0.15 (SD 0.46) in the post-intervention phase (p < 0.0001) (Table 10.2).  
Table 10.2 Comparison of Medication Discrepancies between the Pre-and Post-intervention 
Group  
Outcome Both phases Pre-intervention Post-intervention P-value 
Medications with unintentional 
discrepancies, n (%) 
84 (17) 73 (42) 11 (3.5) <0.0001 
Patients with at least 1 
discrepancy, n (%) 
37 (30) 29 (59) 8 (10.5) <0.0001 
Patients with at least 1 
intentional discrepancy, n (%) 
116 (94) 44 (90) 72 (97.5) 0.11 
Unintentional discrepancies per 
patient, mean (±SD)  
0.68 (1.28) 1.49 (1.66) 0.15 (0.46) <0.0001 
Intentional discrepancies per 
patient, mean (±SD)  
3.07 (2.06) 2.57 (1.87) 3.41 (2.12) 0.027 
Abbreviation: SD, Standard deviation  
 
Among the 84 unintentional medication discrepancies identified from the 489 medications 
surveyed, the most frequent medication error was ‘omission’ (56%), as shown in Figure 10.1.   
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Figure 10.1 Types of Unintentional Medication Discrepancies 
 
 
 
The most common medication classes involved with unintentional discrepancy were those 
which acted on the cardiovascular system, followed by infectious diseases, central nervous 
system and endocrine and metabolic disorders. However, adjustment for prescription frequency 
showed that vitamins and minerals accounted for another common medication class, but this 
estimation was derived from fewer prescriptions (Table 10.3).  
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Table 10.3 Medication Class with Unintended Discrepancies  
Abbreviation: UD, Unintentional discrepancy 
The physician/pharmacist team assessed the potential severity of unintentional discrepancies, 
and found that 5 (7%) of 74 patients in the intervention phase had at least 1 unintentional 
medication discrepancy with the potential to cause severe clinical deterioration, compared with 
14 (29%) of 49 patients in the pre-intervention group (p = 0.001).    There was a moderate level 
of agreement among evaluators in judging the potential clinical impact of medication 
discrepancies (Cohen’s kappa, K= 0.447; p < 0.0001). Among the 84 unintentional medication 
discrepancies identified in both phases of the study, most discrepancies (61%) were evaluated 
as potentially causing severe patient discomfort or clinical deterioration whereas 21% of the 
discrepancies were deemed unlikely to cause harm or clinical deterioration, and the remaining 
18% were judged to have the potential to cause moderate discomfort or clinical deterioration. 
Table 10.4 shows examples of potential clinical severity rating for unintentional medication 
discrepancies. 
Medication class Medications with UD, n (%) Medications with UD adjusted for 
prescription frequency 
Anti-infectives 22 (26.2) 22/177 (12.4) 
Cardiovascular 41 (48.8) 41/166 (24.7) 
Gastrointestinal  4 (4.8) 4/50 (8.0) 
Central nervous system 6 (7.1) 6/29 (20.7) 
Endocrine and metabolic 
disorders 
6 (7.1) 6/25 (24.0) 
Blood and blood products 1 (1.2) 1/17 (5.9) 
Vitamins and minerals 2 (2.4) 2/7 (28.6) 
Respiratory  2 (2.4) 2/16 (12.5) 
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Table 10.4 Examples of Unintentional Medication Discrepancies with their Potential Clinical Severity; rated according to Cornish et al tool [5]  
Examples of  unintentional discrepancy Type of 
discrepancy 
Potential 
clinical 
severity 
Scenario 1. A patient’s home medications were ART and co-trimoxazole prophylaxis therapy (CPT). During hospital admission, the physician 
was well aware of the ART but not CPT use by the patient and was not documented in the patient chart.   
Omission error Mild 
  
Scenario 2. A 27 years old female patient admitted with a diagnosis of CNS toxoplasmosis secondary to retroviral infection (RVI), had been 
prescribed omeprazole at some private clinic for ulcer related complaints and was already taken it for the past 14 days. During admission, she 
did not have any ulcer related complaints but omeprazole was continued without any indication. 
Unnecessary 
drug therapy 
Scenario 3. A known hypertensive patient on enalapril 2.5 mg po/day, hydrochlorothiazide 12.5 mg po/day, aspirin 81 mg po/day, simvastatin 
20 mg po/day was admitted at ED. The patient brought only simvastatin, other medications were not at the patient’s hand. The intern informs 
the patient to continue the medications but the patient was taking only three of the medications. The patient was not taking hydrochlorothiazide 
and the intern was not aware of this. 
Omission error Moderate 
Scenario 4. A patient with 5 home medications [simvastatin, nifedipine, enalapril, aspirin, and hydrochlorothiazide] had detected an 
unintentional reduction of enalapril dose from 10 mg po/day to 5 mg po/day at hospital admission. Simvastatin 20 mg BID was also changed 
to simvastatin 20 mg po/day unintentionally.   
Discrepancy in 
dose 
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Scenario 5. Before hospital admission, the prescribed digoxin dose was 0.125 mg daily but on comprehensive medication history taking, a 
patient was found to take 0.125 mg BID of digoxin. 
Discrepancy in 
dose 
Scenario 6. A patient was taking KCl 1 tablet but what actually on the chart was 2 tablets three times daily. Looking at the patient’s K level, 
it was too low; i.e., 2.4 meq/l, part of the problem might be the patient was taking 1 tab of KCl while instructed to take 2 tab. 
Discrepancy in 
dose 
Severe 
Scenario 7. A patient had been visiting two medical centers, in one of the centers, she was advised to take 40 mg po BID frusemide but no 
improvement. Later, she visited another center and ordered to take 40 mg po of frusemide twice daily. Although in the referral letter it was 
noted as she was taking 40 mg po furosemide, on comprehensive medication history, this patient was taking frusemide 80 mg po BID, the 
patient was assuming as if she was taking two different products from these two different institutions.  
Discrepancy in 
dose 
 Scenario 8. A 50 year old female patient with heart failure was taking furosemide and spironolactone as her regular medicines, and admitted 
for pneumonia. But during admission, the physician was not aware of these medications although the medication (spironolactone) was at the 
patient’s hand and Lasix was at home. The physician only treats the patient’s current diagnosis. 
Omission error 
Scenario 9. A patient was taking 6 regular medications. But after hospital admission, it was found that atorvastatin was missed somewhere in 
the management. In addition, on comprehensive medication history, this patient was taking 5 mg po of warfarin whereas the order was 2.5 mg 
po of warfarin and because of this, the patient’s warfarin was run out a couple of weeks ago before his current admission. 
Omission error, 
unintentional 
non-adherence 
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Scenario 10. Frusemide 20 mg po BID was written in the home medicines list but on the current medicines list, it was written down as 
furosemide 20 mg po daily. In addition, this patient was ordered to take ciprofloxacin 500 mg po TID but on comprehensive medication 
history, it was found that the patient was taking 1 tablet per day of ciprofloxacin (500 mg only). 
Discrepancy in 
frequency  
Scenario 11. A patient was previously ordered to take furosemide 20 mg po TID, spironolactone 25 mg po per day, erythromycin 500 mg po 
BID and hydrochlorothiazide 12.5 mg po per day. But on detail medication history, the patient’s hydrochlorothiazide was unintentionally 
discontinued. Also, a reassessment of the patient’s medication, this patient was taking erythromycin 250 mg po BID instead of 500 mg po 
BID, and spironolactone 50 mg po per day instead of 25 mg po per day. 
Omission error, 
discrepancy in 
dose 
Abbreviation: ART, Antiretroviral; BID, bis in die (two times a day); CNS, Central Nervous System; CPT, Co-trimoxazole prophylaxis therapy; 
ED, Emergency department; mg, Milligram; PO, Per oral; tab., Tablet; TID, ter in die (three times a day). 
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In the univariate analysis of patients who experienced unintended discrepancies revealed 
significant differences in patients with more than 2 preadmission medications compared to 
patients with 2 medications (62% vs 38%, respectively, p = 0.03). However, there was no 
significant association with other variables of interest such as age, gender, the number of 
comorbidities and current medications and major diagnosis. In multivariate analysis, the 
number of preadmission medications was also the only variable that had a significant 
independent relationship with having unintentional medication discrepancy (OR 3.05, 95% CI 
1.12–8.29; p = 0.029). The effect of the intervention remained statistically significant (p < 
0001) after adjustment for all other predictor variables, and the likelihood of occurrence of 
unintentional medication discrepancies was approximately 17 times more often if there was no 
pharmacist intervention (OR 16.45, 95% CI 5.22–51.85). 
10.5 Discussion  
Recently, there has been a trend shift in hospital pharmacy services—from dispensing roles to 
that of ward-based clinical activities—and thus, Ethiopian pharmacists have been increasingly 
engaged in direct patient care roles, such as ward round, medication review and participate in 
morning sessions [27]. However, many challenges surrounding pharmacists’ involvement in 
medication safety activities had been found, and this was mainly due to human resource 
deficiencies as well as the lack of training opportunities and government funding [Chapter 9]. 
National efforts had been undergone to assess the implementation status of clinical pharmacy 
services, and it was found that these services had received wider recognition although limited 
in scope and the practice lacked uniformity across hospitals [27]. For example, medication 
reconciliation was not formally practiced, and the impact of this strategy when performed by 
pharmacists was not dealt.  
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The current study was a medication safety initiative, and to our knowledge, it was the first 
study investigating the impact of pharmacist-led medication reconciliation programs in 
resource-limited settings. Although many patient safety organizations across the globe 
endorsed medication reconciliation as a safety strategy [15–17], the impact of this program was 
not tested in sub-Saharan Africa, including Ethiopia. The findings of this study suggested that 
pharmacists assigned to an ED played a significant role in improving medication safety, and it 
was found that pharmacist-led medication reconciliation within 24 hours of adult admission 
significantly decreased the incidence of patients with at least one unintentional medication 
discrepancy; an absolute reduction of 48.5%. This finding is similar to previous studies [28–
30] conducted at ED that have shown an absolute reduction of 33% to 72% in patients with 
unintentional medication discrepancies. The impact pharmacists might bring in minimizing 
medication discrepancies was an area of interest—and this, could possibly strengthen the 
present findings—and our previous meta-analysis of 13 medication reconciliation interventions 
conducted at a single transition (either admission or discharge) has shown a substantial 
reduction of 66% in patients with medication discrepancies (RR 0.34; 95% CI: 0.23–0.50) in 
favour of pharmacist-led medication reconciliation interventions [21]. In another review of 
electronic medication reconciliation interventions [20], unlike the present study, medication 
reconciliation supported by an electronic tool did not consistently reduce the proportion of 
patients with medication discrepancies. In contrast, this tool was able to show a significant 
reduction of 45 % in the proportion of medications with unintentional discrepancies (RR 0.55; 
95 % CI 0.51–0.58). In the latter measure, the current study also showed a significant reduction 
of the percentage of medications with unintended discrepancies from 42% to 3.5% after the 
intervention (p < 0.0001). Notably, in either of these measures, the international goal of the 
WHO; that is, a 75% relative reduction in medication discrepancies [28], was achieved through 
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pharmacist involvement in medication history taking at ED; it was 82% using patients as a unit 
of analysis and 95% using medications as a unit of analysis (data not shown).  
In the present study, unintentional medication discrepancies at hospital admission were 
common, occurring in 59% of patients during the pre-intervention assessment. This proportion 
is comparable with previous studies that have shown one or more medication discrepancies in 
54–75.6% of patients at hospital admission [5, 28, 29], but there are also higher unintentional 
discrepancy occurrences from reports in other studies [2, 30]. Various definitions pertaining to 
medication discrepancies, and differences in the method of data collection might explain the 
variations between studies. In a systematic review of 95 studies by Almanasreh et al. [31] have 
shown that more than two-thirds of the studies did not utilize a BPMH, and the authors of that 
study urged the need to clearly define and classify medication discrepancies for ease of 
comparisons between studies. As an illustration,  a systematic review of 22 medication history 
error studies; of which, only 5 were able to distinguish between unintentional discrepancies 
and intentional therapeutic changes, at least one medication history error had been found in 
10–67% of patients, overall.  However, it was 27–54% of patients who were in fact experienced 
at least one medication history error when the findings are delimited to these 5 studies [8]. This 
review [8] had been conducted a decade ago, and yet a higher discrepancies rates have been 
reported since then [2, 28–30].  This might be as a result of an emerging complex care needs, 
and an increasing incidence of chronic diseases that put individuals with many health care 
needs and medications. Zoni et al. [18] have identified, for example, the relationship between 
chronic medication use and the occurrence of unintended discrepancy, and our study was also 
substantiated our explanation derived from the multivariate analysis. That is, there existed a 
significant independent relationship between the number of preadmission medications and 
unintentional medication discrepancy. Previous studies [2, 32] have also confirmed the 
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associations between unintentional medication discrepancies and the number of medications at 
admission.  
The most common medication discrepancy identified in this study was the complete omission 
of a preadmission medication a patient was taking before admission, and this was also the most 
common discrepancy reported in some previous studies [2, 5, 29, 30, 32]. Apart from 
medication omission, unintentional non-adherence to medications was highly prevalent in this 
study and this finding has been rarely described in other medication reconciliation studies 
conducted at hospital admission. Given the lower literacy level identified as a barrier to patient 
safety in our previous study [Chapter 8], this finding is not surprising. Because this type of 
discrepancy is emanated from the patient itself unlike other types of discrepancies originated 
from inappropriately taking medication histories by health care professionals—for example, 
the patient’s medication is correctly prescribed as digoxin 0.125 mg daily but what the patient 
was actually taking was 0.125 mg twice per day. An instrument, Medication Discrepancy Tool 
[33], developed for identification and characterization of medication discrepancies was also 
intended to assess the patient’s role in managing his/her medication regimen across care 
transitions. Previous studies that used this tool, for example, Coleman et al [13] have reported 
unintentional nonadherence as one of the most frequently identified medication discrepancies 
during the transition from hospital to home.  
The medication class most commonly associated with unintended discrepancies was that acting 
on the cardiovascular system, which is similar to other publications [3, 5, 18, 32], but  this was 
also among the most frequently prescribed medication group, and thus, after making 
adjustment for the frequency of prescriptions this study identified other higher risk medication 
classes; that is, vitamins and minerals. Accordingly, Pippins et al [3] and Zoni et al [18] have 
also identified other classes of medications, such as gout medications and medications used for 
the treatment of dermatological and ophthalmologic disorders, respectively.   
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Evaluating the potential clinical impact of unintentional discrepancies identified in this study, 
it was judged that 61% of the discrepancies have had the potential to cause severe patient 
discomfort or clinical deterioration. Although clinical measures, such as hospital readmission 
were not collected in this study, we believed that patients with medication discrepancies—
particularly, those with the potential to cause severe clinical deterioration—might encounter a 
higher rate of hospital readmission. Coleman et al [13] have shown that 14.3% of patients with 
medication discrepancies were readmitted at 30 days compared with only 6% of patients who 
did not have any discrepancies (p = 0.04). The present study also demonstrated the pharmacist’s 
impact in reducing severe discrepancies, which is in line with our previous review [22] that has 
identified more clinically important medication discrepancies in the usual care than pharmacy-
led medication reconciliation interventions, implying that the intervention might have resolved 
discrepancies before reaching to the patient.  
Irrespective of the potential severity of medication discrepancies, however, the occurrence of 
unintentional discrepancies was approximately 17 times more often if there was no pharmacist 
intervention. Pharmacists are uniquely trained in therapeutics, including medication history 
taking [34], and thereby, pharmacist-acquired medication history is complete and 
comprehensive than that obtained by other health professionals [35, 36]. Pharmacists could 
potentially play a central role in ensuring accurate and complete medication histories, and in 
this study there had been better documentation of medications as observed from a higher 
number of documentation regarding intentional changes to treatment in the intervention, 
compared to the pre-intervention phase (p = 0.027).  
This study has an important clinical implication in public hospitals in Ethiopia where 
medication history taking was purely assigned to physicians or physician interns. Pharmacists 
could be important resources aiding busy physicians in availing complete medication histories 
important for therapeutic decision at the time of hospital admission. However, having an impact 
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does not mean that this process is easily going given the matters that are dealt in Chapter 9. 
There are various behavioural determinants, such as knowledge, skill, competing priorities and 
willingness of pharmacists in medication history taking that should be targeted for successful 
implementation. Medication reconciliation was initially introduced as one of the Joint 
Commission’s National Patient Safety Goal in 2005 [14], and later endorsed globally, and 
much has been improved since its inception as a strategy to reduce and resolve discrepancies. 
However, there has been a number of hospital wide challenges before success stories have been 
told from various countries, including the Netherlands, Australia, and France [37]; and this will 
not be an exception for Ethiopian hospitals.  
This study had several limitations. We did not follow patients with unintentional discrepancies 
whether these had been resolved subsequently or not, although prescribers agreed that the 
identified discrepancies were unintentional.  It was also difficult to take complete medication 
history from some patients who had a low level of health literacy, and the problem was even 
worse when additional sources of medication history were not available. Because of the nature 
of study design, we could not attribute the impact was due to the intervention only; there was 
no concurrent control group and the study was done as part of a quality initiative. For example, 
during the intervention phase, we created awareness of the staff involved in emergency care 
about the importance of medication reconciliation, and coincidently, there had been some 
process redesign (e.g. changes in patient flow pattern) that could possibly change physicians’ 
usual practices.   
10.6 Conclusion 
This is the first study investigating the impact of pharmacist-led medication reconciliation 
initiative in Africa and has found that pharmacist intervention was able to reduce the incidence 
of unintentional medication discrepancies significantly. Unintentional medication 
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discrepancies were common at hospital admission, mainly medication omissions and most 
were classified as potentially impactful. Implementing this strategy in the Ethiopian setting is 
feasible, and pharmacists may be regarded as an important resource personnel for the safe use 
of medications during care transitions. 
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11.1 Overview 
Given the global burden of medication errors and the resulting adverse outcomes, a number of 
medication safety programs have been in use internationally for improving medication-related 
outcomes. Medication reconciliation is one such program, which has been recognized as an 
important approach to the Quality Use of Medicines. This strategy has been adopted as a 
standard practice in many developed countries. However, the impact of this strategy overall, as 
well as pharmacist-led medication reconciliation programs are inconclusive. Before the 
implementation of this program in settings where this has not been in place, one of the queries 
posed by the researchers of this study was to synthesize the evidence supporting the impact of 
medication reconciliation as a medication safety strategy. Whilst medication-related harms also 
represent one of the patient safety issues that concern the developing nations, including 
Ethiopia, there are not many research publications in medication safety, nor evidence-based 
interventions aimed to tackle the burden of medication errors and subsequent patient harm.  
Although pharmacists’ involvement in clinical services is a relatively new practice in the 
Ethiopian health care system, we hypothesized that the introduction of pharmacist-led 
medication reconciliation initiatives may be beneficial, and we aimed to determine whether 
this strategy is feasible in such settings. The work presented in this thesis has shown the journey 
towards the implementation of this strategy in resource-limited settings and informed by a 
sequence of four separate but inter-related studies; the first three were preparatory works, and 
the last provided evidence for effectiveness. It is our opinion that a program’s success is 
measured by its effectiveness, as well as its sustainability.  The latter was fuelled by the 
preparatory works in guiding the intervention. Broadly, this thesis uses methods from both 
safety and implementation sciences for successful implementation of the medication 
reconciliation program. System approaches to patient safety, such as patient safety culture has 
been explored, and patients’ experiences of medication-related adverse events have been 
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discussed followed by an implementation of a theory informed medication reconciliation 
intervention during hospital admission. This thesis was thus, utilized a multi-method 
exploration of patient safety issues to develop, implement and evaluate a medication safety 
program designed to reduce the burden of unintentional medication discrepancies at transitions 
in care. An overview of how each discrete component of the project forms a cohesive whole is 
graphically illustrated in Figure 11.1 below.   
The findings of the above phases of research were presented in the preceding chapters of this 
thesis, and specifically, this chapter is a summary of discussions and conclusions driven from 
the findings presented in Chapters 2 to 10. The strengths and limitations of the studies included 
in this thesis are also discussed. Finally, this chapter concludes with the implications for future 
medication safety research directions.       
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11.2 Discussion of Main Findings   
11.2.1 Pharmacy-led Approach to Medication Reconciliation  
Previous two systematic reviews of hospital-initiated medication reconciliation interventions 
have shown inconsistent findings regarding the impact of medication reconciliation in either 
improving clinical outcomes or reducing medication discrepancies [1, 2]. As a result, it was 
uncertain to support the effectiveness of medication reconciliation interventions. But, both 
agreed that most successful medication reconciliation interventions are due to pharmacist’s 
involvement; however, the impact on both process and clinical outcomes is largely unknown. 
Having taken this into consideration, we hypothesized that the impact of pharmacists in clinical 
and process outcomes were diluted amidst the various medication reconciliation approaches, 
such as collaborative models and technology supported interventions, and therefore, a pertinent 
step in the journey to medication safety program implementation would be to evaluate the 
effectiveness of pharmacy-led medication reconciliation programs as a stand-alone 
consideration. Systematic reviews and meta-analyses of the effectiveness of pharmacy-led 
medication reconciliation interventions were then conducted, and the findings have 
demonstrated a significant impact from involving pharmacists in the medication reconciliation. 
Most importantly, as detailed in Chapter 2, the intervention helps to cut adverse drug event-
related hospital revisits, subsequent emergency department hospital visits and hospital 
readmissions. However, there is no evidence that such interventions have an impact on 
mortality and composite all-cause readmission and ED visits. Similarly, pharmacy-led 
medication reconciliation interventions were also led to a significant decline in the prevalence 
of unintentional medication discrepancies when conducted at either admission or discharge.  
While much has been said regarding the uncertainties in the impact medication reconciliation 
could have, as well as the lack of clear roles and responsibilities in conducting this service 
among the health care professionals, the above two reviews of ours have demonstrated a clear 
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role for pharmacists in the medication reconciliation process. The issue of who shall be 
responsible for medication reconciliation was debatable, and this has been seen in a survey of 
health care providers’ perceptions of their roles and responsibilities in conducting medication 
reconciliation in the Arabian Gulf [3] and has found a lack of agreement among clinicians about 
their role in the process. On their perception of their role in the process, physicians and 
pharmacists considered their professions as the main providers while nurses considered 
physicians followed by themselves as the main players with limited roles for pharmacists [3]. 
This has also been observed in the USA [4], showing that most implementation efforts involve 
physicians and nurses, with little roles for pharmacists, and thus, pharmacists are underutilized 
in the medication reconciliation process.  Many argue this to the fact that, unlike pharmacists, 
the aforementioned professions are available all the time in the wards, and pharmacy staffing 
is an issue [3]. A recent national survey conducted in the USA to assess pharmacist roles in 
medication reconciliation has shown that pharmacists do not routinely or consistently provide 
medication reconciliation, and there exists insufficient recognition of the value of pharmacists’ 
roles by medical and nursing staff [5]. In fact, a number of health care organizations stated this 
process as a shared responsibility of health care providers in collaboration with patients/clients 
and families, and pharmacists are given the coordination role for the whole process [6, 7]. The 
American Society of Health-System Pharmacists (ASHP) position statement also describes that 
pharmacists, because of their distinct knowledge, skills, and abilities, are uniquely qualified to 
lead interdisciplinary efforts to establish and maintain an effective medication reconciliation 
process in hospitals and across health systems [8]. This clearly shows a discrepancy between 
what most organizations have recommended with what actually is the practice. It should be 
noted that, however, pharmacy staffing may be an issue and scope of pharmacy practice might 
vary from country to country. For example, clinical pharmacy practice is well established in 
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Australia, and medication reconciliation in hospitals is almost exclusively performed by 
pharmacists [9]. 
Furthermore, evidence from effectiveness evaluation of pharmacist-led medication 
reconciliation intervention has shown that this approach has been found as a very sensitive 
strategy in preventing ADE-related hospital revisits, and we believed that this intervention is 
powerful in picking patients with discontinued medications. Medication discontinuity—also 
called as omission of medications—is the most common identified medication discrepancy 
[10], and is also the common reason for discrepancy-related ADEs [11]. It is interesting to note 
that, while previous reviews of pharmacist-led medication reviews did not show a significant 
reduction in unplanned hospital readmissions [12, 13], the systematic review presented in 
Chapter 2 support the evidence that pharmacist-led medication reconciliation is an effective 
strategy, and strengthen our claim that considering medication review without ensuring the 
most accurate list of a patient’s current medication would be theoretical.  
The quest for evidence had not been stopped there, but it extended to searching other patient 
safety solutions, including other health care providers’ initiated interventions. The literature on 
physician- or nurse-led medication reconciliation interventions was scanty, and thus, as a viable 
option, we synthesized the evidence for electronic tools in supporting the medication 
reconciliation process.  
11.2.2 Information Technology Approach to Medication Reconciliation 
In Chapters 2 and 3, we have discussed the impact of pharmacy-led medication reconciliation 
interventions on clinical and process outcomes, respectively. In these days of high techs; 
however, the use of information technology (IT) in facilitating information communication 
overall, and in supporting accuracy in medication documentation are highly demanding. For 
instance, IT supported documentation communication ensures comprehensive medication 
history of patients through information sharing, and is now commonly employed to facilitate 
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the medication reconciliation process [14]. In Chapter 4, we addressed the impact of an 
electronic tool on the incidence of medication discrepancies identified through the medication 
reconciliation process, the findings of which yielded a significantly lower proportion of 
medications with an unintended discrepancy, mainly drug omissions. But, there was no 
significant reduction in either the proportion of patients with medication discrepancies or the 
mean number of discrepancies per patient. The clinical impact of electronic interventions is 
also less clear. There was a lack of rigorous designs to ascertain these findings, however. 
Overall, effective medication reconciliation likely requires a multifaceted approach involving 
people, process, technology and that technology intervention alone may not consistently reduce 
errors.  
One of the lessons learned from this systematic review, as detailed in Chapter 4, is the approach 
to pair computerized physician order entry programs (CPOE) with a medication reconciliation 
service in reducing medication errors. The existence of CPOE would not be able to detect 
unintentional omission of medications the patient is taking at home but would able to fill the 
gaps in prescriber’s knowledge [15]. Therefore, a CPOE program complemented with a 
medication reconciliation service may be able to bridge the gaps in continuity of patient care, 
and further ensures a comprehensive medication history of patients, and is a viable option for 
those hospitals which have an existed CPOE program. However, this also needs careful 
integration of the tool for successful implementation of computerized medication reconciliation 
services.  
Regardless of whether IT-based approaches were clearly superior to a pharmacist (or human) 
led approach, the fact that these interventions are less likely to be implemented in low resource-
settings led to the selection of feasible interventions. Thus, it becomes clear that and taking the 
available resource into consideration, the pharmacy-led approach has been selected for the 
journey towards implementation of medication reconciliation service in the Ethiopian hospital 
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settings. As highlighted in Chapter 1, local and international experiences are the grounds for 
this initiative, and the impact of medication reconciliation had not been tested in Africa, 
including Ethiopia. As the main motive of this thesis is to implement this new service in 
different hospitals in resource-limited settings in Africa, it is imperative to explore the extent 
of medication-related problems, including errors and adverse drug events in the African 
hospital setting  
11.2.3 The Burden of MEs and ADEs in African Hospitals 
While the burden of MEs and ADEs is largely unknown in the African health care setting, our 
systematic review of the African medication safety literature has shown that prescribing errors 
are the most commonly reported types of medication errors, and 4.2% of adult admissions are 
thought to be medication-related. Yet, most are preventable. This paves a way to design and 
implement preventive measures to target the burden of MEs and ADEs, one of which is the 
medication reconciliation intervention. This review, as highlighted in chapter 5, has also 
reported a severe lack of interventional studies in the area of medication safety.  
However, implementation of medication reconciliation as a medication safety strategy is not a 
final outcome but it should be supported by corresponding changes in attitudes, teamwork, 
communication, culture, and leadership. According to the WHO High 5s medication 
reconciliation program [16], the culture of the organization with respect to interdisciplinary 
collaboration and teamwork significantly influence the effectiveness of the medication 
reconciliation process, and we believe this has to be explored to look at the changes necessary 
to improve patient safety. Ensuring a culture of safety and organizational supports for safety 
processes are key to patient safety improvement, and using a system approach is vital to identify 
factors that influence patient safety. In the following sections, we will discuss how health care 
professionals’ perceived patient safety and will identify the existing patient safety problems in 
the Ethiopian public hospitals using both qualitative and quantitative methods. We also 
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believed that the overall picture of patient safety is not complete without addressing patients’ 
experiences of medication-related adverse events from the perspective of patients themselves.  
11.2.4 Health care Professionals’ Perspective of Patient Safety and Patients’ Experiences 
of Medication Related Adverse Events  
Policies with regard to patient safety issues have been inconsistently integrated into the 
Ethiopian health care system, and it is only recently that the government of Ethiopia ratified a 
five year (2016–2020) strategic plan for improving the quality of patient care [17]. Given the 
wider commitment taken by the government for health care coverage and access, most patient 
safety efforts have been limited in scope and practice. As a result, investigation of patient safety 
issues in the Ethiopian health care is an area of research that is relatively new.  
In Chapters 7 and 8, we explored patient safety issues from both the perspective of health care 
professionals and patients sides. Overall, health care professionals’ perspective of patient safety 
culture was not satisfactorily enough, as measured by the HSOPSC instrument. The dimensions 
‘Teamwork within units’ and ‘organizational learning–continuous improvement’ received the 
highest positive score, while ‘staffing’ scored the lowest. Interestingly, the dimensions 
‘handoffs and care transitions’ and ‘punitive response to error’ were the other safety problems 
identified in this study. Particularly, problems with handoffs and care transitions were largely 
correlated and severely affected by a lack of teamwork across units, punitive response to error 
reporting and managerial inaction for promoting patient safety. These findings have also been 
uncovered during the in-depth interviews, as highlighted in Chapter 8. The interview data 
ascertained that incident reporting was infrequently done, when do so, it was usually not 
documented. Poor communication and teamwork, lack of cooperation, respect and supervision, 
together with the lack of an incident reporting system undermine the development of a culture 
of safety in the Ethiopian public hospitals. Previous local studies [18, 19] also reported that 
inter-professional communication is weak—mostly due to hierarchical differences—and 
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patient safety is greatly influenced by the norms and values of professional thought and status. 
The presence of professional hierarchies reflects that HCPs feel uncomfortable, and encounter 
difficulties to raise their concerns with other colleagues [20]. An organizational culture that 
promotes reporting and encourages non-punitive response to error and improved 
communication are reported as important factors to improve patient safety culture [21].  
According to the Institute of Medicine [22], one of the challenges health care organizations 
encountered for the movement towards safer health system is a culture of blame. In other 
words, errors should not be treated as personal failures but as opportunities for improvement.  
This cultural transformation in Ethiopia may need more work and needs a strong leadership 
that enables staffs to be safety conscious, committed to learn from their mistakes and prevents 
errors from happening again. However, according to health care professionals, lack of 
managerial support had been identified as a barrier to patient safety. Participants also 
mentioned that most managers devoted their time for the mere purpose of political promotion 
and that most appointees were based on political affiliation than clinical leadership. There was 
a strong held belief among the participants that without having the appropriate person at the 
right position, it would be unlikely to achieve what hospitals are striving to do, and it does not 
make sense to talk about other problems due to the lack of effective clinical governance. 
Furthermore, the interview data revealed other findings that the HSOPSC as a patient safety 
measure could not evaluate patient safety issues that have arisen as a result of resource 
limitations. Unlike developed countries, for example, the challenges faced by the Ethiopian 
health care system identified the lack of infrastructure (e.g. lack of rooms for patient 
admissions), poor sanitation, and material deficiencies (e.g. supplies, medications, and 
laboratory equipment) for achieving desired patient safety outcomes. While patient safety 
improvement requires adequate resources (e.g. human and material), these are not adequate on 
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their own; it also requires managerial support and change in culture and structure of governance 
[23, 24].  
The interview data also revealed other important findings that the HSOPSC and other local 
studies [18, 19] did not or scarcely reported.  . For instance, participants identified a lack of 
patient safety competencies, such as adequate knowledge and skills pertinent to correctly 
prescribe medications, administer medications and monitor patients. Task factors related to 
patient safety problems, such as the absence of incident reporting, delay in delivering health 
services, and the lack of safety protocols were cited as barriers to patient safety improvement. 
Although the HCPs believed that patient involvement in their own safety positively influenced 
patient safety, economic constraints and health illiteracy negatively impacted patient safety. 
These have also been mentioned from the individual patient interviews. Patients expressed a 
range of experiences related to their medication, and sometimes patients intended to stop their 
chronic medication because of this. Although patients encountered a number of medication-
related adverse events, they were satisfied with the treatment they were taking. The possible 
explanation for this is that the way patients were thinking about their own safety. Patients might 
associated this with an effectiveness of therapy, or might perceived medication-related adverse 
events are inevitable occurrences following medication taking, and mostly they associated their 
satisfaction with the delivery of health services, such as timeliness, affordability and service 
availability.     
Many strategies to promote patient safety have been suggested from the HCPs, as detailed in 
Chapter 8. Given the multifactorial nature of patient safety barriers, however, patient safety 
solutions are as diverse as their problem [25] and could be directed at various levels, such as 
the health care professional, patients, task factors, work environment, and organizations. Many 
of the barriers for patient safety in this study emanated from the lack of resources (e.g. human 
and material), but our medication safety initiative did not address the broad underlying causes 
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of patient safety problems (e.g. inadequate resources), but rather target specific levels, 
including teamwork, patients, communication (e.g. at care transitions) and process design to 
prevent medication errors from actually reaching the patient. As previously mentioned, our 
initiative was a journey towards implementation of a pharmacist-led medication reconciliation 
service in settings where this service had been limited or not available at all. Thus, exploration 
of the barriers and facilitators that might influence hospital pharmacist’s engagement in 
medication safety activities may help service providers or planners to target successful delivery 
of quality patient care. 
11.2.5 Barriers and Facilitators to Hospital Pharmacists’ Engagement in Medication Safety 
Activities 
Unlike the developed countries, pharmacists’ involvement in clinical services is at the early 
stage in Ethiopia [26].  As a result, little is known regarding the current status of Ethiopian 
pharmacist’s extended services, such as medication review and reconciliation, as well as the 
barriers and facilitators to hospital pharmacists’ engagement in medication safety activities. 
As highlighted in Chapter 9, we employed implementation science concepts for the success of 
our journey. It has been suggested that many factors can influence uptake of evidence-based 
interventions, and the success of implementation journey is highly dependent on a careful 
assessment of barriers to, and facilitators of, the behaviour to be changed, and identification of 
such factors provide a theoretically robust evidence base to inform implementation of an 
intervention [27]. Using the Theoretical Domains Framework (TDF), we identified a wide 
range of factors that may influence the uptake of medication safety interventions delivered by 
hospital pharmacists. The majority of hospital pharmacists were very much enthusiastic for 
their extended roles and were positive towards the future of the profession; however, there were 
a number of factors likely to influence their clinical practice. These factors were clustered into 
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six predominant domains: ‘Knowledge’, ‘Skills’, ‘Environmental context and resources’, 
‘Motivation and goals’, ‘Social influences’, and ‘Social/professional role’.      
Environmental constraints (e.g. lack of government funding and human resource) were 
consistently identified as prominent barriers, and there was none which was identified as a 
facilitator in the context of resource issues. There have also been some links with other domains 
judged to be relevant, such as motivation and goals and social/professional role.    
Unlike the environmental constraints, in the remainder of domains, a diverse range of views 
had been reflected from hospital pharmacists. For example, dispensing was thought to be a core 
business for the majority of health managers, and thus, hospital pharmacists were reinforced 
for other competing priorities. There was no remuneration schemes or incentives arranged for 
these cognitive services delivered by hospital pharmacists, and because of this, most 
pharmacists preferred dispensing to clinical services. A recent national study has also shown 
that two-thirds of hospital pharmacists are dissatisfied with their job, and this is mainly due to 
unattractive incentive packages [28]. There were yet enthusiastic hospital pharmacists who 
devoted themselves for the mere growth of the profession, and for these groups of pharmacists, 
the main concern was the lack of managerial and government support and the lack of role 
recognition by other members of the health care team.     
While major differences in individual thoughts related to hospital pharmacists’ knowledge, 
skills, and social/professional role as well as motivation and goals existed, inter-institutional 
variation mainly appeared in the social influence domain. For example, hospital pharmacists 
working in district hospitals clearly indicated that their recommendations were better 
entertained and accepted by other health care professionals, and there was also an increasing 
demand for clinical pharmacy services. Particularly, those HCPs who believed in team and 
collaborative works were the most likely candidates for promoting clinical pharmacy services. 
Previous studies have demonstrated pharmacist provided therapy recommendation in care 
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teams resulted in positive clinical and economic outcomes, and these have been associated with 
high acceptance rates [29, 30]. A study by Anderegg et al [31] has shown that a high acceptance 
rate of pharmacist-provided services is associated with medication reconciliation as compared 
with other clinical services, such as those related to medication indication, efficacy, and 
therapeutic drug monitoring. Given the positive impact of pharmacist-led medication 
reconciliation programs, as outlined in Chapters 2 and 3, and the evidence that these services 
have shown better acceptance [31], it is our opinion that pharmacists’ clinical services in the 
studied hospitals, mainly those above the district level, may be well utilized if they could able 
to implement medication reconciliation services. 
11.2.6 Pharmacist-led medication reconciliation intervention – Pre-post study 
This part of the thesis has been described in Chapter 10, and it was a single center investigation 
of the impact of pharmacist-led medication reconciliation intervention on the incidence of 
unintentional medication discrepancies before and after the implementation of this service. 
Many health care organizations endorsed medication reconciliation as a medication safety 
strategy [32–34], but the impact of this program was not tested in Africa. Our intervention 
suggested that pharmacists assigned to an emergency department played a significant role in 
improving medication safety, and had found that admission medication reconciliation 
significantly minimized the proportion of patients with at least one unintentional medication 
discrepancy. As described in Chapter 3, this finding is consistent with the meta-analysis of 13 
medication reconciliation interventions conduct at either admission or discharge. In contrast, 
medication reconciliation intervention supported by an electronic tool (Chapter 4) did not 
consistently reduce the proportion of patients with medication discrepancies. Most importantly, 
our intervention achieved the international goal of the WHO [35]; that is, a 75% relative 
reduction in medication discrepancies was achieved through pharmacist involvement in 
medication history taking at ED.  
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The most common medication discrepancy identified was the complete omission of a pre-
admission medication a patient was taking before admission, and this was also the most 
commonly reported discrepancy in a previous study [10]. Although it has been rarely reported 
in other medication reconciliation studies, unintentional non-adherence to medications was 
highly prevalent in our study, as highlighted in Chapter 10. This finding may be attributed to 
the lower patient health literacy level, as identified in Chapter 8—as one of the barriers to 
patient safety improvement in Ethiopian public hospitals. This is expected because this type of 
discrepancy is emanated from the patient itself unlike other types of discrepancies originated 
from inappropriately taking medication histories by health care professionals. An instrument, 
Medication Discrepancy Tool [36], developed for identification and characterisation of 
medication discrepancies was also intended to assess the patient’s role in managing his/her 
medication regimen across care transitions. Previous studies that used this tool, for example, 
Coleman et al [37] have reported unintentional nonadherence as one of the most frequently 
identified medication discrepancies during the transition from hospital to home. 
It is also of interest to note that, most of the discrepancies identified were judged to have had 
the potential to cause severe patient discomfort or clinical deterioration. We did not collect 
hospital readmission as an outcome measure, but we believed that patients with medication 
discrepancies—particularly, those with the potential to cause severe clinical deterioration—
may encounter a higher rate of hospital readmission. Coleman et al [37] have shown that 14.3% 
of patients with medication discrepancies were readmitted at 30 days compared with only 6% 
of patients who did not have any discrepancies (P = 0.04). However, our intervention did not 
show a difference between the pre- and post-intervention groups in terms of the potential 
clinical impact of unintentional medication discrepancies. In the contrary, our systematic 
review (Chapter 3) identified more clinically important medication discrepancies in the usual 
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care than pharmacy-led medication reconciliation interventions, implying that the intervention 
might have resolved discrepancies before reaching to the patient.  
Overall, our intervention has an important clinical implication in the Ethiopian health system 
where medication history taking are purely assigned to physicians or physician interns. 
Notably, pharmacists may be an important resource personnel aiding busy physicians in 
availing complete medication histories important for therapeutic decision at the time of hospital 
admission. Given the barriers that could possibly impact pharmacist’s role in medication safety 
activities, as detailed in Chapter 9, having an impact does not mean that this intervention is 
easily implemented. There are various behavioural determinants, such as knowledge, skill, 
competing priorities and willingness of pharmacists in medication history taking that should 
be targeted for successful implementation. Leave alone the Ethiopian health system, 
implementation of medication reconciliation in the developed world had faced the same 
challenges before success stories had been told from various countries, including the 
Netherlands, Australia, and France [38], and this will not be an exception for the Ethiopian 
hospitals.  
11.3 Strengths and Limitations 
This thesis presents a serious of steps in the journey to medication safety program 
implementation. It encompasses systematic reviews to find an evidence-base for a successful 
medication safety program, and the use of a number of research methods to address the research 
aims and objectives. This thesis is unique in many aspects, one of which is the use of a multi-
method approach for the exploration of patient safety issues, and novel in that it used a 
behavioural change theory for a successful implementation of medication safety programs. 
However, it has a number of methodological issues that should be taken into considerations. 
The strengths and limitations of this thesis have been discussed in detail in the previous 
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chapters, consequently, this section will summarize those judged to be the most notable, and 
those which have the broadest relevance to the whole thesis.   
We had conducted a series of systematic reviews pertaining to medication safety (Chapters 2 
to 5). This had been done purposefully given the limited evidence-base available to date 
pertaining to interventions to improve medication safety. Systematic reviews provide data for 
rational decision making [39], and can support policy making [40], as well as able to inform if 
the research question of interest has already been answered before a new study begins [41]. It 
was thus, instrumental to evaluate the available literature to help select an effective medication 
safety program that would be a promising strategy for implementation. Basically, systematic 
reviews and meta-analyses, are important tools for evidence-based medicine [42], and that was 
the primary reason for using these approaches. Meta-analysis, subset of a systematic review, is 
a statistical procedure that integrates the results of several independent studies and plays a central 
role in evidence-based medicine. In the hierarchy of clinical evidence—for example, meta-analyses 
are in the top [42]. However, the evidence-base from the meta-analyses depend strongly on the 
quality of the studies identified to estimate the pooled effect. Typically, but not necessarily, 
randomized controlled studies are frequently employed in deriving conclusions from meta-analytic 
procedures. An empirical evidence showed that non-randomized studies tended to show larger 
treatment effects [42]. In Chapters 2 to 4, we included studies from randomized, non-randomized 
and observational studies to evaluate the effectiveness of interventions, and this is an inherent 
limitation to the review conclusions.      
Given the limited synthesis and review of the literature regarding medication safety, a 
systematic review detailing medication errors and adverse drug events in African hospitals had 
been done to have a broad understanding of the burden of medication-related problems, and to 
search any available medication safety programs in place. In opting to identify and evaluate 
the broader African medication safety literature, we did not focus on a specific research 
question, nor delimited to the Ethiopian setting. It should also be noted that limiting the search 
 Part D – Chapter 11                                                                                                                         251 | P a g e  
to the English language may contribute for lesser included studies; notably, some publications 
from francophone countries were evident.     
In Chapters 7 and 8, health care professionals’ perspective of patient safety and patients’ 
experiences of medication-related adverse events had been addressed. For the better 
understanding of these research questions, we utilized mixed methodological approaches 
involving both quantitative and qualitative methods. A combination of both methodological 
approaches is to provide the most comprehensive results, and it is believed that pharmacy 
practice research can benefit from a study that uses both quantitative and qualitative data to 
develop a strong evidence-base to support pharmacy-led services [43], including medication 
reconciliation. In Chapter 7, we adopted an HSOPSC questionnaire to assess the views and 
perceptions of health care professionals about patient safety culture. In this chapter, calculating 
patient safety culture scores were appropriate to identify existing patient safety problems. The 
questionnaire for this study was kept in English, and this might impact the understandability of 
the instrument. In fact, English is the medium of instruction and language of communication 
in the Ethiopian health care system. Since the HSOPSC survey explores patient safety issues 
from the perspective of systems approach, it did not attest other safety issues from the 
perspective of  personal approach (e.g. health care professionals, patients), and did not 
explicitly evaluate safety issues that would arise as a result of resource limitations (e.g. 
inadequate equipment, unavailability of medications). Although the focus of the thesis was on 
medication safety, we broadly utilized the patient safety culture questionnaire internationally 
used for general patient safety assessment and thus, lacks specificity to medications. But, it is 
our opinion that HSOPSC evaluate safety issues from the perspective of systems approach, and 
this would not be different for medication safety culture as well. Still, we believed that 
medication safety is a core subset of the many patient safety issues, and the use of HSOPSC as 
a tool can elaborate many of the medication safety culture issues in it.  
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The semi-structured interviews, utilized in Chapter 8, were thus essential for eliciting deeper 
views from both HCPs and patients regarding patient safety issues. Text comments (from the 
HSOPSC survey) had been collated and merged to strengthen the findings of the in-depth 
interview. The qualitative results presented in Chapter 8, yielded both similar and unique 
findings—for example, understaffing and work burden was cited as one of the factors affecting 
patient safety in both of the research methods whereas safety issues from the perspective of 
other resource limitations (e.g. poor infrastructure, material deprivation) were reported in the 
qualitative findings. The inclusion of text-comments was also able to provide unique data that 
had not been discussed in the interview data—for example, managerial incapability and 
political affiliation as barriers to patient safety had been mentioned in the text-comments. The 
sampling technique may carry a risk of bias in both the interviews and survey, however, this 
thesis explored safety issues from the wider perspective (including patients) and the use of 
mixed-method gave a complete picture for the whole patient safety issues.   
In Chapter 9, our focus was narrowed to pharmacists only, and focus group discussions were 
employed to facilitate data gathering. FGDs as a tool permits richness and flexibility in the 
collection of data and is an effective method in supplying information about how people think, 
feel, or act regarding a specific topic [44]. Together with other methods, it can be used for 
preliminary research, or to prepare specific subjects in a large project. However, one of the 
limitations in this chapter of the thesis was that homogeneous groups of participants were 
involved in the FGDs. We did not take the thoughts from the perspective of product-oriented 
pharmacists; at the time of data collection, these pharmacists were engaged only in dispensing 
activities. In fact, it is highly recommended to involve homogeneous groups in order to 
capitalize on people’s shared experiences [45].  
The strengths in the focus group discussions were the use of the theoretical framework to guide 
the discussions but also aided to identify many factors that can affect the adaptability of an 
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evidence-based intervention. When designing questions according to the theoretical 
framework, however, we incorporated a wide range of questions exploring a core set of clinical 
pharmacy services. But, it should be noted that admission and discharge medication 
reconciliation is one of the core clinical activities delivered by hospital pharmacists although 
the issue of medication reconciliation was new to the local situation.  
Overall, although the use of various qualitative methods helped to fill the gaps inherent to the 
individual data collection tools, data analysis was done by one researcher that may still carry 
some risk of bias.   
In Chapter 10, we evaluated the impact of pharmacist-led medication reconciliation 
interventions on the incidence of unintentional medication discrepancies and had found that 
implementing this strategy is feasible and pharmacists may be regarded as an important 
resource personnel for the safe use of medications during care transitions.  However, having 
an impact might not be necessary meant that the intervention will be successfully and 
sustainably practiced. One of the innovative solutions to this was the exploration of behavioural 
determinants that were likely influenced medication safety activities delivered by hospital 
pharmacists, as highlighted in Chapter 9. This implies that behavioural determinants should be 
targeted before success is evident. However, we did not target each of the factors, but of course, 
our intention was to prepare hospital pharmacists for new roles. For example, competing 
priorities and the lack of reimbursement for clinical services had been described as barriers to 
hospital pharmacists’ medication safety activities, and such issues need wider attention.  On 
the other hand, in the implementation process, there was a room for equipping hospital 
pharmacists’ with the knowledge and skill important for delivering medication reconciliation.  
We proposed to initiate interventions both at hospital admission and discharge. But, due to 
resource limitation, we limited the implementation to hospital admission only. Although the 
time between pre-intervention and post-intervention assessment was short, there had been 
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important changes to patient flow structure during the implementation phase. Before and during 
implementation, serious of discussions regarding the importance of pharmacist’s involvement 
in medication history taking with the staffs engaged in emergency care had been taken. Thus, 
our findings should be interpreted with caution. .    
11.4 Conclusion 
Overall, this thesis was a medication safety initiative focusing on medication reconciliation 
intervention, and the implementation of this initiative was guided by a multi-method approach 
consisting both qualitative and quantitative methods. It was thus, to the best of our knowledge, 
for the first time that this study has investigated the impact of pharmacist-led medication 
reconciliation in the African hospital setting, and the journey to implementation was informed 
by a serious of systematic reviews, alongside with a theoretically robust evidence-based 
exploration of the barriers to implementation. This journey was also supported by the 
identification of safety processes, such as assessing the culture of safety from the perspective 
of HCPs, and exploration of patients’ experiences of medication-related events.  
The results of systematic reviews and meta-analyses have shown an evidence that medication 
reconciliation interventions carried out through pharmacist assessment at hospital transitions 
were found to be an effective strategy for improving clinical outcomes (e.g. ADE-related 
hospital visits, all-cause readmissions, and ED visits), as well as process outcomes, such as the 
occurrence of unintentional medication discrepancies. More clinically relevant and 
discrepancies of higher impact were easily identified through pharmacy-led medication 
reconciliation programs. Literature exploring medication reconciliation supported by an 
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electronic tool has also been collated and has found that electronic tools did not consistently 
reduce process outcomes. 
Patient safety culture in the studied hospitals has been found lower than the benchmark studies. 
Importantly, understaffing followed by problems during handoffs and care transitions and 
punitive response to error were identified as major safety problems. Particularly, hand offs and 
care transitions were largely affected by the lack of teamwork across units, punitive response 
to error reporting and managerial inaction for promoting patient safety. In addition to system 
factors presumed to affect patient safety, other factors such as individual HPCs, patient, and 
task factors have been identified as challenges to achieve an optimal patient safety in Ethiopian 
public hospitals. Resource limitations (e.g. material deficiencies, poor infrastructure) have been 
indicated as the greatest barriers for patient safety, and these have been scarcely or not reported 
at all in other similar studies elsewhere. Patients expressed a range of perceived experiences 
related to their medication, and a number of strategies required to improve patient safety 
practices have been suggested. Changes in practice, processes, structure, and systems were 
believed to help improve patient safety in the Ethiopian health care system. For example, 
engaging pharmacists in the multidisciplinary team have been one of the suggestions to 
improve medication safety.  
The results of this thesis have demonstrated that hospital pharmacists were very much 
enthusiastic for their extended roles and were positive towards the future of the profession; 
however, there were many factors that likely influenced their behaviour in the clinical practice. 
Theory-based identification of behavioural determinants affecting hospital pharmacists’ 
engagement in medication safety activities were predominantly related to ‘Knowledge’, 
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‘Skills’, ‘Environmental constraints’, ‘Motivation and goals’, ‘Social influences’, and 
‘Social/professional role’.  
Whilst unintentional medication discrepancies were highly prevalent at the time of hospital 
admission, this study also found that pharmacist-led medication reconciliation was able to 
minimize the occurrence of discrepancies significantly. Thus, implementation of medication 
reconciliation as a medication safety strategy is feasible, and pharmacists may be regarded as 
key resource personnel for the safe use of medications at the time of hospital admission. 
However, the sustainability of this service utilization is highly dependent on other behavioural 
determinants, such as knowledge and skill, competing priorities, and reimbursement for clinical 
services.    
11.5 Future Directions  
The research presented in this thesis represents a significant body of work to the journey to the 
implementation of medication reconciliation programs. This is a preliminary step for assessing 
the feasibility of medication reconciliation service in a resource-limited setting, and there are 
yet many avenues for future research in medication safety and in the broader area of patient 
safety. Research opportunities are as diverse as the areas covered in this thesis, and the target 
of subjects for improvement and future research may include patients, HCPs, pharmacists and 
health care managers.  
Given the negative patient safety culture revealed in this thesis, awareness creation campaigns 
targeting HCPs and health care managers in order to be safety conscious, and to further initiate 
development of quality improvement projects are demanding. Patient safety culture as a whole, 
can be taken as a quality improvement agenda in each of the hospitals studied, as well as each 
specific dimensions (e.g. handoffs and care transitions) are in fact, need to be addressed. 
Culture influences health care professional’s motivation to engage in safety behaviours, and 
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creating a safer health care system needs cultural transformation [46]. Leadership in the health 
care shapes the culture, this, in turn, shapes the information flow and processing which has an 
important effect on patient safety. Better up take of innovations, such as patient safety highly 
depend on leaders that favour cooperation, creativity, and safety  [47]. The findings of this 
thesis demonstrated that leadership incapability existed, and leadership positions were mostly 
not merit based. Besides awareness creation campaigns,  leadership skill development schemes 
might be necessary for health care managers, and patient safety from the perspective of health 
care managers should be explored in future studies.   
Although efforts to evaluate patient safety culture over time is an important aspect of ensuring 
safety—this might not be sufficient alone—but, it should also be supported through the 
introduction of patient safety teaching into the curricula for all medical and health science 
students. This could be achieved, for example, by the Multi-professional Patient Safety 
Curriculum Guide developed by the WHO [48]. This guide is mainly used for implementing 
patient safety education in universities/schools worldwide and targets education in the fields of 
dentistry, medicine, midwifery, nursing and pharmacy, and other related health-care 
professions. The guide enables HCPs to facilitate the incorporation of patient safety principles 
into their practice, in a wide range of educational and cultural settings [48]. Patient safety 
teaching should also be corroborated by an increase in awareness, skills, and knowledge in 
medical ethics among the clinicians.  
A number of other suggestions to improve patient safety in the Ethiopian health care system 
have been forwarded, and these included changes in practices, processes, structures, and 
systems. None of these have been evaluated in the Ethiopian health care system and could be 
a subject of research for future studies. 
Although the internal consistency of the whole survey that we employed for measurement of 
patient safety culture (HSOPSC) was fairly satisfied, the reliability analysis of individual 
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constructs showed many factors less than adquate level of Cronbach’s alpha. Unlike other 
studies focused on tool development, this study was not designed for optimization of HSOPSC 
measurement model. Thus, further research is needed to confirm the applicability of the 
translated version of the HSOPSC, preferably Amharic in the Ethiopian hospital settings.  
This thesis covered some patient-related factors which influenced patient safety. Patients’ 
understanding of their medication was also not adequate. The second common unintentional 
medication discrepancy identified in this thesis was unintentional non-adherence (Chapter 10), the 
most likely culprit for this may be related to lack of adequate knowledge about their medication. 
However, comprehensive assessment of the factors affecting patients’ engagement in patient safety 
had not been done. Patients can play an important role in improving patient safety by becoming 
actively involved in their health care, and patient involvement in safety is an emerging field of 
interest [49]. Therefore, future studies targeting factors affecting patient involvement in patient 
safety, as a stand-alone consideration, is of interest. The impact of patient counselling on patients’ 
knowledge about their medication should also be sought in the future. 
With respect to hospital pharmacists’ activities in medication safety, awareness creation 
campaigns targeting the whole medical community (including the management, and other 
HCPs) could help facilitate the uptake of hospital pharmacist’s cognitive services into clinical 
practice. And, yet there is a room for further studies that could also examine these extended 
services in the eyes of patients and other health care providers. Most importantly, product-
oriented pharmacists’ perspective of this new role could be explored. The findings of this thesis 
also highlighted clear gaps in hospital pharmacists’ gaps in knowledge and skills necessary for 
delivering clinical services. While a national in-service training for practicing hospital 
pharmacists is a key first step to equip pharmacists with the necessary knowledge and skills 
needed to solve clinical challenges successfully, but the ultimate solution rests up on revisions 
in the undergraduate pharmacy curriculum that includes pharmacist’s role in medication 
reconciliation.  
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The findings within this thesis have also identified further areas associated with pharmacist-
led medication reconciliation programs which should be prioritized for research. Given the 
extended role of pharmacists in the Ethiopian health care system, medication reconciliation 
service, undoubtedly, represents an additional role that can be assumed by hospital pharmacists.  
As we illustrated in the limitation, however,  it was difficult to attribute the impact was due to 
pharmacist involvement only. Thus, further interventional studies with rigorous study designs, 
possibly a randomized control trial could be used to confirm our results. Further research is 
also warranted to understand the impact of this intervention on some of the clinical outcomes 
of interest (e.g. adverse drug event-related hospital visits, all-cause ED visit). It would be 
intersting as well for future studies to explore the economic value of pharmacist-led medication 
reconciliation where financial constraints are common.    
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Appendix 2. Electronic Supplementary Materials Published Online 
A2.1 Electronic Supplementary Materials Published Online for Chapter 2 
A. Online supplementary appendix A: Electronic database searches 
Medline, IPA and PsychINFO 
#                  Searches Results 
1 ((medic$ or drug$) adj2 discrepanc$).mp.   524 
2 ((medic$ or drug$) adj2 reconciliation$).mp.   1,193 
3 ((medic$ or drug$) adj2 histor$).mp.   75,175 
4 ((medic$ or drug$) adj2 list$).mp.   5, 023 
5 (((medic$ adj2 chart$) or (medic$ adj2 record$)) adj2 assessment).mp.   125 
6 
((medic$ or drug$ or prescription$ or (medic$ adj2 chart$) or (medic$ adj2 record$)) 
adj2 review$).mp.   
35,859 
7 ((medic$ or drug$) adj2 congruence$).mp.   20 
8 ((medic$ or drug$) adj2 management).mp.   37,424 
9 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 151,309 
10 patient admission.mp. or Patient Admission/ 20,054 
11 patient discharge.mp. or Patient Discharge/ 21,100 
12 patient transfer.mp. or Patient Transfer/ 6,658 
13 Hospitalization/ or hospital transfer.mp. 81,536 
14 "Continuity of Patient Care"/ or care transition.mp. 15,531 
15 inpatients.mp. or Inpatients/ 58,575 
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16 seamless care.mp. 154 
17 continuum of care.mp. 3,103 
18 "Delivery of Health Care, Integrated"/ or integrated health care.mp. 10,066 
19 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 199,032 
20 pharmac*.mp. 905,186 
21 9 and 19 and 20 1,144 
22 limit 21 to (abstracts and english language and humans)   1009 
CINHAL 
#              Searches Results 
S18 S14 AND S15 AND S16 Limiters-Peer Reviewed; English Language; Abstract Available   267 
S17  S14 AND S15 AND S16   396 
S16  S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13   306,305 
S15  S1 OR S2 OR S3 OR S4 OR S5 OR S6   9,033 
S14  "Pharmac*"   101,387 
S13  (MH "Continuity of Patient Care+") OR "continu*"   187,044 
S12  "seamless care"   104 
S11  (MH "Inpatients")   55,914 
S10  "emergency medic*"   29,880 
S9  "transition of care"   143 
S8  (MH "Transfer, Discharge")   3058 
S7  (MH "Patient Admission") OR (MH "Hospitalization+") OR (MH "Patient Discharge+")   56,917 
S6  "medication discrepancies"   45 
S5  "medication discrepancy"   10 
S4  "drug history"   122 
S3  (MH "Medication Errors+")   8,626 
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S2  (MH "Medication History")   60 
S1  (MH "Medication Reconciliation")   472 
Embase 
#              Searches Results 
24  
#1.20 AND #1.21 AND #1.22 AND #1.23  [english]/lim AND [humans]/lim AND 
[abstracts]/lim 
 335 
23  #1.15 OR #1.16 OR #1.17 OR #1.18 OR #1.19  375,805 
22  
#1.5 OR #1.6 OR #1.7 OR #1.8 OR #1.9 OR #1.10 OR #1.11 OR #1.12 OR #1.13 OR 
#1.14 
 454,467 
21  #1.1 OR #1.2 OR #1.3 OR #1.4  4,019 
20  pharmac* 3,875,936 
19  'hospitalized patients'/exp OR 'hospitalized patients'  74,696 
18  'inpatients'/exp OR 'inpatients'  108,750 
17  'patient transfer'/exp OR 'patient transfer'  40,927 
16  'patient discharge'/exp OR 'patient discharge'  96,003 
15  'patient admission'/exp OR 'patient admission'  137,129 
14  'medication'/exp OR medication AND record  179,120 
13  'medication'/exp OR medication AND record AND systems  4,687 
12  'medication'/exp OR medication AND record AND assessment  14,853 
11  'medication'/exp OR medication AND record AND ('review'/exp OR review)  44,320 
10  'medication'/exp OR medication AND chart AND ('review'/exp OR review)  9,372 
9  medic* OR drug* AND list*  52,323 
8  'medication'/exp OR medication AND ('history'/exp OR history)  91,985 
7  'drug'/exp OR drug AND ('history'/exp OR history)  213,214 
6  'drug'/exp OR drug AND ('history'/exp OR history) AND taking  9,182 
5  'medication'/exp OR medication AND ('history'/exp OR history) AND taking  5389 
4  'medication'/exp OR medication AND reconciliation AND errors  443 
3  'medication'/exp OR medication AND ('history'/exp OR history) AND errors  570 
2  'medication'/exp OR medication AND discrepancies  2464 
1  'medication'/exp OR medication AND reconciliation 1453 
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PubMed 
((((((medication reconciliation) OR medication discrepancies) OR medication history) OR 
((medication AND (chart OR record) AND assessment)))) AND (((continuity of care) OR 
seamless care) OR ((hospital* OR inpatient* OR interface* OR discharge* OR admission*)))) 
AND pharmac* [640] 
B. Online supplementary appendix B: List of excluded full text papers and of the reasons for their 
exclusion 
No control group/ ineligible comparator 
Boso ribelles et al (2011). "Evaluation of a plan for cardiology medication reconciliation on 
admission, and patient information at discharge, in a teaching hospital.” EJHP Practice 17(1) 
Anderegg, S. V., et al. (2013). "Acceptance of recommendations by inpatient pharmacy case 
managers: unintended consequences of hospitalist and specialist care." Pharmacotherapy: The 
Journal of Human Pharmacology & Drug Therapy 33(1): 11-21. 
Cornu, P., et al. (2012). "Effect of medication reconciliation at hospital admission on medication 
discrepancies during hospitalization and at discharge for geriatric patients." Annals of 
Pharmacotherapy 46(4): 484-494. 
Hellstrom, L. M., et al. (2012). "Errors in medication history at hospital admission: prevalence and 
predicting factors." BMC Clin Pharmacol 12: 9. 
Lessard, S., et al. (2006). "Medication discrepancies affecting senior patients at hospital 
admission." Am J Health Syst Pharm 63(8): 740-743. 
Mergenhagen, K. A., et al. (2012). "Pharmacist- versus physician-initiated admission medication 
reconciliation: impact on adverse drug events." American Journal of Geriatric Pharmacotherapy 
10(4): 242-250. 
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Midlov, P., et al. (2012). "The effect of medication reconciliation in elderly patients at hospital 
discharge." International Journal of Clinical Pharmacy 34(1): 113-119. 
Quennery, S., et al. (2011). "Added value of pharmacist-acquired drug histories in an orthopaedic 
ward." Acta Clinica Belgica 66(3): 196-199. 
Reeder, T. A. and A. Mutnick (2008). "Pharmacist- versus physician-obtained medication 
histories." American Journal of Health-System Pharmacy 65(9): 857-860. 
Not Pharmacist-led medication reconciliation  
Lalonde, L., et al. (2008). "Effectiveness of a medication discharge plan for transitions of care 
from hospital to outpatient settings." American Journal of Health-System Pharmacy 65(15): 1451-
1457. 
 Midlov, P., et al. (2008).  "Medication report reduces number of medication errors when elderly 
patients discharged from hospital." Pharmacy World & Science 30(1): 92-98. 
Schnipper, J. L., et al. (2009). "Effect of an electronic Medication reconciliation application and 
process redesign on potential adverse drug events a cluster-randomized trial." Archives of Internal 
Medicine 169(8): 771-780. 
Showalter, J. W., et al. (2011). "Effect of standardized electronic discharge instructions on post-
discharge hospital utilization." J Gen Intern Med 26(7): 718-723. 
Zoni, A. C., et al. (2012). "The impact of medication reconciliation program at admission in an 
internal medicine department." European Journal of Internal Medicine 23(8): 696-700. 
Study protocol 
Salanitro, A. H., et al. (2013). "Rationale and design of the Multicenter Medication Reconciliation 
Quality Improvement Study (MARQUIS)." BMC Health Serv Res 13: 230. 
 
 Appendices                                                                                                                                          274 | P a g e  
Not English 
Sanchez Ulayar, A., et al. (2012). "Pharmaceutical intervention upon hospital discharge to 
strengthen understanding and adherence to pharmacological treatment." Farm Hosp 36(3): 118-
123. 
Medication reconciliation is not the primary intervention 
Nester TM et al (2002).” Effectiveness of a pharmacist acquired medication history in promoting 
patient safety”. Am J Health-Syst Pharm 59:2221-25.  
Lisby M et al (2010). “The effect of systematic medication review in elderly patients admitted to 
an acute ward of Internal Medicine”. Basic & Clinical Pharmacology & Toxicology 106: 422–427. 
Edwards, S. J., et al. (2014). "Outcomes assessment of a pharmacist-directed seamless care 
program in an ambulatory oncology clinic." Journal of Pharmacy Practice 27(1): 46-52. 
Fera T, Anderson C, Kanel KT, Ramusivich DL. Role of a care transition pharmacist in a primary 
care resource center. Am J Health Syst Pharm. 2014; 71(18):1585-90. 
Hutchison LJ, Mayzell GG, Bailey SC, Broyles JE. Impact of a discharge medication therapy 
management program in an extended care hospital. Consult Pharm 2014; 29(1):33-8. 
Marotti, S. B., et al. (2011). "A randomised controlled trial of pharmacist medication histories and 
supplementary prescribing on medication errors in postoperative medications." Anaesthesia and 
Intensive Care 39(6): 1064-1070. 
Nazareth, I., et al. (2001). "A pharmacy discharge plan for hospitalized elderly patients--a 
randomized controlled trial." Age & Ageing 30(1): 33-40. 
Sarangarm, P., et al. (2013). "Impact of pharmacist discharge medication therapy counselling and 
disease state education: Pharmacist Assisting at Routine Medical Discharge (project PhARMD)." 
American Journal of Medical Quality 28(4): 292-300. 
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Spinewine, A., et al. (2007). "Effect of a collaborative approach on the quality of prescribing for 
geriatric inpatients: a randomized, controlled trial." J Am Geriatr Soc 55(5): 658-665. 
Szkiladz, A., et al. (2013). "Impact of pharmacy student and resident-led discharge counselling on 
heart failure patients." Journal of Pharmacy Practice 26(6): 574-579. 
Taber, D. J., et al. (2013). "Improved patient safety and outcomes with a comprehensive 
interdisciplinary improvement initiative in kidney transplant recipients." Am J Med Qual 28(2): 
103-112. 
Not hospital based 
Stewart S et al (1998). “Effects of a home-based intervention among patients with congestive heart 
failure discharged from acute hospital care". Arch Intern Med 158:1067-1072. 
Boockvar, K. S., et al. (2006). "Medication reconciliation for reducing drug-discrepancy adverse 
events." American Journal of Geriatric Pharmacotherapy 4(3): 236-243. 
Kilcup, M., et al. (2013). "Postdischarge pharmacist medication reconciliation: impact on 
readmission rates and financial savings." J Am Pharm Assoc (2003) 53(1): 78-84. 
Stewart, A. L. and K. J. Lynch (2014). "Medication discrepancies despite pharmacist-led 
medication reconciliation: the challenges of maintaining an accurate medication list in primary 
care." Pharm Pract (Granada) 12(1): 360. 
Ineligible study design/procedure 
Carter, M. K., et al. (2006). "Pharmacist-acquired medication histories in a university hospital 
emergency department." American Journal of Health-System Pharmacy 63(24): 2500-2503. 
Karapinar-Carkit, F., et al. (2009). "Effect of medication reconciliation with and without patient 
counselling on the number of pharmaceutical interventions among patients discharged from the 
hospital." Annals of Pharmacotherapy 43(6): 1001-1010. 
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Musgrave, C. R., et al. (2013). "Improving transplant patient safety through pharmacist discharge 
medication reconciliation." American Journal of Transplantation 13(3): 796-801. 
Mudge AM, Shakhovskoy R, Karrasch A. Quality of transitions in older medical patients with 
frequent readmissions: opportunities for improvement. Eur J Intern Med. 2013;24(8):779-83. 
Sen S, Siemianowski L, Murphy M, McAllister SC. Implementation of a pharmacy technician-
centered medication reconciliation program at an urban teaching medical center. Am J Health Syst 
Pharm. 2014;71(1):51-6. 
Stitt, D. M., et al. (2011). "Medication discrepancies identified at time of hospital discharge in a 
geriatric population." American Journal of Geriatric Pharmacotherapy 9(4): 234-240. 
Unroe, K. T., et al. (2010). "Inpatient medication reconciliation at admission and discharge: A 
retrospective cohort study of age and other risk factors for medication discrepancies." American 
Journal of Geriatric Pharmacotherapy 8(2): 115-126. 
Not medication reconciliation intervention 
Eijsbroek, H., et al. (2013). "Medication issues experienced by patients and carers after discharge 
from the intensive care unit." J Crit Care 28(1): 46-50. 
Hohmann, C., et al. (2013). "Adherence to hospital discharge medication in patients with ischemic 
stroke: a prospective, interventional 2-phase study." Stroke 44(2): 522-524. 
Hohmann, C., et al. (2014). "Providing systematic detailed information on medication upon 
hospital discharge as an important step towards improved transitional care." Journal of Clinical 
Pharmacy & Therapeutics 39(3): 286-291. 
Romero, C. M., et al. (2013). "Effects of the implementation of a preventive interventions program 
on the reduction of medication errors in critically ill adult patients." Journal of Critical Care 28(4): 
451-460. 
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are discharged home from hospital". Br J Clin Pharmacol 1997; 44: 163–165. 
Michels R et al (2003). "Programme using pharmacy technicians to obtain medication histories.” 
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Duggan, C., et al. (1998). "Reducing adverse prescribing discrepancies following hospital 
discharge." International Journal of Pharmacy Practice 6(Jun): 77-82. 
Henneman, E. A., et al. (2014). "An evaluation of a collaborative, safety focused, nurse-pharmacist 
intervention for improving the accuracy of the medication history." J Patient Saf 10 (2): 88-94. 
Jack, B. W., et al. (2009). "A reengineered hospital discharge program to decrease 
rehospitalisation: a randomized trial." Annals of Internal Medicine 150(3): 178-187. 
Nassaralla, C. L., et al. (2007). "Implementation of a medication reconciliation process in an 
ambulatory internal medicine clinic." Qual Saf Health Care 16(2): 90-94. 
Setter, S. M., et al. (2009). "Effectiveness of a pharmacist-nurse intervention on resolving 
medication discrepancies for patients transitioning from hospital to home health care." American 
Journal of Health-System Pharmacy 66(22): 2027-2031. 
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C. Online supplementary appendix C: Summary of risk of bias assessment⃰  
Study reference Randomiza
tion 
Allocation 
concealment 
Similarity of   
baseline 
characteristics 
Similarity 
of baseline 
outcomes 
Incomplete 
outcome data 
Assessors 
blind to 
outcome 
Absence of 
contamination 
Selective 
outcome 
reporting 
Free of other 
biases  
Total† 
Anderegg 2014  - + + ? ? + - - + 4 
Bolas 2004 + + + ? - - ? - + 4 
Eisenhower 2014 - - ? ? - + + - - 2 
Farris 2014 + + + ? + + - + + 7 
Gardella 2012 - - ? ? ? + + + - 3 
Gillespie 2009 + + ? ? ? + + + + 6 
Hawes 2014 + + ? ? ? + + + + 6 
Hellstrom 2011 - - + ? + + - + - 4 
Hellstrom 2012 - - + ? + + + + - 5 
Koehler 2009 + + + ? ? + + + - 6 
Pal 2013 - - + ? + + - + - 4 
Schnipper 2006 + + + ? ? + + + + 7 
Scullin 2007 + + + ? ? + ? + + 6 
Stowasser 2002 + ? + + + + + - + 8 
Walker 2009 - - + ? - ? + + + 4 
Warden 2014 - - + ? ? + + + + 5 
Wilkinson  2011 - - ? ? ? - ? + - 1 
 
Key: +, clear; -, not done;?, unclear.           
*EPOC risk of bias assessment; modified for non-controlled studies. 
†Studies with a ‘clear data’ on each of the domains were given a score of 1. 
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D. Online supplementary appendix D: Subgroup analysis 
 All-cause readmission 
 Subgroup analysis based on outcome timing 
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Subgroup analysis based on study design 
 
All-cause ED visits 
Subgroup analysis based on outcome timing 
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Subgroup analysis based on study design 
 
 
All-cause mortality 
Subgroup analysis based on outcome timing 
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Subgroup analysis based on study design 
 
 
Composite readmission and/or ED visit 
Subgroup analysis based on outcome timing 
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Subgroup analysis based on study design 
 
 
E. Online supplementary appendix E: Funnel plots 
a. All-cause readmission                                 Egger's test, p= 0.08; Begg's test, p=0.13
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b. All-cause ED visit                                Egger's test, p= 0.04; Begg's test, p=0.01                                                                 
 
c. Composite readmission and/or ED visit        Egger's test, p= 0.57; Begg's test, p=0.35 
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d. All-cause mortality                                            Egger's test p=0.83; Begg's test p=0.71
 
Funnel plots for the four outcomes for patients at hospital transitions. a) all-cause readmission 
b) all-cause ED visit c) composite readmission and/or ED visit d) all-cause mortality. The 
vertical line in the graphs corresponds to the pooled relative risk across studies.    
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 A2.2 Electronic Supplementary Materials Published Online for Chapter 3 
A. Appendix S1: Electronic database searches  
- The same search strategy used in A2.1 – A was employed for this systematic review. 
B. Appendix S2: List of excluded full-text papers and of the reasons for their exclusion 
No/ineligible comparator       
Boso ribelles et al (2011). "Evaluation of a plan for cardiology medication reconciliation on 
admission, and patient information at discharge, in a teaching hospital.” EJHP Practice 17(1) 
Anderegg, S. V., et al. (2013). "Acceptance of recommendations by inpatient pharmacy case 
managers: unintended consequences of hospitalist and specialist care." Pharmacotherapy: The 
Journal of Human Pharmacology & Drug Therapy 33(1): 11-21. 
Carter, M. K., et al. (2006). "Pharmacist-acquired medication histories in a university hospital 
emergency department." American Journal of Health-System Pharmacy 63(24): 2500-2503. 
Cornu, P., et al. (2012). "Effect of medication reconciliation at hospital admission on 
medication discrepancies during hospitalization and at discharge for geriatric patients." Annals 
of Pharmacotherapy 46(4): 484-494. 
Hellstrom, L. M., et al. (2012). "Errors in medication history at hospital admission: prevalence 
and predicting factors." BMC Clin Pharmacol 12: 9. 
Lessard, S., et al. (2006). "Medication discrepancies affecting senior patients at hospital 
admission." Am J Health Syst Pharm 63(8): 740-743. 
Midlov, P., et al. (2012). "The effect of medication reconciliation in elderly patients at hospital 
discharge." International Journal of Clinical Pharmacy 34(1): 113-119. 
Quennery, S., et al. (2011). "Added value of pharmacist-acquired drug histories in an 
orthopaedic ward." Acta Clinica Belgica 66(3): 196-199. 
Reeder, T. A. and A. Mutnick (2008). "Pharmacist- versus physician-obtained medication 
histories." American Journal of Health-System Pharmacy 65(9): 857-860. 
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Not pharmacy-led medication reconciliation  
Lalonde, L., et al. (2008). "Effectiveness of a medication discharge plan for transitions of care 
from hospital to outpatient settings." American Journal of Health-System Pharmacy 65(15): 
1451-1457. 
Midlov, P., et al 2008. “Medication report reduces number of medication errors when elderly 
patients are discharged from hospital.” Pharmacy World & Science 30(1): 92-98.   
Schnipper, J. L., et al. (2009). "Effect of an electronic Medication reconciliation application 
and process redesign on potential adverse drug events a cluster-randomized trial." Archives of 
Internal Medicine 169(8): 771-780. 
Showalter, J. W., et al. (2011). "Effect of standardized electronic discharge instructions on 
post-discharge hospital utilization." J Gen Intern Med 26(7): 718-723. 
Zoni, A. C., et al. (2012). "The impact of medication reconciliation program at admission in an 
internal medicine department." European Journal of Internal Medicine 23(8): 696-700. 
Study protocol 
Salanitro, A. H., et al. (2013). "Rationale and design of the Multicenter Medication 
Reconciliation Quality Improvement Study (MARQUIS)." BMC Health Serv Res 13: 230. 
Not English 
Sanchez Ulayar, A., et al. (2012). "Pharmaceutical intervention upon hospital discharge to 
strengthen understanding and adherence to pharmacological treatment." Farm Hosp 36(3): 118-
123. 
Medication reconciliation is not the primary intervention 
Nester TM et al (2002).” Effectiveness of a pharmacist acquired medication history in 
promoting patient safety”. Am J Health-Syst Pharm 59:2221-25.  
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Lisby M et al (2010). “The effect of systematic medication review in elderly patients admitted 
to an acute ward of Internal Medicine”. Basic & Clinical Pharmacology & Toxicology 106: 
422–427. 
Edwards, S. J., et al. (2014). "Outcomes assessment of a pharmacist-directed seamless care 
program in an ambulatory oncology clinic." Journal of Pharmacy Practice 27(1): 46-52. 
Fera T, Anderson C, Kanel KT, Ramusivich DL. Role of a care transition pharmacist in a 
primary care resource center. Am J Health Syst Pharm. 2014;71(18):1585-90. 
Fertleman, M., et al. (2005). "Improving medication management for patients: The effect of a 
pharmacist on post-admission ward rounds." Quality and Safety in Health Care 14(3): 207-211. 
Hutchison LJ, Mayzell GG, Bailey SC, Broyles JE. Impact of a discharge medication therapy 
management program in an extended care hospital. Consult Pharm 2014;29(1):33-8. 
Marotti, S. B., et al. (2011). "A randomised controlled trial of pharmacist medication histories 
and supplementary prescribing on medication errors in postoperative medications." 
Anaesthesia and Intensive Care 39(6): 1064-1070. 
Nazareth, I., et al. (2001). "A pharmacy discharge plan for hospitalized elderly patients--a 
randomized controlled trial." Age & Ageing 30(1): 33-40. 
Sarangarm, P., et al. (2013). "Impact of pharmacist discharge medication therapy counselling 
and disease state education: Pharmacist Assisting at Routine Medical Discharge (project 
PhARMD)." American Journal of Medical Quality 28(4): 292-300. 
Spinewine, A., et al. (2007). "Effect of a collaborative approach on the quality of prescribing 
for geriatric inpatients: a randomized, controlled trial." J Am Geriatr Soc 55(5): 658-665. 
Szkiladz, A., et al. (2013). "Impact of pharmacy student and resident-led discharge counselling 
on heart failure patients." Journal of Pharmacy Practice 26(6): 574-579. 
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Taber, D. J., et al. (2013). "Improved patient safety and outcomes with a comprehensive 
interdisciplinary improvement initiative in kidney transplant recipients." Am J Med Qual 28(2): 
103-112. 
Not hospital-based 
Stewart S et al (1998). “Effects of a home-based intervention among patients with congestive 
heart failure discharged from acute hospital care". Arch Intern Med 158:1067-1072. 
Boockvar, K. S., et al. (2006). "Medication reconciliation for reducing drug-discrepancy 
adverse events." American Journal of Geriatric Pharmacotherapy 4(3): 236-243. 
Kilcup, M., et al. (2013). "Postdischarge pharmacist medication reconciliation: impact on 
readmission rates and financial savings." J Am Pharm Assoc (2003) 53(1): 78-84. 
Stewart, A. L. and K. J. Lynch (2014). "Medication discrepancies despite pharmacist-led 
medication reconciliation: the challenges of maintaining an accurate medication list in primary 
care." Pharm Pract (Granada) 12(1): 360. 
Not medication reconciliation intervention 
Eijsbroek, H., et al. (2013). "Medication issues experienced by patients and carers after 
discharge from the intensive care unit." J Crit Care 28(1): 46-50. 
Hohmann, C., et al. (2013). "Adherence to hospital discharge medication in patients with 
ischemic stroke: a prospective, interventional 2-phase study." Stroke 44(2): 522-524. 
Hohmann, C., et al. (2014). "Providing systematic detailed information on medication upon 
hospital discharge as an important step towards improved transitional care." Journal of Clinical 
Pharmacy & Therapeutics 39(3): 286-291. 
Romero, C. M., et al. (2013). "Effects of the implementation of a preventive interventions 
program on the reduction of medication errors in critically ill adult patients." Journal of Critical 
Care 28(4): 451-460. 
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Not relevant outcome 
Anderegg SV, Wilkinson ST, Couldry RJ, Grauer DW, Howser E. Effects of a hospitalwide  
pharmacy practice model change on readmission and return to emergency department rates. 
Am J Health Syst Pharm 2014;71:1469-79. 
Eisenhower C. Impact of pharmacist-conducted medication reconciliation at discharge on 
readmissions of elderly patients with COPD. The Annals of pharmacotherapy. 014;48(2):203-
8. 
Hellstrom LM, Bondesson A, Hoglund P, Midlov P, Holmdahl L, Rickhag E, et al. Impact of 
the Lund Integrated Medicines Management (LIMM) model on medication appropriateness 
and drug-related hospital revisits. European Journal of Clinical Pharmacology. 
2011;67(7):741-52. 
Hellstrom LM, Hoglund P, Bondesson A, Petersson G, Eriksson T. Clinical implementation 
of systematic medication reconciliation and review as part of the Lund Integrated Medicines   
Management model--impact on all-cause emergency department revisits. Journal of Clinical  
Pharmacy & Therapeutics. 2012;37(6):686-92. 
Koehler BE, Richter KM, Youngblood L, Cohen BA, Prengler ID, Cheng D, et al. Reduction 
of  30-day postdischarge hospital readmission or emergency department (ED) visit rates in 
high-risk  elderly medical patients through delivery of a targeted care bundle. Journal of 
Hospital Medicine (Online). 2009;4(4):211-8. 
Pal A, Babbott S, Wilkinson ST. Can the targeted use of a discharge pharmacist significantly  
decrease 30-day readmissions? Hosp Pharm. 2013;48(5):380-8. 
Smith L et al (1997). “An investigation of hospital generated pharmaceutical care when 
patients are discharged home from hospital". Br J Clin Pharmacol 1997; 44: 163–165. 
Scullin C, Scott MG, Hogg A, McElnay JC. An innovative approach to integrated medicines 
management. Journal of Evaluation in Clinical Practice. 2007;13(5):781-8. 
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Warden BA, Freels JP, Furuno JP, Mackay J. Pharmacy-managed program for providing 
education and discharge instructions for patients with heart failure. American Journal of 
Health-System Pharmacy. 2014;71(2):134-9. 
Michels R et al (2003). "Programme using pharmacy technicians to obtain medication 
histories.” American Journal of Health-System Pharmacy 60: 1982-86. 
Alassaad, A., et al. (2013). "Prescription and transcription errors in multidose-dispensed 
medications on discharge from hospital: an observational and interventional study." J Eval 
Clin Pract 19(1): 185-191. 
Basey AJ, Krska J, Kennedy TD, Mackridge AJ. Prescribing errors on admission to hospital 
and their potential impact: A mixed-methods study. BMJ Quality and Safety. 2014;23(1):17-
25. 
 Benson, J. M. and G. Snow (2012). "Impact of medication reconciliation on medication error 
rates in community hospital cardiac care units." Hospital Pharmacy 47(12): 927-932. 
 Brownlie K, Schneider C, Culliford R, Fox C, Boukouvalas A, Willan C, Maidment ID. 
Medication reconciliation by a pharmacy technician in a mental health assessment unit. Int J 
Clin Pharm 2014;36(2):303-9. 
Buckley MS, Harinstein LM, Clark KB, Smithburger PL, Eckhardt DJ, Alexander E, et al. 
Impact of a clinical pharmacy admission medication reconciliation program on medication 
errors in "high-risk" patients. The Annals of pharmacotherapy. 2013;47(12):1599-610. 
Chan, E. W., et al. (2010). "An intervention to encourage ambulance paramedics to bring 
patients' own medications to the ED: impact on medications brought in and prescribing 
errors." Emerg Med Australas 22(2): 151-158. 
Conklin, J. R., et al. (2014). "Care Transitions Service: A pharmacy-driven program for 
medication reconciliation through the continuum of care." American Journal of Health-
System Pharmacy: 802-810. 
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 Grant, R. W., et al. (2003). "Improving Adherence and Reducing Medication Discrepancies 
in Patients with Diabetes." Ann Pharmacother 37(7): 962-969. 
 Hale, A. R., et al. (2013). "Perioperative medication management: expanding the role of the 
preadmission clinic pharmacist in a single  center, randomised controlled trial of 
collaborative prescribing." BMJ Open 3(7). 
Hayes, B. D., et al. (2007). "Pharmacist-conducted medication reconciliation in an emergency 
department." American Journal of Health-System Pharmacy 64(16): 1720-1723. 
Hick, H. L., et al. (2001). "The impact of the pharmacist on an elective general surgery pre-
admission clinic." Pharmacy World & Science 23(2): 65-69. 
Gillespie U1, Alassaad A, Henrohn D, Garmo H, Hammarlund-Udenaes M, Toss H, Kettis-
Lindblad A, Melhus H, Mörlin C. A comprehensive pharmacist intervention to reduce 
morbidity in patients 80 years or older: a randomized controlled trial. Arch Intern Med 2009; 
169:894-900. 
Ho, P. M., et al. (2014). "Multifaceted intervention to improve medication adherence and 
secondary prevention measures after acute coronary syndrome hospital discharge: a 
randomized clinical trial." JAMA Intern Med 174(2): 186-193. 
Nielsen TR, Andersen SE, Rasmussen M, Honore PH. Clinical pharmacist service in the 
acute ward. Int J Clin Pharm. 2013; 35(6):1137-51. 
Magalhães GF, Santos GB, Rosa MB, Noblat Ld A. Medication Reconciliation in Patients 
Hospitalized in a Cardiology Unit. PLoS ONE 2014; 9(12): e115491. 
Mudge AM, Shakhovskoy R, Karrasch A. Quality of transitions in older medical patients 
with frequent readmissions: opportunities for improvement. Eur J Intern Med. 2013; 
24(8):779-83. 
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Farris KB, Carter BL, Xu Y, Dawson JD, Shelsky C, Weetman DB, Kaboli PJ, James PA, 
Christensen AJ, Brookset JM. Effect of a care transition intervention by pharmacists: an 
RCT. BMC Health Serv Res 2014; 14:406. 
Mortimer, C., et al. (2011). "The impact of an aged care pharmacist in a department of 
emergency medicine." J Eval Clin Pract 17(3): 478-485. 
Mergenhagen, K. A., et al. (2012). "Pharmacist- versus physician-initiated admission 
medication reconciliation: impact on adverse drug events." American Journal of Geriatric 
Pharmacotherapy 10(4): 242-250. 
Peyton, L., et al. (2010). "Evaluation of medication reconciliation in an ambulatory setting 
before and after pharmacist intervention." J Am Pharm Assoc (2003) 50(4): 490-495. 
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179-185. 
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patient counselling on the number of pharmaceutical interventions among patients discharged 
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Am J Health Syst Pharm. 2014; 71(1):51-6. 
Stitt, D. M., et al. (2011). "Medication discrepancies identified at time of hospital discharge 
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Pharmacy is not the sole provider 
Poole DL et al (2006). “Medication reconciliation: a necessity in promoting a safe hospital 
discharge." Journal for Health care Quality 28(3):12-19. 
Coffey M et al (2009).   “Implementation of admission medication reconciliation at two 
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Setter, S. M., et al. (2009). "Effectiveness of a pharmacist-nurse intervention on resolving 
medication discrepancies for patients transitioning from hospital to home health care." 
American Journal of Health-System Pharmacy 66(22): 2027-2031. 
 Appendices                                                                                                                                                                                                                             300 | P a g e  
C. Appendix S3: Risk of bias assessment 
RCT: EPOC summary of risk of bias assessment 
Study reference Randomiza
tion 
Allocation 
concealment 
Similarity of   
baseline 
characteristics 
Similarity 
of baseline 
outcomes 
Incomplete 
outcome data 
Assessors 
blind to 
outcome 
Absence of 
contamination 
Selective 
outcome 
reporting 
Free of other 
biases  
Total 
Becerra-Camargo 2013 + + + + + + + + + 9 
Beckett 2012 + ? + ? + - - + + 5 
Bolas 2004 + + + ? - - - - + 4 
Eggink 2010 + - + ? + ? ? + + 5 
Farley 2014 + ? + ? - + + + - 5 
Hawes 2014 + + ? ? ? + + + + 6 
Kripalani 2012 + + ? + + + + + - 7 
Kwan 2007 + + + ? + + + + - 7 
Nickerson 2005 + + - ? + ? + + + 6 
Schnipper 2006 + + + ? + + + + + 8 
Tompson 2012 + - + ? + - + + + 6 
 
NRCT: A  Cochrane Risk of Bias Assessment Tool: for  Non-randomized studies of  Interventions (ACROBAT-NRSI) summary of risk of bias assessment 
References Bias due to 
confounding 
Bias in selection 
of participants into 
the study 
Bias in 
measurement of 
interventions 
Bias due to 
departures from 
intended 
interventions 
Bias due to 
missing data 
Bias in measurement of 
outcomes 
Bias in selection of the 
reported result 
Overall bias 
Bergkvist 2009 Moderate Low Low Serious Moderate Low Low Moderate 
Gardella 2012 Serious No information Serious No information No information Critical Moderate Serious 
Grimes 2014 Moderate Low Low No information Serious Low Low Moderate 
Leguelinel-
Blache  2014 
Serious Moderate Moderate Serious No information Low Low Serious 
Van den Bemt 
2009 
Moderate Low Low Moderate No information Serious Low Moderate 
Van den Bemt 
2013 
Moderate Low Low Low No information Moderate Low Moderate 
Vasileff 2009 Moderate Low Moderate No information No information Serious Low Moderate 
Walker 2009 Low Low Moderate Low Low Low Low Low 
Note: risk of bias judgment was based on a scale of low, moderate , serious, critical and no information 
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D. Appendix S4: Publication bias assessment 
a. Single transitions 
 
 
 
 
b. Multiple transitions 
 
Funnel plots for patients with medication discrepancies at hospital transitions. a) Single 
transition interventions b) multiple transitions interventions. The vertical line in the graphs 
corresponds to the pooled relative risk across studies.    
 Appendices                                                                                                                                       302 | P a g e  
 
A2.3 Electronic Supplementary Materials Published Online for Chapter 4 
A. Additional file 1: Search strategy employed in the electronic databases search 
 MEDLINE 
Database: Ovid MEDLINE(R) <1946 to November Week 3 2015> 
 1     Medication Errors/ or Medical History Taking/ or medication discrepancies.mp. or 
Medication Reconciliation/ (28739) 
2    ((medic$ or drug$ or prescription$ or (medic$ adj2 chart$) or (medic$ adj2 record$)) adj2 
review$).mp. (26100)  
3   ((medic$ or drug$) adj2 histor$).mp. (67680) 
4    (((medic$ adj2 chart$) or (medic$ adj2 record$)) adj2 assessment).mp. (87) 
5    ((medic$ or drug$) adj2 list$).mp. (2789) 
6     exp "Continuity of Patient Care"/ or electronic medication reconciliation.mp. (41625) 
7    electronic health records.mp. or exp Medical Records Systems, Computerized/ or exp 
Electronic  Health Records/ or exp Hospital Information Systems/ (46859) 
8     patient admission.mp. or Patient Admission/ (20332) 
9     patient discharge.mp. or Patient Discharge/ (22203) 
10    inpatients.mp. or Inpatients/ (36275) 
11    Patient Transfer/ or hospital transfer.mp. or Hospitalization/ (86171) 
12     1 or 2 or 3 or 4 or 5 or 6 (253,018) 
13     8 or 9 or 10 or 11 (152106)  
14     7 and 12 and 13 (816) 
15     limit 14 to (english language and humans) (688) 
PubMed  
((((((("medication errors"[MeSH Terms] OR ("medication"[All Fields] AND "errors"[All 
Fields]) OR "medication errors"[All Fields]) OR (("pharmaceutical preparations"[MeSH 
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Terms] OR ("pharmaceutical"[All Fields] AND "preparations"[All Fields]) OR 
"pharmaceutical preparations"[All Fields] OR "medication"[All Fields]) AND 
discrepancies[All Fields])) OR ("medication reconciliation"[MeSH Terms] OR 
("medication"[All Fields] AND "reconciliation"[All Fields]) OR "medication 
reconciliation"[All Fields])) OR (("pharmaceutical preparations"[MeSH Terms] OR 
("pharmaceutical"[All Fields] AND "preparations"[All Fields]) OR "pharmaceutical 
preparations"[All Fields] OR "medication"[All Fields]) AND ("safety"[MeSH Terms] OR 
"safety"[All Fields]))) OR ("patient safety"[MeSH Terms] OR ("patient"[All Fields] AND 
"safety"[All Fields]) OR "patient safety"[All Fields])) OR (("pharmaceutical 
preparations"[MeSH Terms] OR ("pharmaceutical"[All Fields] AND "preparations"[All 
Fields]) OR "pharmaceutical preparations"[All Fields] OR "medication"[All Fields]) AND 
("history"[Subheading] OR "history"[All Fields] OR "history"[MeSH Terms]))) AND 
(((("electronic health records"[MeSH Terms] OR ("electronic"[All Fields] AND "health"[All 
Fields] AND "records"[All Fields]) OR "electronic health records"[All Fields] OR 
("electronic"[All Fields] AND "medical"[All Fields] AND "record"[All Fields]) OR 
"electronic medical record"[All Fields]) OR ("electronic health records"[MeSH Terms] OR 
("electronic"[All Fields] AND "health"[All Fields] AND "records"[All Fields]) OR "electronic 
health records"[All Fields])) OR ("electronic prescribing"[MeSH Terms] OR ("electronic"[All 
Fields] AND "prescribing"[All Fields]) OR "electronic prescribing"[All Fields])) OR 
("medication systems"[MeSH Terms] OR ("medication"[All Fields] AND "systems"[All 
Fields]) OR "medication systems"[All Fields]))) AND (((("patient admission"[MeSH Terms] 
OR ("patient"[All Fields] AND "admission"[All Fields]) OR "patient admission"[All Fields]) 
OR ("patient discharge"[MeSH Terms] OR ("patient"[All Fields] AND "discharge"[All 
Fields]) OR "patient discharge"[All Fields])) OR ("patient transfer"[MeSH Terms] OR 
("patient"[All Fields] AND "transfer"[All Fields]) OR "patient transfer"[All Fields])) OR 
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(("hospitals"[MeSH Terms] OR "hospitals"[All Fields] OR "hospital"[All Fields]) AND 
transition[All Fields])) AND (hasabstract[text] AND "humans"[MeSH Terms] AND 
English[lang])  [484] 
EMBASE 
Id.  Query                                                                                                                         Results                                 
#19. (('medication errors'/exp OR 'medication errors')                                                         65    
     OR (medication AND discrepancies) OR 'medication 
     reconciliation' OR (medication AND history) OR 
     (adverse AND events) OR 'patient safety') AND 
     ('electronic health records' OR 'electronic 
     medical records' OR 'electronic prescribing' OR 
     (medication AND record AND systems)) AND 
     ('patient admission' OR 'patient discharge' OR 
     'patient transfer' OR (hospital AND transition)) 
     AND [english]/lim AND [humans]/lim 
#18. (('medication errors'/exp OR 'medication errors')                                                           76   
     OR (medication AND discrepancies) OR 'medication 
     reconciliation' OR (medication AND history) OR 
     (adverse AND events) OR 'patient safety') AND 
     ('electronic health records' OR 'electronic 
     medical records' OR 'electronic prescribing' OR 
     (medication AND record AND systems)) AND 
     ('patient admission' OR 'patient discharge' OR 
     'patient transfer' OR (hospital AND transition)) 
#17. 'patient admission' OR 'patient discharge' OR                                                          39,746    
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     'patient transfer' OR (hospital AND transition) 
#16. 'electronic health records' OR 'electronic                                                                 16,447    
     medical records' OR 'electronic prescribing' OR 
     (medication AND record AND systems) 
#15. ('medication errors'/exp OR 'medication errors')                                                    301,291  
     OR (medication AND discrepancies) OR 'medication 
     reconciliation' OR (medication AND history) OR 
     (adverse AND events) OR 'patient safety' 
#14. hospital AND transition                                                                                           36,177   
#13. 'patient transfer'                                                                                                        953  
#12. 'patient discharge'                                                                                                    1,682   
#11. 'patient admission'                                                                                                   1,070   
#10. medication AND record AND systems                                                                  2,806   
#9.  'electronic prescribing'                                                                                            1,915   
#8.  'electronic medical records'                                                                                    7,990  
#7.  'electronic health records'                                                                                      4,373   
#6.  'patient safety'                                                                                                       80,714   
#5.  adverse AND events                                                                                            192,591 
#4.  medication AND history                                                                                      23,266   
#3.  'medication reconciliation'                                                                                    1,554   
#2.  medication AND discrepancies                                                                            1,206  
#1.  'medication errors'/exp OR 'medication errors'                                                   15,174    
CINHAL 
#              Searches Results 
S16  
    S12 AND S13 AND S14 Limiters-Peer Reviewed; English Language;   
Abstract Available 
435 
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S15     S12 OR S13 OR S14 674 
S14     S9 OR S10 OR S11 72,625 
S13     S7 OR S8 61,923 
S12   S1 OR S2 OR S3 OR S4 OR S5 OR S6  75,743 
S11  (MH "Patient Admission") OR "patient admission" OR (MH "Readmission") 13,316 
S10   (MH "Transfer, Discharge") OR "patient transfer"   3,522 
S9  (MH "Inpatients") OR "hospital transition"   58,707 
S8  (MH "Electronic Order Entry")  OR "electronic prescribing"   1,750 
S7  
(MH "Computerized Patient Record") OR "electronic health records"  OR (MH 
"Medical Records+")    
60,556 
S6   (MH "Patient Safety+") OR "patient safety"     60,966 
S5  
(MH "Adverse Health Care Event+") OR  (MH "Adverse Drug Event+") OR  
"adverse event" 
34,393 
S4  
(MH "Medication History") OR  "medication history" OR (MH "Patient History 
Taking+")   
12,227 
S3  (MH "Medication Reconciliation") OR  "medication reconciliation"   768 
S2  "medication discrepancies"  55 
S1  
(MH "Medication Errors+")  OR "medication errors" OR (MH "Treatment 
Errors+")    
14,370 
 
B. Additional file 2: The main reasons for exclusion of full-text articles 
Excluded studies with reasons  
Electronic prescribing tool on the impact of other medication errors 
1. Abramson, E. L., et al. (2011). "Transitioning between electronic health records: 
Effects on ambulatory prescribing safety." Journal of General Internal Medicine 
26(8): 868-874. 
2. Abramson, E. L., et al. (2013). "A long-term follow-up evaluation of electronic health 
record prescribing safety." Journal of the American Medical Informatics Association 
20(E1): e52-e58. 
3. Agostini, J. V., et al. (2007). "Use of a computer-based reminder to improve sedative-
hypnotic prescribing in older hospitalized patients." Journal of the American 
Geriatrics Society 55(1): 43-48. 
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4. Armada, E. R., et al. (2014). "Computerized physician order entry in the cardiac 
intensive care unit: Effects on prescription errors and workflow conditions." Journal 
of Critical Care 29(2): 188-193 186p. 
5. Barron, W. M., et al. (2006). "Information technology. Implementing computerized 
provider order entry with an existing clinical information system." Joint Commission 
Journal on Quality & Patient Safety 32(9): 506-516 511p. 
6. Callen, J., et al. (2010). "Accuracy of medication documentation in hospital discharge 
summaries: A retrospective analysis of medication transcription errors in manual and 
electronic discharge summaries." International Journal of Medical Informatics 79(1): 
58-64. 
7. Shawahna, R., et al. (2011). "Electronic prescribing reduces prescribing error in 
public hospitals." Journal of Clinical Nursing 20(21/22): 3233-3245 3213p.  
8. Turchin, A., et al. (2011). "Unexpected effects of unintended consequences: EMR 
prescription discrepancies and hemorrhage in patients on warfarin." AMIA ... Annual 
Symposium Proceedings/AMIA Symposium 2011: 1412-1417. 
9. Upperman, J. S., et al. (2005). "The impact of hospitalwide computerized physician 
order entry on medical errors in a pediatric hospital." J Pediatr Surg 40(1): 57-59. 
10. Weant, K. A., et al. (2007). "Medication-error reporting and pharmacy resident 
experience during implementation of computerized prescriber order entry." Am J 
Health Syst Pharm 64(5): 526-530. 
No control group 
1. Agrawal, A., et al. (2007). "Evaluation of an electronic medication reconciliation 
system in inpatient setting in an acute care hospital." Studies in Health Technology & 
Informatics 129(Pt 2): 1027-1031. 
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2. Arora, V., et al. (2007). "Medication discrepancies in resident sign-outs and their 
potential to harm." Journal of General Internal Medicine 22(12): 1751-1755. 
3. Lee, J. Y., et al. (2010). "Medication reconciliation during internal hospital transfer 
and impact of computerized prescriber order entry." Annals of Pharmacotherapy 
44(12): 1887-1895. 
4. Palchuk, M. B., et al. (2010). "An unintended consequence of electronic prescriptions: 
prevalence and impact of internal discrepancies." J Am Med Inform Assoc 17(4): 
472-476. 
5.   Sinvani, L., et al. (2012). "Medication reconciliation in transition of care: Broken 
telephone or patient safety goal?" Journal of the American Geriatrics Society 60: 
S216. 
6. Walke, L. M., et al. (2012). "Identification of medication discrepancies in discharge 
paperwork among patients in the co-operate geriatrics/surgery co management 
program." Journal of the American Geriatrics Society 60: S230.  
Not electronic medication reconciliation 
1. Bala, M., et al. (2011). "Medicines reconciliation on discharge: Implementation of a 
new model of working on the cardiology unit at the Leeds Teaching Hospitals NHS 
Trust." Clinical Pharmacist 3(4): S8. 
2. Beckett, R. D., et al. (2012). "Effectiveness and feasibility of pharmacist-led 
admission medication reconciliation for geriatric patients." J Pharm Pract 25(2): 136-
141. 
3. Bergkvist, A., et al. (2009). "Improved quality in the hospital discharge summary 
reduces medication errors--LIMM: Landskrona Integrated Medicines Management." 
European Journal of Clinical Pharmacology 65(10): 1037-1046. 
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4. Becerra-Camargo, J., et al. (2013). "A multicentre, double-blind, randomised, 
controlled, parallel-group study of the effectiveness of a pharmacist-acquired 
medication history in an emergency department." BMC Health Serv Res 13: 337. 
5. Grimes, T. C., et al. (2014). "Collaborative pharmaceutical care in an Irish hospital: 
uncontrolled before-after study." BMJ Qual Saf 23(7): 574-583. 
6. Lee, Y. Y., et al. (2013). "Pharmacist-conducted medication reconciliation at hospital 
admission using information technology in Taiwan." Int J Med Inform 82(6): 522-
527. 
7. Lindquist, L. A., et al. (2013). "Primary care physician communication at hospital 
discharge reduces medication discrepancies." J Hosp Med 8(12): 672-677. 
8. Lingaratnam, S., et al. (2013). "A controlled before and after study to evaluate a 
patient and health professional partnership model towards effective medication 
reconciliation." J Oncol Pharm Pract 19(1): 48-56.  
9. Lu, Y., et al. (2013). "Quality improvement through implementation of discharge 
order reconciliation." Am J Health Syst Pharm 70(9): 815-820. 
10. Schwarz, M. and R. Wyskiel (2006). "Medication reconciliation: developing and 
implementing a program." Critical Care Nursing Clinics of North America 18(4): 
503-507. 
11. Tompson, A. J., et al. (2012). "Utilizing community pharmacy dispensing records to 
disclose errors in hospital admission drug charts." International Journal of Clinical 
Pharmacology & Therapeutics 50(9): 639-646. 
12. Andreoli, L., et al. (2014). "Medication reconciliation: a prospective study in an 
internal medicine unit." Drugs Aging 31(5): 387-393. 
13. Pronovost, P., et al. (2003). "Medication reconciliation: a practical tool to reduce the 
risk of medication errors." Journal of Critical Care 18(4): 201-205. 
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Different outcome of interest 
1. Al-Dorzi, H. M., et al. (2011). "Impact of computerized physician order entry (CPOE) 
system on the outcome of critically ill adult patients: a before-after study." BMC 
Medical Informatics & Decision Making 11: 71.  
2. Bourne, R. S. and C. L. Choo (2012). "Pharmacist proactive medication 
recommendations using electronic documentation in a UK general critical care unit." Int 
J Clin Pharm 34(2): 351-357. 
3. Cooley, T. W., et al. (2012). "Implementation of computerized prescriber order entry in 
four academic medical centers." Am J Health Syst Pharm 69(24): 2166-2173. 
4. Ghibelli, S., et al. (2013). "Prevention of Inappropriate Prescribing in Hospitalized 
Older Patients Using a Computerized Prescription Support System (INTERcheck)." 
Drugs & Aging 30(10): 821-828 828p.  
5. Gurwitz, J. H., et al. (2014). "An electronic health record-based intervention to increase 
follow-up office visits and decrease rehospitalization in older adults." J Am Geriatr Soc 
62(5): 865-871. 
6. Kirkendall, E. S., et al. (2013). "Transitioning from a computerized provider order entry 
and paper documentation system to an electronic health record: expectations and 
experiences of hospital staff." Int J Med Inform 82(11): 1037-1045. 
7. Leung, A. A., et al. (2013). "Impact of vendor computerized physician order entry on 
patients with renal impairment in community hospitals." Journal of Hospital Medicine 
(Online) 8(10): 545-552.  
8. Maslove, D. M., et al. (2009). "Electronic versus dictated hospital discharge summaries: 
a randomized controlled trial." Journal of General Internal Medicine 24(9): 995-1001 
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9. McCoy, A. B., et al. (2015). "Clinician satisfaction before and after transition from a 
basic to a comprehensive electronic health record." Journal of Investigative Medicine 
63(2): 467. 
10. Mekhjian, H. S., et al. (2002). "Immediate benefits realized following implementation of 
physician order entry at an academic medical center." J Am Med Inform Assoc 9(5): 
529-539. 
11. Moy, N. Y., et al. (2014). "Development and sustainability of an inpatient-to-outpatient 
discharge handoff tool: a quality improvement project." Jt Comm J Qual Patient Saf 
40(5): 219-227.  
12. Munck, L. K., et al. (2014). "The use of shared medication record as part of medication 
reconciliation at hospital admission is feasible." Danish Medical Journal 61(5): A4817. 
13. Palma, J. P., et al. (2011). "Impact of electronic medical record integration of a handoff 
tool on sign-out in a newborn intensive care unit." Journal of Perinatology 31(5): 311-
317 317p. 
14. Patterson, M. E., et al. (2014). "Comprehensive electronic medical record implementation 
levels not associated with 30-day all-cause readmissions within Medicare beneficiaries 
with heart failure." Appl Clin Inform 5(3): 670-684. 
15. Pinto Thirukumaran, C., et al. (2015). "The impact of electronic health record 
implementation and use on performance of the Surgical Care Improvement Project 
measures." Health Serv Res 50(1): 273-289. 
16. Schnipper, J. L., et al. (2011). "Development of a tool within the electronic medical record 
to facilitate medication reconciliation after hospital discharge." Journal of the American 
Medical Informatics Association 18(3): 309-313. 
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17. Stengel, D., et al. (2004). "Comparison of handheld computer-assisted and conventional 
paper chart documentation of medical records: a randomized, controlled trial." Journal of 
Bone & Joint Surgery, American Volume 86-A(3): 553-560 558p. 
18. Turchin, A., et al. (2007). "The use of electronic medication reconciliation to establish the 
predictors of validity of computerized medication records." Studies in Health Technology 
& Informatics 129(Pt 2): 1022-1026. 
19. Showalter, J. W., et al. (2011). "Effect of standardized electronic discharge instructions 
on post-discharge hospital utilization." J Gen Intern Med 26(7): 718-723.  
20. Phansalkar, S., et al. (2015). "Impact of incorporating pharmacy claims data into 
electronic medication reconciliation." American Journal of Health-System Pharmacy 
72(3): 212-217 216p. 
21. Moore, P., et al. (2011). "Medicines reconciliation using a shared electronic health care 
record." Journal of patient safety 7(3): 148-154. 
Review 
1. Bayoumi, I., et al. (2009). "Interventions to improve medication reconciliation in primary 
care." Ann Pharmacother 43(10): 1667-1675. 
2. Motamedi, S. M., et al. (2011). "The efficacy of computer-enabled discharge 
communication interventions: a systematic review." BMJ Quality & Safety 20(5): 403-
415 
3. Niazkhani, Z., et al. (2009). "The impact of computerized provider order entry systems 
on inpatient clinical workflow: a literature review." Journal of the American Medical 
Informatics Association 16(4): 539-549 511p. 
4. Reckmann, M. H., et al. (2009). "Does computerized provider order entry reduce 
prescribing errors for hospital inpatients? A systematic review." Journal of the American 
Medical Informatics Association 16(5): 613-623 611p 
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5. van Rosse, F., et al. (2009). "The effect of computerized physician order entry on 
medication prescription errors and clinical outcome in pediatric and intensive care: a 
systematic review." Pediatrics 123(4): 1184-1190 1187p. 
Study protocol 
1. Okoniewska, B. M., et al. (2012). "The Seamless Transfer-of-Care Protocol: a randomized 
controlled trial assessing the efficacy of an electronic transfer-of-care communication tool." 
BMC Health Serv Res 12: 414. 
Not hospital-based 
1. Shivji, F. S., et al. (2015). "Improving communication with primary care to ensure patient 
safety post-hospital discharge." British Journal of Hospital Medicine 76(1): 46-49. 
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A2.4 Electronic Supplementary Materials Published Online for Chapter 5 
A. Appendix 1: Medline search strategy 
1st concept - terms related to medication errors and adverse drug events 
1. medication errors.mp. 
2. exp Medication Errors/ 
3. exp Medication Systems, Hospital/ 
4. exp "Drug-Related Side Effects and Adverse Reactions"/  
5. medication safety.mp. 
6. prescribing errors.mp. 
7. exp Pharmacy Service, Hospital/  
8. exp Drug Prescriptions/  
9. dispensing errors.mp.  
10. transcribing errors.mp.  
11. exp Nursing Staff, Hospital/ or administration errors.mp. 
12. medication history.mp.  
13. exp Medical History Taking/  
14. medication errors.ti.  
15. prescribing errors.ti.  
16. dispensing errors.ti. 
17. administration errors.ti. 
18. adverse drug reactions.ti.  
19. adverse drug events.ti.  
2nd concept - terms describing hospital setting 
20. exp Hospitals/ 
21. exp Hospitalization/ 
22. hospitalization.mp. 
23. exp Patient Admission/ 
24. admission.mp. 
25. exp Patient Discharge/ 
26. discharge.mp. 
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3rd concept - describing African regions 
27. exp Africa, Western/ 
28. exp Africa, Northern/ 
29. exp South Africa/ 
30. exp Africa, Southern/ 
31. exp Africa, Eastern/ 
32. exp Africa, Central/ 
33. exp "Africa South of the Sahara"/  
34. Africa.mp. 
The search terms used in each key concept were combined using the OR Boolean operator, 
and then all the 3 key concepts were connected using the ‘AND’ operator. Broadly, this 
searching strategy was similar between databases. 
B. S2 Appendix: Excluded articles with reasons 
ADE/ADRs reports from single disease/agents 
1. Abah IO, Akanbi M, Abah ME, Finangwai AI, Dady CW, Falang KD, et al. Incidence 
and predictors of adverse drug events in an African cohort of HIV-infected adults 
treated with efavirenz. Germs. 2015; 5(3):83-91.  
2. Abdissa SG, Fekade D, Feleke Y, Seboxa T, Diro E. Adverse drug reactions associated 
with antiretroviral treatment among adult Ethiopian patients in a tertiary hospital. 
Ethiop Med J. 2012; 50(2):107–13. 
3. Adeyemi A, Adesola O, Olaogun O. Risk factors for virologic failure and adverse 
reactions among patients on triple antiretroviral therapy. Journal of Acquired Immune 
Deficiency Syndromes. 2009; 51:125. 
4. Alexander A, Rode H. Adverse reactions to the Bacillus Calmette-Guerin vaccine in 
HIV-positive infants. J Pediatr Surg. 2007; 42(3):549–52. 
5. Ankrah DN, Mantel-Teeuwisse AK, De Bruin ML, Amoo PK, Ofei-Palm CN, 
Agyepong I, et al. Incidence of adverse events among health care workers following 
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H1N1 Mass immunization in Ghana: a prospective study. Drug Saf. 2013; 36(4):259–
66. 
6. Bepe N, Madanhi N, Mudzviti T, Gavi S, Maponga CC, Morse GD. The impact of 
herbal remedies on adverse effects and quality of life in HIV-infected individuals on 
antiretroviral therapy. J Infect Dev Ctries. 2011; 5(1):48–53. 
7. Birbal S, Dheda M, Ojewole E, Oosthuizen F. Adverse drug reactions associated with 
antiretroviral therapy in South Africa. African Journal of AIDS Research. 2016; 
15(3):243-8. 
8. Bwire R, Kawuma HJ. Hospital-based epidemiological study of reactions, Buluba 
Hospital, 1985-89. Leprosy Review. 1993;64(4):325-9. 
9. Elkhabbazi H, Benkirane R, Khadmaoui A, Sefiani H, Quyou A, Hami H, et al. 
Cutaneous adverse drug reactions in Morocco: A prospective study. Drug Saf. 2014; 37 
(10):888. 
10. Kajungu DK, Erhart A, Talisuna AO, Bassat Q, Karema C, Nabasumba C, et al. 
Paediatric pharmacovigilance: use of pharmacovigilance data mining algorithms for 
signal detection in a safety dataset of a paediatric clinical study conducted in seven 
African countries. PloS one. 2014;9(5):e96388. 
11. Khaled A, Kharfi M, Ben Hamida M, El Fekih N, El Aidli S, Zeglaoui F, et al. 
Cutaneous adverse drug reactions in children. A series of 90 cases. La Tunisie medicale. 
2012; 90(1):45-50. 
12. Kiguba R, Ononge S, Karamagi C, Bird SM. Herbal medicine use and linked suspected 
adverse drug reactions in a prospective cohort of Ugandan inpatients. BMC 
complementary and alternative medicine. 2016; 16:145. 
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13. Korhonen C, Peterson K, Bruder C, Jung P. Self-reported adverse events associated 
with antimalarial chemoprophylaxis in peace corps volunteers. American Journal of 
Preventive Medicine. 2007; 33(3):194-9. 
14. Lartey M, Asante-Quashie A, Essel A, Kenu E, Ganu V, Neequaye A. Adverse drug 
reactions to antiretroviral therapy during the early art period at a tertiary hospital in 
Ghana. Pan Afr Med J. 2014; 18(25). 
15. Lorent N, Sebatunzi O, Mukeshimana G, Van den Ende J, Clerinx J. Incidence and risk 
factors of serious adverse events during antituberculous treatment in Rwanda: a 
prospective cohort study. PloS ONE. 2011; 6(5):e19566. 
16. Luyckx VA, Steenkamp V, Rubel JR, Stewart MJ. Adverse effects associated with the 
use of South African traditional folk remedies. Cent Afr J Med. 2004; 50(5–6):46–51. 
17. Masenyetse LJ, Manda SO, Mwambi HG. An assessment of adverse drug reactions 
among HIV positive patients receiving antiretroviral treatment in South Africa. AIDS 
Research and Therapy. 2015;12:6.  
18. Namme Luma H, Doualla MS, Choukem SP, Temfack E, Ashuntantang G, Achu Joko 
H, et al. Adverse drug reactions of Highly Active Antiretroviral Therapy (HAART) in 
HIV infected patients at the General Hospital, Douala, Cameroon: a cross sectional 
study. Pan Afr Med J. 2012; 12:87. 
19. Njuguna C, Stewart A, Mouton JP, Blockman M, Maartens G, Swart A, et al. Adverse 
Drug Reactions Reported to a National HIV & Tuberculosis Health Care Worker 
Hotline in South Africa: Description and Prospective Follow-Up of Reports. Drug 
safety. 2016; 39(2):159-169.  
20. Paul IM, Reynolds KM, Kauffman RE, Banner W, Bond GR, Palmer RB, et al. Adverse 
events associated with pediatric exposures to dextromethorphan. Clinical toxicology 
(Philadelphia, Pa). 2017; 55(1):25-32. 
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21. Peter JG, Lehloenya R, Dlamini S, Risma K, White KD, Konvinse KC, et al. Severe 
delayed cutaneous and systemic reactions to drugs: A global perspective on the science 
and art of current practice. J Allergy Clin Immunol Pract. 2017; 5(3):547-63. 
22. Sabry N, Farid S, Dawoud D. Drug-related problems in cardiac children. Minerva 
Pediatr. 2016;68(2):89-95. 
23. Salami TA, Asalu AF, Samuel SO. Prevalence of cutaneous drug eruptions in adult 
Nigerians with HIV/AIDS. Nigerian Postgraduate Medical Journal. 2010; 17(2):160-3. 
24. Schnippel K, Berhanu RH, Black A, Firnhaber C, Maitisa N, Evans D, et al. Severe 
adverse events during second-line tuberculosis treatment in the context of high HIV 
Co-infection in South Africa: a retrospective cohort study. BMC Infect Dis. 2016; 
16(1):593. 
25. Stewart A, Lehloenya R, Boulle A, de Waal R, Maartens G, Cohen K. Severe 
antiretroviral-associated skin reactions in South African patients: a case series and case-
control analysis. Pharmacoepidemiology and Drug Safety. 2016; 25(11):1313-9. 
26. Zaraa I, Jones M, Trojjet S, Cheikh Rouhou R, El Euch D, Mokni M, et al. Severe 
adverse cutaneous drug eruptions: epidemiological and clinical features. International 
journal of dermatology. 2011; 50(7):877-80.  
27. Tadesse WT, Mekonnen AB, Tesfaye WH, Tadesse YT. Self-reported adverse drug 
reactions and their influence on highly active antiretroviral therapy in HIV infected 
patients: a cross sectional study. BMC Pharmacol Toxicol. 2014; 15:32. 
Studies assessing ADR reporting (KAP studies) 
1. Alraie NA, Saad AA, Sabry NA, Farid SF. Adverse drug reactions reporting: a 
questionnaire-based study on Egyptian pharmacists' attitudes following an awareness 
workshop. J Eval Clin Pract. 2016;22(3):349-55. 
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2. Bello SO, Umar MT. Knowledge and attitudes of physicians relating to reporting of 
adverse drug reactions in Sokoto, north-western Nigeria. Ann Afr Med. 2011;10(1):13-
8. 
3. Cliff-Eribo KO, Choonara I, Dodoo A, Darko DM, Sammons H. Adverse drug reactions 
in Ghanaian children: review of reports from 2000 to 2012 in VigiBase. Expert opinion 
on drug safety. 2015;14(12):1827-33. 
4. Elnour AA, Ahmed AD, Yousif MA, Shehab A. Awareness and reporting of adverse 
drug reactions among health care professionals in Sudan. Joint Commission journal on 
quality and patient safety. 2009;35(6):324-9. 
5. Fadare JO, Enwere OO, Afolabi AO, Chedi BAZ, Musa A. Knowledge, attitude and 
practice of adverse drug reaction reporting among health care workers in a tertiary  
center in Northern Nigeria. Trop J Pharm Res. 2011;10(3):235–42. 
6. Gurmesa LT, Dedefo MG. Factors affecting adverse drug reaction reporting of 
healthcare professionals and their knowledge, attitude, and practice towards ADR 
reporting in Nekemte town, West Ethiopia. Biomed Res Int. 2016;2016:5728462. 
7. Kabore L, Millet P, Fofana S, Berdai D, Adam C, Haramburu F. Pharmacovigilance 
systems in developing countries: An evaluative case study in Burkina Faso. Drug Saf. 
2013;36(5):349-58. 
8. Katusiime B, Semakula D, Lubinga SJ. Adverse drug reaction reporting among health 
care workers at Mulago National Referral and Teaching hospital in Uganda. Afr Health 
Sci. 2015;15(4):1308-17. 
9. Khoza S, Madungwe I, Nyambayo P, Mthethwa J, Chikuni O. Adverse drug reactions 
reporting at a referral hospital in Zimbabwe. Cent Afr J Med. 2004;50(11–12):104–7. 
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10. Kiguba R, Karamagi C, Waako P, Ndagije HB, Bird SM. Recognition and reporting of 
suspected adverse drug reactions by surveyed health care professionals in Uganda: key 
determinants. BMJ Open. 2014; 4(11). e005869. 
11. Kiguba R, Karamagi C, Waako P, Ndagije HB, Bird SM. Rare, serious and 
comprehensively described suspected adverse drug reactions reported by surveyed 
health care professionals in Uganda. Ann Glob Health. 2015; 81(1): 77.   
12. Kinuani L, Nzolo DB, Aloni MN, Makolo P, Ntamabyaliro N, Ntamba YL, et al. 
Assessment of attitudes towards adverse events following immunization with oral 
poliovirus vaccine: a pilot study among high school students of Kinshasa, the 
Democratic Republic of Congo. Pathog Glob Health. 2014; 108(6):292–7. 
13.  Obebi Cliff-Eribo K, Sammons H, Star K, Ralph Edwards I, Osakwe A, Choonara I. 
Adverse drug reactions in Nigerian children: a retrospective review of reports submitted 
to the Nigerian Pharmacovigilance Centre from 2005 to 2012. Paediatr Int Child Health. 
2016;36(4):300-4  
14. Ohaju-Obodo JO, Iribhogbe OI. Extent of pharmacovigilance among resident doctors 
in Edo and Lagos states of Nigeria. Pharmacoepidemiol Drug Saf. 2010;19(2):191–5. 
15. Okezie EO, Fawole OI. Adverse drug reactions reporting by physicians in Ibadan, 
Nigeria. Pharmacoepidemiology Drug Saf. 2008;17(5):517–22. 
16. Okonkwo PO, Egere JU, Ogbuokiri JE. Adverse drug reactions in a developing country: 
problems encountered in a surveillance programme in a Nigerian hospital. Cent Afr J 
Med. 1980;26(11):239–42. 
17. Ruud KW, Srinivas SC, Toverud E-L. Addressing gaps in pharmacovigilance practices 
in the antiretroviral therapy program in the Eastern Cape Province, South Africa. Res 
Social Adm Pharm. 2010;6(4):345–53. 
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18. Sabblah GT, Akweongo P, Darko D, Dodoo ANO, Sulley AM. Adverse drug reaction 
reporting by doctors in a developing country: a case study from Ghana. Ghana Med J. 
2014;48(4):189–93. 
Non-relevant outcome 
1. Anyika EN, Alade TB. Evaluation of pharmacists' participation in post-admission ward 
rounds in a tertiary hospital in South-West Nigeria. Nig Q J Hosp Med. 
2009;19(3):151–4. 
2. El-Shazly AN, Al-Azzouny MA, Soliman DR, Abed NT, Attia SS. Medical errors in 
neonatal intensive care unit at Benha University Hospital, Egypt. Eastern 
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C. S3 Appendix: Methodological quality assessment 
1. Methodological quality assessment for ADE studies 
Abbreviation: Y, yes; N, no; NR, not reported  
 Aderemi-
Williams 
2015 [30] 
Benkiran
e 2009 
[31] 
Benkira
ne 
2009 
[78] 
Cooke 
1985 
[32] 
Dedefo 
2016 
[79] 
Eshetie 
2015 [33] 
Jennane 
2011 
[80] 
Kiguba 
2017 
[34] 
Letaief 
2010 
[35] 
Mabadej
e 1979 
[35] 
Study design 
Was the study design clear (prospective, retrospective, 
combined)? 
Y Y Y Y Y Y Y Y Y Y 
Methods for identifying ADEs  
Were the methods used to identify ADEs described in 
sufficient detail?  
N Y Y N Y Y Y Y N Y 
Were data collection methods (case-record review, 
medication chart review and laboratory data) clearly 
described? 
Y Y Y NR Y Y Y Y Y Y 
Were the individuals (physicians, pharmacists, nurses) 
who identifies ADEs clearly described? 
N Y Y NR N Y Y Y Y N 
Methods for determining the causality 
Was the process of establishing the casual relationship 
described in detail? 
N Y N Unclear N Y N Y Y NR 
Were standard methods (validated tool) used in the 
assessment? 
N N Y Y N Y N Y Y NR 
Methods for determining preventability 
Was the assessment process of establishing preventability 
described in detail?  
NR N N NR Y Y N Y N NR 
Were standard methods (validated tool) used in the 
assessment? 
 Y N NR Y Y N Y Y NR 
Methods for determining severity  
Was the assessment process of establishing predictability 
described in detail?  
NR N Y NR Y Y Y Y N NR 
Were standard methods (validated tool) used in the 
assessment?    
NR Y Y NR Y Y Y Y Y NR 
Total    2 7 7 2 7 10 6 10 7 3 
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Methodological quality assessment for ADE studies (Cont’d) 
 
 
Abbreviation: Y, yes; N, no; NR, not reported  
 Matsaseng 
et al 2005 
[37] 
Mehta 
2008 [38] 
Mouton 
2015 
[39] 
 
Mouton 
2016 [40] 
Oshikoya 
2011 [42] 
Tipping 
2006 
[43]  
Tumwikirize 
2011 
[44] 
Oshikoya 
2007 [41]  
Study design      
Was the study design clear (prospective, retrospective, combined)? Y Y Y Y Y Y Y Y 
Methods for identifying ADEs       
Were the methods used to identify ADEs described in sufficient detail?  N N Y Y Y N Y Y 
Were data collection methods (case-record review, medication chart 
review and laboratory data) clearly described? 
Y Y Y Y Y N Y Y 
Were the individuals (physicians, pharmacists, nurses) who identifies 
ADEs clearly described? 
Y Y Y Y Y Y Y Y 
Methods for determining the causality      
Was the process of establishing the casual relationship described in detail? Y Y Y Y Y N N Y 
Were standard methods (validated tool) used in the assessment? Y Y Y Y Y Y Y Y 
Methods for determining preventability      
Was the assessment process of establishing preventability described in 
detail?  
NR Y Y Y Y NR N N 
Were standard methods (validated tool) used in the assessment? Y Y Y Y Y NR Y N 
Methods for determining severity       
Was the assessment process of establishing predictability described in 
detail? 
NR Y N Y Y NR N NR 
Were standard methods (validated tool) used in the assessment? Y Y N Y Y NR Y NR 
total 7 9 8 10 10 3 7 6 
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2. Methodological quality assessment: MEs 
 Agalu 
2011 
[45] 
Agalu  
2012 
[58] 
Ajemigbitse 
2016 [49] 
 
Ajemigbitse 
2013 [46] 
 
Ajemigbitse 
2013 [47] 
 
Ajemigbitse 
2014 [48] 
 
Alagha 
2011 
[50] 
 
Arulogun  
2011 
[51] 
 
Oshikoya 
2007 
[52] 
 
Sada 
2015 
[53] 
Yinusa 
 2004 
[54] 
Aims/objectives of the study clearly 
stated. 
Y Y Y Y Y Y Y  Y Y Y Y 
Definition of what constitutes a 
medication error. 
Y  N N Y N Y Y Y Unclear Y N 
Error categories specified. Y Y Y Y Y Y Y Y Y Y Y 
Error categories defined. Y N N Y N Y Y N N Y N 
Presence of a clearly defined 
denominator. 
Y Y Y Y N N Y Y Unclear N Unclear 
Data collection method described clearly. Y Y N Y Y Y Y Y Y Y N 
Setting in which study conducted 
described. 
Y Y Y Y Y Y Y Y Y Y Y 
Sampling and calculation of sample size 
described. 
N N N Y N N N Y N Y N 
Reliability measures N N N N N N N N N N N 
Measures in place to ensure that results 
are valid. 
N N Y N N N N N N N N 
Limitations of study listed. Y Y Y Y Y N Y N N Y N 
Mention of any assumptions made. N N N N N N N N N N N 
Ethical approval. Y Y Y Y Y Y N N N Y N 
Total 9 7 7 10 6 7 8 7 4 9 3 
Abbreviation: Y, yes; N, no; 
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Abbreviation: Y, yes; N, no 
Methodological quality assessment: MEs (Cont’d)  
 Yousif  
2011 
[55] 
Zeleke  
2014 
[56] 
Amucheazi 
2009 [61] 
Gordon  
2004 
[63] 
Gordon  
2006 
[64] 
 
Feleke  
2010 
[65] 
Feleke  
2015 
[66] 
Labuschagne 
2011 [67] 
Llewellyn 
2009 [68] 
 
Agu 2014 
[71] 
 
al Tehewy  
2016 [59] 
Aims/objectives of the study clearly stated. Y Y N Y Y Y N Y Y Y Y 
Definition of what constitutes a medication error. N  Y N N N Y Y N Y Y Y 
Error categories specified. Y Y Y Y Y Y Y Y Y N Y 
Error categories defined. N Y N N N Y Y N N N N 
Presence of a clearly defined denominator. Y N Y Unclear Unclear Y N Unclear Y Y Y 
Data collection method described clearly. Y Y N N N Y N Y Y Y Y 
Setting in which study conducted described. Y Y N Y Y Y Y Y Y Y Y 
Sampling and calculation of sample size described. N N N N N N Y N N N N 
Reliability measures N N N N N N Y N N N Y 
Measures in place to ensure that results are valid. N N N N N N N N N Y N 
Limitations of study listed. N Y N N Y N Y N N Y N 
Mention of any assumptions made. N N N N N N N N N N N 
Ethical approval. N Y N N Y N Y Y Y Y Y 
Total 5 8 2 3 5 7 8 5 7 8 8 
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Methodological quality assessment: MEs (Cont’d) 
 Benkirane 
2009  [78] 
Dedefo 
2016 [79] 
 Negash 
2013 [72] 
Jennane 
2011 [80] 
Kandil  
2012 
[73] 
Sabry  
2014 
[75] 
Sabry 
2009 
[76] 
Nwasor 
2014 [69] 
 
Oshikoya  
2013 
[70] 
 
Shehata  
2016 
[77] 
Aims/objectives of the study clearly stated. Y Y Y Y  Y Y Y Y Y Y 
Definition of what constitutes a medication error. Y Y Y Y N N N N Y N 
Error categories specified. N Y N N N N N Y Y Y 
Error categories defined. N Y Y N Y Y N N N N 
Presence of a clearly defined denominator. Y Y Unclear Y N Y N Unclear N Y 
Data collection method described clearly. Y Y N Y N Y N N Y Y 
Setting in which study conducted described. Y Y Y Y Y Y Y Y Y Y 
Sampling and calculation of sample size described. N N N N N N N N N N 
Reliability measures Y Y N Y N N N N N N 
Measures in place to ensure that results are valid. Y N N N N N Y N Y N 
Limitations of study listed. Y Y N N N Y Y N Y Y 
Mention of any assumptions made. N N N N N N N N N N 
Ethical approval. N Y Y Y N Y N N Y Y 
Total 8 7 5 7 3 7 4 3 8 7 
Abbreviation: Y, yes; N, no 
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Methodological quality assessment: MEs (Cont’d)  
 Acheampong 
2016 [57] 
Amponsah 
2016 [60] 
Blignaut 
2017 
[62] 
Ogunleye 
2016 
[74] 
 
Aims/objectives of the study clearly stated. Y N Y Y  
Definition of what constitutes a medication error. Y N N Y  
Error categories specified. Y N Y Y  
Error categories defined. Y N N N  
Presence of a clearly defined denominator. Y N N Y  
Data collection method described clearly. Y Y Y Y  
Setting in which study conducted described. Y N Y Y  
Sampling and calculation of sample size described. N N Unclear N  
Reliability measures Y N Y N  
Measures in place to ensure that results are valid. Y N Y N  
Limitations of study listed. Y N Y N  
Mention of any assumptions made. Y N N N  
Ethical approval. Y Y Y Y  
Total 12 2 8 7  
Abbreviation: Y, yes; N, no    
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D. S4 Appendix: Definition and assessment of ADEs and MEs 
1. Definition and assessment of ADEs 
Author, year Definition  and/or description of the 
incident 
A person/ team 
responsible for 
identification  
Further verification of ADEs Person responsible for causality, 
severity and preventability 
assessment 
Adverse drug events 
Aderemi-Williams 
2015 [30] 
NR NR NR NR 
Benkirane  2009 
[31] 
An injury resulting from medical 
interventions related to a drug 
(WHO definition)[26]    
Medical residents NR Causality, 2 experienced 
investigators 
Severity, NR 
Preventability, NR 
Benkirane 2009 
[78] 
Bates et al 1995 [25] ADE definition 
(ADRs and complications from 
MEs)   
      
Pharmacists 
investigators 
 Two reviewers of the 
pharmacovigilance centre staffs 
evaluated causality and severity  
Preventability: NR  
Cooke  1985 [32] Any undesired or unintended effect 
of  drugs  
NR NR NR 
Eshetie 2015 [33] Any incident resulting in injury from 
any stage of the medication use 
process (ordering, transcribing, 
dispensing, administrating and 
monitoring) 
Multidisciplinary Pediatrics team  Causality: clinical pharmacist 
Severity and preventability: two 
senior pediatric residents  
 
Dedefo 2016 [79]   An ADE refers to all ADRs, 
including allergic or idiosyncratic 
reactions, as well as MEs that result 
in harm to a patient 
Pharmacist researcher NR Severity and preventability: one 
pediatrician and one clinical 
pharmacist   
 
Jennane  2011 [80] Any injury resulting from medical 
interventions related to a drug  
  
A pharmacist and a 
physician 
NR Causality, NR 
Severity: Physician reviewers 
rated the severity of ADEs 
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Preventability, NR 
Kiguba 2017       
[34] 
WHO definition of ADR [85]  A medical doctor, 
pharmacist and 
degree nurse 
Study physicians ( 
gynecologist/obstetrician, 
internist) and research 
pharmacist (senior clinical 
pharmacist) 
Consensus agreement on ADR 
causality, prevent- 
ability, severity and seriousness 
was reached in a commit- 
tee headed by the ward-based 
study physician and senior 
clinical pharmacist 
Letaief  2010 [35] Injury related to medical 
management in contrast to 
complications of the disease 
Medical student 2 expert physicians NR 
Mabadeje  1979 
[36] 
NR NR NR NR 
Matsaseng   2005 
[37] 
An injury that was  caused by 
medical management (rather than 
the underlying disease)  
Researcher  Supervising specialist NR 
Mehta  2008 [38] WHO definition of ADR [89]  Clinical 
pharmacology team 
Clinical pharmacist, 4 
clinical pharmacology 
registrars and a hospital 
pharmacist 
2 clinical pharmacology 
consultants   assess cases for 
causality, severity and 
preventability 
Mouton  2015 [39]  ADR according to the definition of 
Aronson and Fernera 
Clinical 
pharmacologist 
Clinical pharmacologist,  
clinical pharmacist, at least 1 
physician/internist 
A multidisciplinary review panel 
assessed ADRs for causality and 
preventability 
Mouton 2016 [40] ADR according to the definition of 
Aronson and Fernera 
One medical doctor 
and 2 pharmacists 
Multidisciplinary panel 
discussion 
A multidisciplinary case review 
panel assessed ADRs for 
causality, preventability, and 
severity 
Oshikoya 2007 
[41] 
WHO definition of ADR [26] 
 
Clinical 
pharmacologist, 
pediatrician, 
pharmacist 
Pharmacists, 
pharmacologist, pediatric 
dermatologist 
NR 
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   NR, Not reported 
aAronson JK, Ferner RE. Clarification of terminology in drug safety. Drug Saf 2005; 28:851-70. 
 
 
Oshikoya  
2011 [42] 
WHO definition of ADR [26] 
  
A pediatric 
clinical 
pharmacologist, 
pediatricians, 2 
hospital pharmacists 
NR The pediatric clinical 
pharmacologist and one of the 
two pharmacists assess the 
suspected ADRs for causality, 
severity and preventability 
independently 
Tipping  2006 [43] ADEs, as defined by the South 
African Medicines Formulary 
Primary physician 
and/or the principal 
investigator 
NR NR 
Tumwikirize 
2011[44] 
WHO definition of ADR [89]  A physician and 
a pharmacist 
NR NR 
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2. Definition and assessment of MEs 
Author, year Definition  and/or description of the incident Person/team assessing the clinical 
significance 
Prescribing errors 
Agalu  2011 [45] Prescribing error implies deviation of medication 
prescribing from standard practices excluding dosage 
form errors, illegible hand writing, and failure to 
authenticate the prescription with signature and/or date 
NR 
Ajemigbitse 2016 
[49] 
NR NR 
Ajemigbitse  2013 [46] 
 
Any deviation from a complete, accurate and legible 
prescription, as it pertains to errors on the prescription 
and not the prescribing decision or dispensed medicines 
3 clinical pharmacists 
Ajemigbitse  2014 [48] NR NR 
Ajemigbitse 2013 [47] A prescribing decision or prescription writing process 
that results in an unintentional, significant reduction in 
the probability of treatment being timely and 
effective or increases the risk of harm when compared 
with generally accepted practice 
NR 
Alagha 2011 [50] An error that occurs at the stage of prescribing excluding 
date of order and signature of the prescriber 
A clinical pharmacist 
and a consultant pediatrician 
Arulogun 2011 [51] 
 
Prescriptions were evaluated for legality (name of 
patient, date, prescription number, signature) and for 
other types of error such as dose, duration, illegible 
writing 
NR 
Oshikoya  2007 [52]  NR NR 
Sada  2015 [53] Prescribing error: deviation of medication prescribing 
from standard practices (as indicated in standard 
The principal investigator and 1 
internist  
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treatment guidelines, textbooks, and software) excluding, 
indication without drug, dosage form errors, illegible 
hand writing, and failure to authenticate the prescription 
with signature and/or date. 
Yinusa 2004 [54] All prescription items which did not conform to the 
criteria for prescription writing as stated in the British 
National formulary 
NR 
Yousif 2011 [55] Neville et al [97] definition of prescribing errors NR 
Zeleke 2014 [56] Deviation of medication prescribing from standard 
practices and includes inappropriate (incorrect) drug 
selection, wrong dose, wrong frequency, wrong route and 
wrong dosage form 
NR 
Medication administration errors  
Acheampong 2016 [57]  An administration error is said to be occurred when what 
was administered is different from what had been 
prescribed. 
2 clinical pharmacists 
Agalu 2012 [58] Deviation from the conventional method of 
administration of a particular drug as ordered by the 
prescribing physician 
NR  
al Tehewy  2016 [59] A deviation from a prescriber's valid prescription or the 
hospital's policy in relation to drug administration, 
including failure to correctly document the 
administration of a medication. 
NR 
Amponsah 2016 [60]  NR Self-report 
Amucheazi 2009  [61] NR NR 
Blignaut 2017 [62] NR NR 
Gordon  2004  [63] Wrong drug administrations or  the right drug into the 
wrong site 
Self-report 
Gordon 2006 [64] Wrong drug administrations Self-report 
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Feleke  2010 [65] A medication error that occurs while administering a 
medication to a patient including unauthorized use of 
medicines 
NR 
Feleke 2015 [66] Medication administration error: A medication error 
(time, dose, missed drug, unauthorized, route, technique, 
and documentation errors) that occurs while the time of 
administering IV, IM, SC, and PO medication to the 
patient by the nurse 
NR 
Labuschagne 2011  [67] NR Self-report 
Llewellyn 2009  [68] NR Self-report 
Nwasor 2014 [69] NR Self-report 
Oshikoya 2013 [70] Wrong medicine dose measurement, administration of 
wrong medicines, wrong patient, wrong route of 
administration, wrong timing and speed of 
administration, and omission of medications 
NR 
Medication errors (Mixed) 
Agu  2014 [71] NR NR 
Dedefo  2016 [79] NR NR 
Benkirane 2009 [78] Adopted from NCCMERP [24] 2 reviewers of the 
pharmacovigilance center  
Negash 2013 [72] Adopted from ASHPb NR 
Jennane 2011[80] Adopted from NCCMERP [24]  2 physician evaluators  
Kandil 2012 [73] Administration error: a medication error that occurred 
while administering a medication to a patient including 
unauthorized error,  
Prescription error: a failure in the prescription writing 
process that resulted in a wrong instruction 
NR 
  Ogunleye 2016 [74] Any error in prescribing, dispensing, or administration of 
drugs, irrespective of whether such errors lead to adverse 
consequences or not 
NR 
Sabry 2014 [75] Prescribing errors, adopted from Anderson 2003; NR 
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NR, not reported 
b ASHP guidelines on preventing medication errors in hospitals. Am J Hosp Pharm 1993; 50:305-14. 
 
 
 
 
 
 
 
 
 Administration errors, any deviation from the physician’s 
medication order as written on the patient’s chart  
including timing problems, missing doses as observed 
from the administration sheet and after confirming with 
the nurse, an extra dose as observed from the quantities 
of unit doses remaining in the patient’s tray, or wrong 
infusion flow rate 
Sabry 2009  [76] Any problems connected with medications prescribed to 
the enrolled patients 
NR 
Shehata 2016 [77] Adopted from NCCMERP [24] NR 
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A2.5 Electronic Supplementary Materials Published Online for Chapter 7 
A. Additional file 1. Comparison of mean composite scores across type of hospital, staff position and work experience 
Composites Type of hospital,  
   Mean (SD) 
Staff position, Mean (SD)  Work experience, Mean (SD) 
 District Teaching 
/referral 
P 
value 
Nurse Physician Pharmacis
t 
Others P 
Value 
< 1 year 1-5 year > 5 year P value 
Teamwork within units 3.71(0.68) 3.62(0.79) 0.18 3.73(0.68) 3.65(0.71) 3.54(0.78) 3.64(0.85) 0.35 3.67(0.69) 3.71(0.76) 3.44(0.82) 0.07 
Supervisor/manager expectations and 
actions promoting patient safety 
3.08(0.46) 3.13(0.50) 0.35 3.14(0.48) 3.12(0.52) 3.03(0.44) 3.11(0.47) 0.47 3.13(0.47) 3.08(0.50) 3.14(0.48) 0.55 
Organizational learning–continuous 
improvement 
3.82(0.70) 3.66(0.75) 0.02 3.86(0.68) 3.57(0.74) 3.57(0.74) 3.78(0.78) 0.004 3.78(0.71) 3.76(0.75) 3.49(0.73) 0.04 
Management support for patient safety 3.12(0.87) 3.06(0.88) 0.47 3.22(0.76) 2.72(0.96) 3.14(0.89) 3.13(0.90) 0.000 3.06(0.93) 3.13(0.82) 3.00(0.90) 0.53 
Feedback and communication about 
error 
3.41(0.88) 3.24(0.92) 0.06 3.39(0.89) 3.20(0.97) 3.26(0.89) 3.33(0.89) 0.44 3.23(0.89) 3.34(0.93) 3.45(0.87) 0.27 
Frequency of events reported 3.05(0.99) 2.95(0.99) 0.33 3.00(0.96) 2.90(1.04) 2.90(0.90) 3.15(1.03) 0.30 3.00(1.02) 3.04(0.95) 2.84(1.02) 0.44 
Overall perception of patient safety 3.01(0.49) 3.03(0.58) 0.67 2.96(0.55) 3.05(0.49) 3.01 (0.59) 3.09(0.53) 0.32 3.03(0.54) 2.99(0.54) 3.09(0.58) 0.50 
Communication openness 3.24(0.82) 3.02(0.86) 0.01 3.24(0.82) 3.01(0.97) 2.98(0.74) 3.12(0.84) 0.11 3.11(0.87) 3.14(0.84) 3.03(0.84) 0.69 
Teamwork across units 3.45(0.70) 3.29(0.72) 0.02 3.45(0.71) 3.16(0.76) 3.29(0.69) 3.43(0.66) 0.14 3.32(0.70) 3.39(0.73) 3.40(0.70) 0.59 
Staffing 2.42(0.76) 2.54(0.70) 0.11 2.54(0.71) 2.52(0.78) 2.56(0.70) 2.32(0.71) 0.09 2.42(0.71) 2.51(0.73) 2.59(0.75) 0.28 
Handoffs and transitions 2.88(0.77) 2.81(0.76) 0.40 2.86(0.76) 2.76(0.75) 2.89(0.74) 2.85(0.80) 0.73 2.92(0.74) 2.78(0.78) 2.85(0.76) 0.22 
Non-punitive response to error 2.89(0.79) 2.94(0.76) 0.52 2.83(0.75) 2.90(0.74) 2.99(0.80) 3.02(0.81) 0.20 2.95(0.77) 2.86(0.79) 3.01(0.72) 0.28 
Overall score 3.19(0.32) 3.12(0.39) 0.08 3.20(0.35) 3.07(0.42) 3.10(0.35) 3.18(0.31) 0.03 3.16(0.38) 3.15(0.34) 3.12(0.37) 0.82 
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B. Additional file 2. Factor loadings in each item 
  
Items 1 2 3 4 5 6 7 8 9 10  11 
A4. In this unit, people treat each other with respect 0.75           
A6. We are actively doing things to improve patient 
safety  
0.70           
A1. People support one another in this unit 0.66           
A3.When a lot of work needs to be done quickly, 
we work together as a team to get the work done 
0.65           
A12. After we make changes to improve patient 
safety, we evaluate their  effectiveness 
0.50           
A17. Our procedures and systems are good at 
preventing errors from happening 
0.44           
F8. The actions of hospital management show that 
patient safety is a top priority   
 0.75          
F1. Hospital management provides a work climate 
that promotes patient safety 
 0.70          
F10. Hospital units work well together to provide 
the best care for patients 
 0.67          
F4. There is good cooperation among hospital units 
that need to work together   
 0.60          
C2. Staff will freely speak up if they see something 
that may negatively affect patient care 
  0.72         
C5. In this unit, we discuss ways to prevent errors 
from happening again   
  0.64         
C3. We are informed about errors that happen in 
this unit    
  0.62         
C1. We are given feedback about changes put into 
place based on event reports   
  0.62         
C4. Staff feel free to question the decisions or 
actions of those with more authority   
  0.54         
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B2.My supervisor/manager seriously considers 
staff suggestions for improving patient safety 
   0.72        
B1.My supervisor/manager says a good word when 
he/she sees a job done according to established 
patient safety procedures 
   0.72        
B4. My supervisor/manager overlooks patient 
safety problems that happen over and over 
   -0.65        
B3.Whenever pressure builds up, my 
supervisor/manager wants us to work faster, even if 
it means taking shortcuts 
   -0.58        
F5. Important patient care information is often lost 
during shift changes 
    0.70       
F7. Problems often occur in the exchange of 
information across hospital units  
    0.66       
F9. Hospital management seems interested in 
patient safety only after an adverse event happens 
    0.62       
F11. Shift changes are problematic for patients in 
this hospital 
     0.60       
F6. It is often unpleasant to work with staff from 
other hospital units 
    0.49       
D2. When a mistake is made, but has no potential 
to harm the patient, how often is this reported? 
     0.79      
D3. When a mistake is made that could harm the 
patient, but does not, how often is this reported? 
     0.74      
D1. When a mistake is made, but is caught and 
corrected before affecting the patient, how often is 
this reported? 
     0.70      
A11. When an event is reported, it feels like the 
person is being written up, not the problem 
      0.73     
A9. It is just by chance that more serious mistakes 
don’t happen around here 
       0.55     
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A15. Staff worry that mistakes they make are kept 
in their personnel file 
      0.46     
F3. Things “fall between the cracks” when 
transferring patients from one unit to another   
       0.64    
F2. Hospital units do not coordinate well with each 
other  
       0.59    
A2. We have enough staff to handle the workload         0.72   
A14. Patient safety is never sacrificed to get more 
work done 
         0.67  
A16. We have patient safety problems in this unit            0.50  
C6. Staff are afraid to ask questions when 
something does not seem right 
           0.65 
A5. Staff in this unit work longer hours than is best 
for patient care  
-0.43           0.55 
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Appendix 3. Ethical Approvals 
A3.1 Ethics Approval - The University of Sydney 
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A3.2 Ethics Approval – The University of Gondar, Ethiopia 
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A3.3 Statutory Declarations 
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Appendix 4. Survey Instruments 
A4.1Participant Information Statement – Hospital Survey 
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A4.2 Questionnaire 
 
 
 Appendices                                                                                                                                            354 | P a g e  
 
 
 
 
 
 
 Appendices                                                                                                                                            355 | P a g e  
 
 
 
 
 
 
 Appendices                                                                                                                                            356 | P a g e  
 
 
 
 
 
 
 
 Appendices                                                                                                                                            357 | P a g e  
 
 
 
 
 Appendices                                                                                                                                            358 | P a g e  
 
 
 
 
 Appendices                                                                                                                                            359 | P a g e  
 
Appendix 5. Qualitative Study Documents 
A5.1 Letter of Invitation 
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 A5.2 Participant Information Statement – English Version 
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 A5.3 Participant Information Statement – Amharic Version 
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 A5.4 Consent Form – English Version 
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 A5.5 Consent Form – Amharic Version 
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 A5.6 Interview Guide Questions – English Version 
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 A5.7 Interview Guide Questions – Amharic Version 
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Appendix 6. Prospective Study Documents 
A6.1 Participant Information Statement – English Version 
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 A6.2 Participant Information Statement – Amharic Version 
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 A6.3 Consent Form – English Version 
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 A6.4 Consent form – Amharic Version 
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 A6.5 Data Collection Tool 
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 Appendix 7.  Safety Protocol 
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Appendix 8.  Coding Guide: Description of 12 Theoretical Domains from TDF 
 
Domain label Description of domain content  
Knowledge Knowledge of the field (i.e. whether there is adequate evidence) 
and individuals’ knowledge of the evidence or of a guideline. 
Skills Covers the possibility that new skills would be required by the 
staff who are required to implement a new procedure. 
Social/professional role 
and identity 
The clinical thinking and norms of a particular profession. 
 
Beliefs about 
capabilities 
How confident clinicians are that they could change their practice 
effectively 
Beliefs about 
consequences 
Often regarded as core to clinical reasoning, this domain covers 
the perceived benefits and harms of a clinical action. In some 
contexts it can also include consequences for the clinician such as 
workload, pay, career progression, or for the hospital or health 
service. 
Motivation and goals The relative priority that is given to one clinical issue, compared 
with other demands. 
Memory, attention and 
decision processes 
The level of attention that is needed to perform the key clinical 
action (i.e. is forgetting likely to be a problem) and the processes 
by which clinical decisions are made by individuals and teams. 
Environmental context 
and resources 
Includes the physical (including financial) issues that may limit 
change, including staffing levels and time as well as equipment or 
space. 
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Social influences The influence of other individuals or groups on clinical practice, 
for example, patients, patients’ families, pressure groups. 
Emotion Includes issues such as work stress, patient anxiety and other 
emotional factors that may help or hinder the uptake of new 
approaches to care. 
Behavioural regulation Includes the ‘how’ of changing clinical practice: what are the 
practical strategies that would facilitate or hinder uptake of a new 
practice. 
Nature of the 
behaviours 
Some new practices are very similar to current practice and so are 
easier to implement than new practices that require a dramatic 
change in ways of working. 
Source: Cuthbertson et al 2013. 
 
 
